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Abstract
Encoded Hydrogel Microparticles for High-throughput
Molecular Diagnostics and Personalized Medicine
by
Stephen Clifford Chapin
Submitted to the Department of Chemical Engineering on May 7th, 2012,
in partial fulfillment of the requirements for the degree of
Doctor of Philosophy in Chemical Engineering
The ability to accurately detect and quantify biological molecules in complex mixtures is
crucial in basic research as well as in clinical settings. Advancements in genetic analysis,
molecular diagnostics, and patient-tailored medicine require robust detection technologies
that can obtain high-density information from a range of physiological samples in a rapid
and cost-effective manner. Compared to conventional microarrays and methods based on
polymerase chain reaction (PCR), suspension (particle-based) arrays offer several
advantages in the multiplexed detection of biomolecules, including higher rates of sample
processing, reduced consumption of sample and reagent, and rapid probe-set modification
for customizable assays. This thesis expands the utility of a novel hydrogel-based
microparticle array through (1) the creation of a microfluidic, flow-through fluorescence
scanner for high-throughput particle analysis, (2) the development of a suite of techniques
for the highly sensitive and specific detection of microRNA (miRNA) biomarkers, and (3)
the investigation of new methods for directly measuring biomolecules at the single-cell
level.
Graphically-encoded hydrogel microparticles synthesized
from non-fouling, bioinert poly(ethylene glycol) (PEG) and
functionalized with biomolecule probes offer great promise in
the development of high-performance, multiplexed bioassays.
To extend this platform to applications in high-throughput
analysis, particle design was optimized to ensure mechanical
stability in high-velocity flow systems, and a single-color
microfluidic scanner was constructed for the rapid fluorescence interrogation of each
particle's spatially-segregated "code" and "probe" regions.
The detection advantages of three-dimensional, probe-laden hydrogel scaffolds and the
operational efficiencies of suspension array technology were then leveraged for the rapid
multiplexed expression profiling of miRNA. The graphical encoding method and ligation-
based labeling scheme implemented here allowed for scalable multiplexing with a simple
workflow and an unprecedented combination of sensitivity, flexibility, and throughput.
Through the rolling circle amplification of a labeling oligonucleotide, it was possible to
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further enhance the system's sensitivity and resolve single-molecule miRNA binding events
on particle surfaces, enabling the first direct detection of low-abundance miRNA in human
serum without the need for RNA extraction or target amplification. Finally, by arraying
cells and gel particles in polydimethylsiloxane (PDMS) microwells, it was possible to
dramatically improve the particles' target capture efficiency and thereby move closer to a
regime in which miRNAs and other biological molecules may be directly detected without
target amplification from single cells.
Thesis Supervisor: Patrick S. Doyle
Title: Professor of Chemical Engineering
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NaCl, 2% SDS, and 200 ug/mL PK without target............................................................................... 120
Figure 6.3: Images of probe regions of miR-141 and cel-miR-39 particles following assay in
lysis buffer containing 2% SDS, 200 pg/mL PK, 1 amol miR-141, and 0 amol cel-miR-39. The
lowest background and cleanest particles were obtained when using 1 uL of biotinylated
dNTP master mix and a 30% 6M urea/70% R50 treatment following RCA. Volume of bio-
dNTP represents amount of master mix added to reaction tube prior to RCA. Images in
yellow boxes were taken from assays with incubation buffers that did not contain SDS or PK
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Figure 6.4: Workflow of well loading for confinement assay. PDMS well height was dictated
by the feature height on the corresponding master wafer. After depositing a wetting liquid
and allowing the wells to fill, particles (and cells if desired) were deposited in a TET-based
buffer without SDS or PK For calibration experiments, synthetic targets were diluted in
lysis buffer and manually mixed into the deposited droplet with a pipette to ensure even
dispersion. For cell experiments, pure lysis buffer was mixed into the droplet. In both cases,
wells were immediately sealed with a cover slide following manual mixing to prevent mass
transport between microwells. Pipette and hybridiza tion chamber images adapted from [235]
an d [236], resp ectively ............................................................................................................................ 124
Figure 6.5: Results of well-sealing test. (A) Brightfield image of gel particle (outlined in
yellow) in 300 x 100 x 113 pm well after incubation at 55"C for 90 min but before cover glass
had been removed. Particle was irradiated with UVlight for 5 min. (B) Fluorescent image of
gel particle 15 min after UV irradiation. The cleaved Cy3 groups have diffused away from
their particle source but seem to have been retained within the bounds of the PDMS well,
indicating that wells have indeed been effectively sealed. It should be noted that the cleaving
wavelength was sufficiently different from the fluorescence excitation wavelength to avoid
photobleaching. Scale bars are 100 pim .................................................................................................. 125
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Figure 6.6: Magnetic particle scheme for well-based assays. (A) Depiction of 4-probe magnetic
particle (250 X 70 X 30 pm) in PDMS microwell. Each probe region was embedded with a
DNA probe bearing a miRNA -specific region (blue) and a universal adapter region (red). (B)
Fluorescence images of magnetic particles incubated with 500 amol of the indicated RNA
target in a 50-pL reaction volume. Scale bar in B is 30 pm.................................................................. 126
Figure 6.7: Detection of synthetic RNA targets with magnetically functionalized gel particles
(250 x 70 x 30 pm) and the confinement assay. (A) Image of 4-probe magnetic particles after
well loading with hand magnet. (B) Fluorescence image of particle incubated within well
with the indicated target amounts and then labeled using the non-amplified scheme. (C)
Fluorescence image of particle incubated within well with the indicated target amounts and
then labeled using the bio -dNTP RCA scheme. (D) Fluorescence image and width -averaged
intensity profiles for six particles incubated in six separate wells with 500 zmol miR -221 and
250 zmol miR-141. Dotted black curve represents mean profile. All experiments in this figure
performed with type 2b wells and target capture incubations of 90 min at 550C in lysis buffer
containing 2% SDS, 10% BSA, and 200 pg/mL PK Scale bars in A, B, C, and D are 100, 30, 30,
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Figure 6.8: Confinement assay with HeLa cells. (A) Image of deposition droplet containing
HeLa cells and eight encoded gel particles (250 x 70 x 30 pm) bearing probe for miR-21. Cell
density within wells can be tuned by adjusting the concentration of cells in deposition buffer.
(B) Enlarged view of three particles co-localized with several HeLa cells within type 2b
PDMS wells prior to the introduction of lysis buffer. (C) Gel particle after target incubation
and removal of glass-PDMS-glass construct from hybridization chamber. Note that the
particle has slightly contracted due to high incubation temperature (550C) and that cells have
been fully lysed. Scale bars (in yellow) in A, B, and C are 300, 150, and 100,pm, respectively........ 128
Figure 6.9: Width-averaged fluorescence profiles of probe region of miR-21 particles in
confinement assay. Solid curves represent particles incubated within a type 2b well with the
indicated range of HeLa cells and lysis buffer. Dotted curves represent control particles
incubated without cells in 50 pL of the same lysis buffer and at the same temperature.
Yellow box over the image represents the area of analysis depicted in plots. Cell ranges
rather than absolute numbers are provided for well occupancy due to the inability to
correlate each analyzed particle's identity with original well condition. Each quoted range
reflects the minimum and maximum number of cells in particle -occupied wells in a specific
trial prior to well sealing. Particle width in image is 70 pm. ............................................................... 129
Figure 6.10: Gel encapsulation of HeLa cells. (A) Image of the cavity left by a single cell
within the gel particle after the lysis procedure. (B) Fluorescence image of the area
surrounding a cavity after cell lysis and ligation labeling of lysis products. In this case, the
PEG-DA gel is incorporated with DNA probe for let-7a. (C) Encoded gel particle with an
encapsulated cell that was lysed and produced a spread of fluorescently-labeled material that
was abruptly retarded by the particle's less porous 35% PEG -DA region. (D) Example of the
the tendency for cells to lyse and spill fluorescently -labeled material towards the interior of
the gel particle. Fluorescent signal on the left side of the particle is from Rh -Ac incorporated
during synthesis to serve as an orientation marker. Scale bars in A, C, and D are 50 pm;
scale bar in B is 2 0 p m . ........................................................................................................................... 131
Figure 7.1: Fluorescence images of particles exposed to different amounts of synthetic miR-
145 target, labeled with SA -HRP, and exposed to Amplex UltraRed substrate. Fluorescence
intensity was seen to rise in the surrounding solution and within the hydrogel as target level
was increased. It is important to note that the low porosity regions of the particle (code and
inert) seem to capture the fluorescent enzymatic product more readily than the probe region,
suggesting that chemical composition of the particle can be tuned to localize the reporter
molecule in future iterations of this assay. Scale bar is 50 pm. ........................................................... 138
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Chapter 1
In troduction
The work presented in this thesis focuses on the development of a hydrogel-based
microparticle array for the multiplexed detection of biological molecules in both clinical and
research settings. There is a strong need for flexible biomolecule analysis platforms that
can rapidly and precisely quantify low levels of multiple target molecules in a range of
biological media for applications in diagnostics and personalized medicine. These systems
have the potential to transform existing disease treatment models by enabling researchers
to better understand the molecular basis of disease and thereby develop safer, more
effective therapeutic interventions. This chapter outlines (1) the existing strategies
employed for multiplexed biomolecule detection, (2) the emerging clinical significance of
micro-ribonucleic acid (miRNA) profiling, and (3) the microfluidic advances that have
enabled the creation of graphically-encoded hydrogel microparticle arrays.
1.1 Multiplexed Biomolecule Analysis
The accurate detection and quantification of specific biological molecules in a complex
mixture is crucial in both basic research and clinical settings. The advancement of the
emerging fields of personalized genomics and proteomics requires robust technologies that
can obtain high-density information from biological samples in a rapid and cost-effective
manner [1-6]. High-throughput screening for genetic analysis and clinical diagnostics
benefits greatly from multiplexed analysis, which is the simultaneous detection of several
different analytes ("targets") in a single test [7, 8]. While this approach significantly
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reduces the required assay time, sample volume, and cost, it also introduces the need for an
encoding scheme that can be used to identify the multiple types of capture ("probe")
molecules employed in the assay. Through such identification, the encoding scheme enables
the reporting signal from a given probe to be correlated to the expression level of the
appropriate target molecule during post-assay data analysis.
1.1.1 Planar Arrays
High-throughput multiplexed biological assays emerged in the late 1980s with the
introduction of high-density oligonucleotide microchips (planar arrays) created using
technologies adapted from the semiconductor industry [7, 9]. To profile multiple
deoxyribonucleic acid (DNA) targets in a single assay, these arrays relied on a positional
encoding scheme in which each probe molecule type was attached to a distinct site on the
array using precise photolithographic techniques or robotic spotting. In a typical workflow,
after a sample was incubated with the chip and pre-labeled target had bound to the probe
molecules, laser confocal fluorescence scanning would be employed to interrogate the
molecular binding events at specific sites of the array to provide data on the abundance of
hundreds to thousands of different targets of interest. Within the nucleic acid research
community, this planar array format quickly replaced conventional assay systems such as
enzyme assays and DNA reverse dot blots. The older methods required repetitive manual
labor and large amounts of reagents, while the chip-based platform's miniature scale (106
synthesis sites/cm2) and ease of automation enabled cheaper, more rapid analysis.
During the mid-1990s, the explosion in genomic research led to the widespread use of the
chip platform in large-scale DNA sequence analysis. As a result, the format has been
thoroughly studied and many steps have been taken to optimize the duplex formation of
oligonucleotides on solid microchips as a means to increase the efficiency and accuracy of
sequencing by hybridization (SBH), gene expression analysis, and mutant diagnostics [10,
11]. By varying probe design, immobilization chemistry, and hybridization conditions,
researchers sought to minimize the amount of input sample required for reliable target
detection (high sensitivity) and to minimize the capture of unintended targets by
immobilized probes (high specificity). In addition to fluorescent reporting schemes,
nanomechanical [12], surface plasmon resonance (SPR) [13], and colorimetric [14]
strategies have been employed for target quantification on microarrays for a range of
applications (Figure 1.1). Through the attachment of antibody probes and other binding
motifs such as DNA and RNA aptamers, the platform has also been successfully adapted for
numerous applications in protein profiling and screening [15-17].
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Figure 1.1: Examples of planar array formats used for biomolecule detection. The DNA
microarray with fluorescence readout is the most common implementation [18]. A
range of other formats have also been developed, including arrays with hydrogel-based
detection pads [191 and ultrasensitive arrays that can detect single-molecule binding
events with nanomechanical measurements [121.
The most significant factor in determining the sensitivity and specificity of a detection
system is the dissociation constant (Kd) of the target-probe complex, which is dictated by the
nature of the molecules that form the complex as well as the local environment in which the
binding takes place. The dissociation constant for a system with target T, probe P, and
target-probe complex TP is the ratio of their concentrations at equilibrium:
K = Equation 2.1
[TP]
It is well known that biomolecule probes immobilized on solid surfaces such as those used
in conventional microarrays exhibit less favorable (higher) dissociation constants than
probes that are allowed to bind to targets in solution. This is primarily due to the additional
energy cost incurred for the transfer of target molecules into the dense probe "forests" that
are formed on the solid surface. To improve binding affinity researchers have tested a
variety of different "spacer" sequences for probe immobilization and have also developed
locked nucleic acid (LNA) probes, which are modified oligonucleotides containing a bridge
between the 2' oxygen and the 4' carbon that is designed to augment target-probe complex
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stability [20]. In a more radical departure the Mirzabekov group introduced hydrogel-based
immobilized microarrays of gel elements (IMAGE) [10, 21-23]. These modified arrays
achieved higher sensitivity and specificity than solid microarrays by using hydrated, three-
dimensional gel pads to increase probe loading capacity and provide a more solution-like
(and thus more thermodynamically-favorable) environment for target capture (Figure 1.2).
Gel Glass
C
Figure 1.2: Comparison of gel-based and
glass-based microarrays for the detection of
protein and DNA targets [24, 25].
While the microarray platform and its variants have proven useful for large-scale screening
and ultra-high-density discovery applications, their limitations have become apparent as
researchers and clinicians push towards an era of cost-effective diagnostic and therapeutic
practice tailored to the genetic signatures of individual patients. The high degree of
multiplexing capacity available on a microarray is not always necessary, particularly when
interrogating small, focused target panels for medical applications. The long incubation
times (12-24 h) required for highly sensitive results on microarrays can also be difficult to
integrate into workflows designed to process hundreds of samples per day. Furthermore,
the complexity of array fabrication and the high cost associated with deploying the platform
can often prevent its adoption in low-resource research and clinical environments.
1.1.2 Particle Arrays
Suspension (particle-based) arrays have been developed in recent years as an alternative to
planar arrays for situations in which a modest number of targets (<1000) need to be
detected over large populations of patients or for applications in which rapid probe-set
modification is required [26]. The use of micrometer-sized particles for detection has many
advantages over planar microarrays, including the ability to use smaller sample volumes,
24
faster probe-target binding kinetics due to mixing during incubation, and more efficient
separation and washing steps. Microparticles can be quickly and inexpensively produced in
large numbers and with high reproducibility to limit batch-to-batch variations in assay
performance. Suspension arrays can use optical (spectrometric) [27, 28], chemical [29],
graphical [30-35], radio frequency [36], shape [37-39], or physical [26] encoding schemes to
carry out multiplexed analysis, and additional targets can be detected in a sample simply
by adding microparticles bearing an appropriate code and probe molecules to the
hybridization mixture (Figure 1.3). The incorporation of the same probe on many different
microparticles in a single assay allows for thorough statistical scrutiny and ultimately
provides high quality results. In contrast, the complex, often slow fabrication of planar
arrays results in a lower degree of reproducibility and prevents the rapid design of new sets
of probes for additional assays.
Spectrometric Encoding
Han et al., 2001
Luminex and Millipore Lee et al., 2010
Chemical Encoding Fenniri et al., 2003
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Vaino et a., 2000
Figure 1.3: Examples of encoding techniques for the multiplexed measurement of
biomolecules on particle-based arrays. The methods shown here include spectrometric [28,
40-42, graphical [31-35], chemical [29], radio frequency [36], and shape [37-39] encoding.
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1.1.2.1 Fundamental Principles and Current Systems
For applications involving a low to medium density of targets (1-1000) and requiring high-
throughput processing of samples, particle-based arrays offer many advantages over the
more conventional planar arrays. This range of multiplexing is commonly required in
clinical diagnostics and drug discovery, and over the last decade, several particle-based
assays have been developed to detect and quantify soluble analytes in biological fluids [8,
27, 43-48]. The ideal particle is made of a low-density material that can be maintained in
suspension without rapid settling so as to promote efficient interaction with soluble
analytes. Furthermore, the ideal particle is small enough that a large collection of particles
does not occupy more than one percent of the working volume during hybridization.
However, it must be sufficiently dense and large to facilitate easy washing and separation
by simple methods like centrifugal precipitation and filtration. Magnetic separation
methods have also been employed [49]. The particle must be significantly larger than the
reporter/probe molecules used in the assay to ensure sufficient loading of the particle for
signal generation. In addition, the perfect microcarrier for the array would be able to be
inexpensively and reproducibly manufactured in large batches using common reagents and
materials.
The vast majority of particles used in suspension arrays are optically encoded latex
microspheres with diameters between 0.3 and 10 pim that can be interrogated and decoded
with laser-based flow cytometry [27, 50, 51]. Optical encoding is accomplished by swelling
(or "doping") the latex spheres with fluorescent organic dyes with different emission
spectra. It should be noted that there are several limitations to the number of distinct codes
that can be achieved using this strategy. First and foremost, the dyes must be compatible
with the solvents used in the swelling procedure and must be incorporated uniformly and
reproducibly from batch to batch. Second, the excitation wavelengths of the reporter dyes
need to be compatible with the excitation lasers available. Moreover, the encoding dyes
must be chosen so that their emission spectra do not overlap with the spectra of the
reporter dyes used to generate the optical signal used for quantification of analyte; such
overlap can result in radiative and/or nonradiative energy transfer, thus increasing the
difficulty of resolving encoding signals and requiring the employment of more sensitive and
expensive decoding equipment [52].
The most prevalent commercially-available particle-based assay platform is the xMAP
array technology sold by Luminex Corp (Austin, TX) [27]. This platform utilizes 5.6-sm
diameter polystyrene microspheres doped with three dyes to generate 500 distinct sets of
particles. Using this technology and associated flow analysis instruments (Luminex
100/200, FlexMAP 3D), researchers have reported successful multiplexed assays of single
nucleotide polymorphisms (SNPs) [53], human cytokines [51], biological warfare agents
[54], and kinases [55], with analyte concentrations as low as 100 attomolar able to be
detected. While this system was the first particle-based array to truly challenge the
dominance of microarrays, its current format suffers from several technical drawbacks,
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including poor reproducibility, difficulty in utilizing the full coding capacity due to spectral
overlap, and significant capital costs associated with the decoding and quantification
instrument. It should be noted that a range of other commercial particle-based products
have become available in the past decade, but the vast majority fail in at least one major
way to achieve truly high-throughput analysis of medium density samples. For example,
the Becton Dickinson Cytometric Assay is compatible with several conventional flow
cytometers but is only capable of a 10-plex assay [56, 57]. Nanoplex Technologies, Inc.
produces metal nanorods with gold and silver stripes that serve as a graphical code for
multiplexing [33]. As mentioned earlier, the high density of the rods leads to rapid settling
in solution and thus requires the rods to be vigorously mixed during assays, a procedure
which can damage fragile biological molecules like antibodies. SmartBead Technologies Ltd
markets graphically encoded aluminum rods that suffer from the same drawback [58].
Perhaps the most promising commercially-available particle system is Illumina's
BeadXpress technology, which uses probe-laden glass cylinders (240 pim long, 28 ptm in
diameter) for high-throughput analysis with sensitivities that surpass those achieved with
other solid bead systems [35, 59]. A 24-bit holographic code is embedded in each cylinder for
probe identification, providing ultra-high coding capacity for multiplexing and for tracking
samples and reagents used. The system has been extensively employed by a number of
leading laboratories in recent years for genotyping, gene expression analysis, methylation
analysis, and protein-based assays [35]. An accompanying analysis instrument (BeadXpress
Reader) maneuvers the beads into microchannels that can then be scanned with a
translating laser, providing the ability to interrogate particles after assay at a rate of 80
samples/h for a 96-plex trial or 120 samples/h for a 10-plex trial [35].
1.1.2.2 Flow Cytometry for Particle Analysis
Many researchers have turned to flow cytometry for the efficient processing and decoding of
the microparticles used in multiplexed biomolecule assays. Flow cytometry is the
measurement of the physical and chemical properties of micron-scale bodies as they are
carried past a detector in a fluid stream. The strength of cytometric analysis is its capacity
to interrogate cells or particles on an individual basis rather than measuring the average
values displayed by larger populations. Developed in the 1940s, the earliest cytometers
were expensive, bulky, and largely confined to the research laboratory for the purpose of
counting blood cells [60]. Improvements in micromachining and signal processing facilitated
gradual reductions in size, and the current generation of instruments is able to fit on the
bench top. In the past two decades flow cytometry has emerged as a crucial analytical tool
in clinical laboratories for the high-throughput (40,000 objects/s) quantification of various
characteristics of viruses, bacteria, cells, and microparticles. Researchers have employed
cytometers to diagnose disease, characterize immunological states, monitor response to
treatment, interrogate cell surfaces, and even detect and sort rare cell types [61].
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Despite their impressive track record in the clinical setting, conventional cytometers have
several drawbacks. They require relatively large sample and reagent volumes, time-
consuming sample pre-treatment techniques, and specialized personnel for their daily
operation [61]. Miniaturized microfluidic flow cytometers fabricated from silicon/glass and
poly(dimethylsiloxane) (PDMS) elastomer were developed in response to these issues. The
small dimensions of the microfluidic channels greatly reduce the required sample and
reagent volumes, making the system ideal for applications such as the diagnosis of fetal
genetic disorders and the screening of infant blood. The tight confinement of the fluids also
ensures high surface-to-volume ratios for increased reaction times and can even aid in the
detection scheme used to interrogate the objects of interest. Furthermore, many of the
elastomer-based miniature cytometers are portable and inexpensive to manufacture on a
large scale. As a result, several disposable cytometers have been developed and marketed
for human immunodeficiency virus (HIV) screening and monitoring, cell screening assays,
and blood analysis [60].
The primary challenge in flow cytometry is confining, or focusing, the cells and particles
under investigation to a small region of the flow chamber for efficient and accurate
detection (Figure 1.4). The simplest and most common method employs the pressure-driven
flow of sheath fluids to hydrodynamically focus a central particle-bearing stream to a width
comparable to the dimensions of the particles [62, 63]. A stream width larger than this will
lead to the passage of multiple particles through the detection zone at the same time, thus
complicating signal processing. Meanwhile, smaller stream widths are also unfavorable, as
agglomeration of particles can occur. Since standard PDMS microfabrication methods
employ two-dimensional patterns (in the x-y plane), the confinement of particles to a small
length along the "z-axis" has often been problematic and has limited throughput. However,
two different groups have reported the fabrication of PDMS microchannels capable of three-
dimensional hydrodynamic focusing. Simonnet et al. used this advanced degree of focusing
to create both a high-throughput device (17,000 particles/s) and a high-resolution device
from a single cast of PDMS [62, 64]. Chang et al cleverly configured two separate casts of
PDMS to develop an even more robust three-dimensional focusing channel loosely based on
Simonnet's results [65]. Because sheath strategies can lead to undesired sample dilution
and higher waste volumes, silicon-based chips utilizing embedded fiber optic reflection
probes rather than sheath streams have also been created [66]. Additional focusing
methods employ vacuum pumps [67, 68], settling due to gravity [69], and electroosmotic-
induced flow [70-72].
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Figure 1.4: Summary of cytometric systems used for the focusing and analysis of micron-
scale bodies. Hydrodynamic focusing is commonly used to manipulate cells and
microparticles into well-ordered flows so that they may be interrogated on an individual
basis with scattered light or laser-induced fluorescence [61, 62, 64, 73]. Compact "lab-on-a-
chip" devices employ integrated optical detection elements to monitor the characteristics of
passing particles [741. A recently developed microfluidic analysis system allows for the
automated manipulation, phenotyping, and sorting of Caenorhabditis elegans specimens at
rates of several hundred worms per hour [751.
The schemes used to analyze the focused, particle-bearing stream are typically based on the
detection of scattered light, fluorescence, or electrical signals. Most systems, such as the
Luminex FlexMAP 3D instrument discussed earlier, employ optical detection. The simplest
scheme analyzes the forward scattering, large angle scattering, and extinction of a laser
beam focused on the particle-bearing stream [76]. Laser-induced fluorescence (LIF) offers a
higher level of sensitivity, with the more complex approaches employing optical waveguides
for both laser excitation and fluorescence detection [77]. A compact cytometer (50 cm x 30
cm x 15 cm) with a single photon counting avalanche diode (SPAD), diode laser, and digital
data acquisition board was assembled by Niehren et al. [78]. In separate work,
nanoparticles as small as 26 nm were detected using a relatively inexpensive Ar-
laser/photomultiplier tube (PMT) optical setup [79]. Schemes that integrate detection
elements into the microfluidic chip are far more costly and difficult to produce, but they
eliminate the need to precisely align optical detectors like SPADs and PMTs. Impedometric
detection also avoids this difficulty by using embedded electrodes that flank the focused
stream to measure the spectral impedance of individual particles [80]. A recent advance in
impedometric detection was made by Chun et a]. with the introduction of embedded
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polyelectrolytic salt bridge-based electrodes (PSBEs) [81, 82]. Photolithographic techniques
were used to fabricate gel plugs that function like a salt bridge to size-selectively count
passing particles as well as measure their velocities. Despite this recent advance, optical
detection remains the most popular cytometry scheme because of its ability to extract more
information on particle morphology and velocity. Currently, the vast majority of impedance-
based systems can only serve as conventional counters.
1.1.3 Polymerase Chain Reaction Methods
The polymerase chain reaction (PCR) is perhaps the most powerful tool in molecular
biology. First discovered in the early 1970s, the technique enables the creation of millions of
copies of DNA from a single target sequence, a process with powerful implications for the
detection of biomolecule species [83]. In its most conventional form, PCR utilizes a heat-
stable DNA polymerase, deoxynucleoside triphosphates (dNTPs), and short complementary
primer sequences to amplify the number of target sequences in solution. Thermal cycling
allows for the repeated denaturation/melting of species, attachment of primers and
polymerase to the target, and extension of the primers via incorporation of dNTPs. Most
methods use between 20 and 40 cycles to generate a sufficient number of amplicons.
Although primarily used for the amplification and detection of DNA targets, the process has
been modified in a multitude of ways to enable the analysis of single-nucleotide
polymorphisms (SNPs) [84], methylation points [85], RNA targets (reverse transcription
PCR or RT-PCR) [86], and even protein species [87]. Quantitative PCR (qPCR) is a
particularly powerful variant that offers the ability to measure the copy number of specific
nucleic acids, often in real-time [88]. In this process the amount of amplified product is
determined by quantifying a fluorescent signal that arises from the generation of
amplicons. By monitoring the number of cycles required to bring the fluorescent signal
above a predetermined threshold, it is possible to calculate how many target molecules
were present in the starting mixture.
The ability of PCR to augment the number of target molecules in a sample leads to better
sensitivity than that which can be achieved with standard planar and particle arrays. For
example, for the detection of short RNA targets, the limit of detection of most PCR-based
methods is 103-fold lower than conventional microarrays and 10 5-fold lower than solid-
particle systems. While this enhanced sensitivity offers many advantages for the detection
of rare targets in small, clinically-valuable samples, it should be noted that multiplexed
sensing with PCR-based approaches generally requires more optimization and preparation
steps than with multiplexing systems that do not amplify the number of target molecules.
The amplification process almost always requires a purified input sample that is devoid of
proteins and other factors that can interfere with the activity of the polymerase. For
multiplexing approaches in which multiple primer sets are added into a single PCR mixture
(typically contained within a snap-top tube), it is crucial to ensure that the annealing and
melting temperatures of all involved complementary sequences are compatible with the
cycling conditions and that the primer sets produce amplicons of distinct lengths that can
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be distinguished from one another when run on an electrophoresis gel. Optimization of
these parameters can become difficult for even modest levels of multiplexing, and as a
result, optimized reagent mixes are often commercially-available for targets of significant
clinical or research interest.
Applied Biosystems' TaqMan multiplexing technology consists of 96- and 384-well
microfluidic cards, with each well containing a primer set for a specific target of interest
[89]. While the spatial segregation of primer sets allows for easier readout of amplicon
amount, this method typically requires larger input sample amounts and restricts the
multiplexing flexibility by requiring the target to be covered by a commercial primer
library. Furthermore, the cost of analyzing a single sample with the method is higher than
for commercially available planar and particle arrays. The need to incubate the cards in an
expensive temperature-cycling instrument also limits the processing throughput (number of
samples per day) of the system, making this approach less than ideal for diagnostic and
screening applications which require the analysis of hundreds of samples on a daily basis
(Figure 1.5).
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Figure 1.5: Comparison of sample throughput
and detection sensitivity for the three most
common multiplexing platforms. The ideal
system for clinical applications would enable
high-volume processing while only requiring
small amounts of easily accessible input
sample.
1.1.4 Single-cell Analysis
As the TaqMan card technology illustrates, the development of micro- and nanofluidic
technologies has greatly expanded analysis capabilities, enabling the massively parallel
interrogation of hundreds to thousands of tiny sample aliquots in a single trial on small,
disposable chips. The ability to rapidly segment samples in nanoliter and picoliter volumes
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with automated liquid handling and other injection techniques offers tremendous
advantages in rapidly extracting information from precious samples. In addition to
consuming less reagent and sample, smaller incubation chambers typically provide faster
capture kinetics and localize/concentrate reporting signal for improved signal-to-noise ratio
during post-assay analysis [90, 91]. One area of research that has greatly benefited from
these features is single-cell analysis (SCA), which can broadly be defined as the
interrogation of the genetic, proteomic, or metabolic profile of isolated cells to identify and
characterize the heterogeneity of expression produced by stochastic cellular processes [92].
In the past a lack of suitable analysis technologies forced researchers to interrogate cell
ensembles, a practice which cannot effectively identify "outlier" cells and which can often
mask the true dynamics of the individual cells that make up the ensemble [93]. There are
numerous examples of gene expression studies in which the ensemble average fails to
accurately describe the expression levels of the individual cells, preventing the discovery of
significant bifurcation behavior that can be indicative of disease development [92, 94]. In
addition, the ability to measure molecular profiles with single cell resolution allows for the
efficient analysis of rare or precious sample types such as embryonic cells and circulating
tumor cells (CTCs) [95].
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Figure 1.6: Single-cell analysis techniques. Examples shown include the single-cell
barcode chip (SCBC) [96], microengraving [97, dielectrophoretic cell trapping [98],
Fluidigm's 96.96 Dynamic Array [99], and hydrodynamic cell trapping [91].
The advent of technologies for SCA (Figure 1.6) has the potential to improve medical
diagnostics and disease treatment by enabling the targeting of specific cell populations of
interest in order to more clearly understand signaling pathways and the ways in which
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those pathways influence the development of cells destined to effect disease. For example,
by elucidating the characteristics of individual cells, it becomes easier to isolate the
aberrations and heterogeneities within a network that give rise to tumor initiation,
progression, and metastasis [92]. Furthermore, SCA can provide valuable insight into the
susceptibilities of cancer stem cells, allowing for the rational design of therapeutic
interventions [100]. The isolation and analysis of single cells from growing embryos also
has powerful implications for the creation of diagnostic tests for genetic diseases and
developmental abnormalities [101].
A significant amount of progress has been made in the design of systems for the
manipulation and arrangement of single cells. To facilitate analysis, researchers have
generated arrays of cells through the use of physical trapping structures [97, 102, 103],
hydrodynamic traps [91, 104], holographic optical tweezers [105], dielectrophoretic traps
[106], electroactive microwells [107], and emulsions [108]. The Quake lab's pioneering work
with large-scale integration and on-chip PCR has enabled several high-throughput studies
in which cells could be rapidly isolated and analyzed [109, 110]. A commercial venture
(Fluidigm Corporation) spun out of these techniques now markets the Fluidigm Dynamic
ArrayTM, which is a microfluidic chip capable of measuring the expression level of 96
different mRNA transcripts in 96 individual cells [99]. Meanwhile, in "microengraving"
approaches, cells are deposited in subnanoliter wells and their secreted products are
captured on probes immobilized on a cover glass that is used to seal the wells for incubation
[97]. In addition to providing high sensitivity in protein secretion assays (experimental
limits of detection ranging from 0.5 to 4 molecules/s), this method allows for the 4-plex
analysis of up to 105 cells/assay as well as the recovery of intact cells that exhibit
interesting secretion profiles [111]. This ability to screen large populations and isolate
atypical cells has led to applications in monoclonal antibody discovery [112]. The
microengraving concept has also been extended to the massively parallel detection of gene
expression in single cells [113].
The single-cell barcode chip (SCBC) is another microfluidic-based technology that enables
the multiplexed measurement of secreted proteins. Originally designed for the multiplexed
analysis of proteins in whole blood [114], the barcoded chip has recently been modified to
facilitate the loading of thousands of cells per assay into 3-nL chambers [96]. The bottom
surface of the chip consists of a polylysine-coated glass slide that has been microfluidically
patterned with strips of spatially segregated capture probes. When the PDMS isolation
chambers are properly registered with these strips, the chip enables 12-plex analysis of the
secretions of the individual cells, with limits of detection as low as 100 molecules. The
SCBC was recently utilized to measure functional heterogeneity in phenotypically similar T
cells [96]. Ongoing modification of the chip and its loading valves should also enable the
lysis of the entrapped cells, allowing for the analysis of various nucleic acid targets as well.
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1.2 MicroRNA Profiling
A biomarker can generally be defined as a substance that indicates the biological condition
of an organism and/or its susceptibility to therapeutic intervention. The degree to which
molecular diagnostics is able to transform the medical landscape in future years depends as
much on the identification of quality biomarkers with strong predictive power as it does on
innovation in detection technology. The successful correlation of disease diagnosis,
prognosis, and treatment efficacy to the expression patterns of a select set of molecular
entities is crucial for the development of an era of predictive and personalized medicine.
MicroRNAs (miRNAs) are short, non-protein-coding nucleic acids that have recently been
shown to exert a significant amount of control over the translation of proteins from mRNA,
and as a result, they have rapidly become a focal point in the search for effective
biomarkers.
1.2.1 Biological Importance of MicroRNAs
Despite their abundance and their widespread influence over gene expression in both
plants and animals, miRNAs were only recently discovered in 1993, during a study of the
developmental timing of Caenorhabditis elegans larva by the Ambros lab [115]. Subsequent
research uncovered that these non-protein-coding RNAs function as negative gene
regulators either by directing the cleavage of mRNAs or by repressing mRNA translation
through attachment to the 3' untranslated regions (UTRs) of their targets. The mechanism
of posttranscriptional regulation depends on the degree of complementarity that exists
between the miRNA and its target. The biogenesis of miRNAs begins in the nucleus of the
cell, where pri-microRNA (pri-miRNA) transcripts produced by RNA polymerase II are
separated into pre-microRNA (pre-miRNA) segments by the RNase III enzyme Drosha and
the double-stranded-RNA-binding protein Pasha (Figure 1.7) [116-118]. These -70
nucleotide precursors are then exported into the cytoplasm and processed further by the
RNase III enzyme Dicer, producing a double-stranded RNA duplex typically between 21
and 25 nucleotides in length. Upon association with a ribonucleoprotein structure known as
the RNA-induced silencing complex (RISC), one strand (termed the "mature" strand) is
retained and used to target transcripts, while the other strand (termed the "passenger"
strand) is degraded.
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Figure 1.7: Schematic description of the biogenesis and
post-transcriptional regulatory function of microRNA.
Adapted from [1191
By regulating the expression of approximately half of all gene-encoding mRNAs, miRNAs
play a crucial role in physiological as well as pathological processes. Most notably, this class
of molecules has been implicated in the development and progression of various types of
cancers including breast, lung, ovarian, cervical, prostate, colorectal, and liver cancers
[117]. In addition to serving as oncogenes and tumor suppressor genes, miRNAs have also
been identified as significant agents in the development of HIV/AIDS, cardiovascular
diseases, neurodegenerative diseases, and herpesvirus infections [120-124]. This connection
between aberrant expression of miRNAs and the emergence of disease states has led many
researchers to look upon the -1,000 known human miRNAs as a biomarker set that can be
analyzed for diagnostic and prognostic purposes. Early efforts have demonstrated that
profiling select sets of miRNAs offers a surprising wealth of information on the
developmental lineage and differentiation state of tumors and provides more accurate
diagnostic predictions than simply measuring transcript (mRNA) levels. For example, in
one set of studies, the expression profiling of only 200 miRNA targets provided a better
classification of cancer (12 of 17 correct) than a dramatically larger set of >16,000 mRNAs
(1 of 17 correct) [125, 126].
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The stability of miRNAs in a wide range of biological contexts is another significant factor
in their emergence as a new class of biomarker. It has been shown that their small size and
association with both ribonucleoprotein complexes and exosomes can protect them from
degradation by RNases [127]. In recent years, circulating miRNAs have been discovered in
several readily accessible biological fluids including serum, plasma, and urine. Correlations
between disease state and expression levels of these circulating species suggest that
miRNAs could be strong candidates for the development of noninvasive biomarker screens
for the early, asymptomatic detection of tumorigenesis and for the monitoring of treatment
response [128-131]. Further studies of the exosome-mediated transfer of miRNAs between
cells indicate that the measurement of circulating miRNAs could have important
implications for understanding cancer metastasis as well as intercellular communication
between cells of the immune system [132, 133].
1.2.2 Current MicroRNA Detection Technologies
Despite tremendous advances in technologies for the multiplexed assay of nucleic acids, it
has proven challenging to accurately and efficiently profile miRNAs [134, 135]. Their small
size, wide range of abundance, secondary structure, and high degree of sequence homology
have made it difficult to adapt existing quantification strategies originally developed for the
detection of long DNA and mRNA sequences. MicroRNA profiling applications in the
discovery and clinical fields require a detection platform that offers high-throughput
processing, large coding libraries for multiplexed analysis, and the flexibility to develop
custom assays.
Microarray systems provide high sensitivity and sufficient multiplexing capacity to probe
the full set of human miRNAs in a single assay. During an initial preparation step, the
total RNA in a sample is isolated and then the purified small RNA fraction is either
enzymatically labeled with fluorophore in an overnight step ("direct labeling") or it is
reverse transcribed and the resulting cDNA is labeled with a dye ("indirect labeling") [136].
As described in Section 1.1.1, the labeled entities are then hybridized to the array in a 12-
24 h incubation step, and the fluorescence pattern of the array is interrogated with a
scanning instrument and software, enabling quantification. Due to the short size of the
miRNA targets, there is significant variability in the melting temperatures (T,'s) of the
hundreds of different target-probe complexes formed on the surface of the microarray,
which can lead to challenges in accurately determining the amount of target initially
present in the starting sample [137]. This problem can be alleviated through the
optimization of probe design (i.e., subtracting bases or varying attachment spacer) or by the
use of specialized capture probes such as LNAs. From a workflow perspective, microarray
strategies for miRNA detection are relatively low-throughput and inflexible due to the fixed
design of the probe-set, cumbersome preparation steps, and the long incubation times
required for sensitive analysis. Furthermore, the mass-labeling of all species prior to
hybridization introduces the possibility of labeling biases and can be prohibitively
expensive for the high-volume sample analysis involved in clinical applications [137, 138].
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Current particle-based platforms for miRNA profiling offer more versatility, greater
reproducibility, and higher processing speeds than microarrays, although they are not
nearly as sensitive (Table 1.1) [137]. The encoded polystyrene and glass particles produced
by Luminex (50-plex) and Illumina (735-plex), respectively, are selectively added to samples
(usually isolated total RNA) to create a custom multiplexing panel for each experiment
performed. This modular design to multiplexing enables more efficient consumption of
reagents. In general, miRNA assays with particle platforms are faster than those with
microarrays due to the enhanced mass transfer provided by particle mixing during
incubation and the high-throughput particle scanning systems capable of analyzing
hundreds of samples per day. The Illumina BeadArray system boasts the best performance
characteristics, with a dynamic range of four logs, an enzyme-assisted labeling scheme that
improves detection specificity, and the ability to profile almost the entire set of human
miRNAs in 100-200 ng of total RNA [35, 59]. In contrast to microarray protocols which
often take two full days, the Illumina technology can process over 100 samples per day from
start to finish. The Luminex system offers a similar throughput but requires larger total
RNA inputs and provides a smaller coding library [41].
Microarray qRT-PCR Luminex Illumina
[134, 138] [134, 139] Beads BeadArray
[41, 59] [35, 59]
Limit of Detection 0.2 amol lOs-100s of 200 amol 1 amol
copies
Recommended Total 100-1000 500 500-2000 10-200
RNA Input (ng) for 950-plex for 754-plex for 50-plex for 735-plex
Throughput (samples per 8-h 1 2 150 500
day per machine)
Total Assay Time (h) 24-48 6 5 6
Multiplexing Capacity 106 754 50 735
Dynamic Range 4 logs 7 logs 3 logs 4 logs
Target Amplification Step? No Yes No Yes
Table 1.1: Comparison ofplatforms for multiplexed miRNA detection.
Quantitative real-time PCR (qRT-PCR) currently provides the highest degree of sensitivity
for miRNA profiling, with as little as 25 pg of total RNA required for multiplexed assay.
Initial efforts to adapt PCR to the detection of clinically-relevant mature miRNAs were
hampered by the small size of the targets and by the presence of pre-miRNAs. An
innovative stem-loop primer design was introduced in 2005 to markedly improve
discrimination between mature and precursor sequences and to augment amplification
efficiency of the short miRNA targets [136, 139]. Further proof-of-concept work has
combined the stem-loop primer strategy with additional stages of target/cDNA
amplification to boost sensitivity to a level that allows for the 220-plex and 384-plex
expression profiling of single cells [140-142]. Although these single-cell protocols can take
up to seven days and require extensive reagent optimization to prevent amplification
biases, they are powerful methods that underscore the analytical advantages of target-
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based amplification. Commercial vendors have sought to balance the need for exquisite
sensitivity with the end-user desire for an efficient, semi-automated workflow that delivers
reliable quantification. Microfluidic cards that employ carefully optimized stem-loop
primers and the TaqMan fluorescent labeling scheme are now commercially available for
the simultaneous assay of fixed panels of 384 human miRNAs. While this TaqMan miRNA
platform offers tremendous sensitivity (limits of detection between 10 and 100 copies),
dynamic range (7 logs), and specificity (high discrimination efficiency for single-base
mismatches), it requires dedicated, expensive instruments for assay and analysis, which
can limit sample processing throughputs. A single PCR machine, for example, can process
only two samples in an eight-hour workday. The high cost of the qRT-PCR reagents also
makes it less than ideal for high-volume sample analysis in clinical and research settings
[136].
In addition to microarrays, particle systems, and qRT-PCR, a range of other specialized
methods have been employed for the multiplexed detection of miRNA, including Northern
blotting [143], isotachophoresis [144], nanomechanical arrays [12], nanopore sensors [145],
electrochemical genosensors [146], silver nanocluster probes [147], and cation exchange-
based fluorescence amplification (CXFluoAmp) [148]. Deep sequencing efforts have also
expanded considerably within the miRNA community in the past few years, with new
technologies increasing the throughput and decreasing the cost of such analysis [149].
Although current approaches require large amounts (1-10 pg) of highly purified input RNA
and time-consuming preparation steps, sequencing does not require knowledge of target
identity and can thus be utilized for the discovery of unknown small RNAs, a powerful
feature that distinguishes it from other techniques [149]. As technological advances further
improve the efficiency and lower the cost of this method, it is expected that sequencing will
become an increasingly common method for miRNA analysis in biological samples.
1.3 Flow Lithography
Over the last 20 years, microfluidic technologies have transformed how researchers
approach challenges in clinical diagnostics and disease treatment. Although the greatest
amount of attention has been reserved for integrated "lab-on-a-chip" technology and other
complex devices that promise "sample in, answer out", there have been equally impressive
advances in the use of microfluidics for the production of high-value biomedical products
and tools [150-152]. A prime example of this innovation is the flow lithography (FL)
procedure, a high-throughput microfluidic process capable of generating chemically and
geometrically complex microparticles with physical properties that can be tuned for a range
of applications.
1.3.1 Operational Principles
The FL procedure combines the advantages of microfluidics (low reagent consumption,
laminar co-flow properties, continuous processing capability) with the flexibility and
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precision of lithographic patterning to create polymeric microparticles and colloids. The
first version of the process (continuous flow lithography, CFL) involved the injection of a
polymeric precursor liquid into a simple PDMS microfluidic channel that had been bonded
to a glass slide coated with a thin layer of PDMS [153, 154]. The precursors typically
contained a monomer species as well as an appropriate photoinitiator, and upon irradiating
the precursor flow with a shutter-controlled burst of UV light, gelation would occur within
the stream and produce a free-floating polymeric particulate that was advected along with
the flow towards an outlet port for harvesting. The use of a PDMS device and a PDMS-
coated substrate allowed for the penetration of oxygen into the synthesis chamber; this thin
oxygen inhibition zone served to terminate the polymerization at the liquid-PDMS
interfaces and facilitated the creation of flowing particles rather than structures affixed to
the surfaces of the synthesis chamber [155].
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Figure 1.8: Flow lithography for the synthesis of cemically and geometrically complex gel
microparticles. Laminar co-flowing streams of photoreactive monomers are periodically exposed
to bursts of UV light through a transparency mask to create free floating particulates of
arbitrary two-dimensional shape that can then be advected out of the synthesis zone for
collection and use [52, 1531.
When the synthesis device was mounted on a standard inverted microscope with a UV
illumination source, a transparency mask with a desired set of features could be inserted
into the field stop of the microscope to physically limit the passage of the UV light, thereby
selectively gelling only certain portions of the stream and allowing for the creation of
polymeric particles with arbitrary two-dimensional designs (Figure 1.8) [156]. This
photolithographic printing of particles represented a new paradigm in continuous
microparticle synthesis in microchannels because it afforded unprecedented control over
particle size, morphology, and chemistry [157, 158]. Previous flow-synthesis methods relied
on the dispersion of a precursor fluid in an inert continuous phase, a strategy which limited
the microparticle geometry to a sphere or a deformation of a sphere and which significantly
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complicated efforts to impart chemical anisotropy [157]. The microfluidic nature of the CFL
process also enabled the laminar co-flow of several precursor streams so that anisotropic
particles could be created with multiple distinct chemistries adjacent to one another. This
aversion to stream mixing was the result of the small length scales of the synthesis devices
(typical cross-sections of 200 tm X 30 pm) and the low injection velocities of the precursors,
which together produced low-Reynolds number (low-Re) flows dominated by viscous rather
than inertial forces [153, 159].
Although the continuous process of CFL afforded many advantages, it was necessary to
limit flow velocity to ensure that particle interfaces would not be smeared during the UV
exposure step. To address this resolution issue and to augment the production rate of
particles by allowing for higher flow velocity, the semi-continuous stop-flow lithography
(SFL) procedure was developed [160]. Leveraging the rapid response time of a pressure-
driven flow control system, the precursor flow in SFL was quickly pulsed and synchronized
to a computer-controlled shutter for precise UV dosage [161]. In the cyclical procedure, flow
was automatically initiated, stopped, subjected to a UV burst, and then re-initiated to
remove particles from the synthesis zone. Depending on particle complexity, SFL synthesis
throughputs as high as 105 particles/h could be achieved, with a minimum feature size of 6
pm when using a 20x objective for the photolithographic exposure [160].
Since its introduction, SFL and technical variants of SFL have been employed extensively
for the creation of a wide range of chemically complex polymeric particles, including some
with anisotropy along multiple dimensions [40, 49, 162-171]. Perhaps the most active area
of SFL research has been the synthesis of hydrogel microparticles, which are composed of
hydrophilic polymer chains that characteristically retain water. Although many materials
are available for the synthesis of such particles, poly(ethylene glycol) (PEG) precursors have
proven especially useful due to their compatibility in biological applications. PEG-based
hydrogels are both bioinert and non-fouling and thus can be inserted into biological
contexts without significantly perturbing the environment and without non-specifically
adsorbing biological molecules. These features make them ideal for biosensing applications
in which probes need to be immobilized on passive substrates that will selectively capture
only those targets they are designed against. Furthermore, PEG oligomers can be obtained
in a variety of molecular weights and with a range of functionalities, making it
straightforward to tailor the chemical, physical, and material properties of the gels
produced [172]. For example, PEG-diacrylate (PEG-DA) oligomers can be polymerized with
nucleic acids functionalized with an acrylate group to produce a gel network with covalently
bound DNA or RNA. The porosity and cross-link density of the resulting gel can also be
controlled by adjusting the relative amounts of PEG-DA, photoinitiator, and an inert
species such as aqueous buffer or PEG [173].
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1.3.2 Hydrogel Microparticles for Biomolecule Analysis
Despite the dramatic advances in multiplexing technology over the last 30 years, it has
become clear that the current paradigm of surface immobilization of probe species in both
microarrays and particle systems is suboptimal [4, 23]. The attachment of probes to the
surfaces of slides and beads inevitably leads to steric hindrance of probe-analyte
interactions, nonideal kinetics, and slow approaches to equilibrium. As described earlier in
Section 1.1.1, microchips featuring oligonucleotides immobilized throughout a porous,
three-dimensional hydrogel were developed by Mirzabekov et aL. in the early 1990s for SBH
and later extended to the detection of DNA polymorphism, proteins and even whole cells
[10, 21-23]. In addition to boasting high probe incorporation efficiencies and short
hybridization times, the novel three-dimensional platform reduced molecular crowding,
thereby providing a thermodynamically more favorable environment for biomolecule
capture.
Nearly two decades after the initial work of Mirzabekov, the SFL process was used to
combine the advantages of gel-based immobilization with suspension array technology to
create multifunctional, graphically-encoded hydrogel microparticles for biomolecule
analysis [52]. Using precursor mixtures containing PEG-DA, PEG, Darocur 1173
photoinitiator, and Tris-EDTA buffer, tablet-shaped microgel particles were simultaneously
synthesized, encoded, and functionalized with DNA capture probes in a single step at rates
up to 104 particles/h (Figure 1.8). Utilizing SFL's ability to polymerize across laminar co-
flowing streams, each particle consisted of multiple chemical sections, with one "code"
region and one or more "probe" regions. In the code region, a fluorescently-labeled acrylate
molecule was added to the precursor, and unpolymerized holes in the wafer structure of the
particle (created with an appropriate transparency mask) were used to construct a 20-bit
graphical code. This code was then used to identify the acrylate-modified DNA probe(s)
added to and covalently incorporated within the other region(s) of the particle. The physical
separation of code and probe regions on each particle enabled the use of a common
wavelength for all optical signaling purposes, thus avoiding the spectral issues and
cumbersome equipment requirements of other particle systems. In addition, although the
tablet-shaped microparticles were larger (200 pim long x 60 pm wide x 30 pim thick) than
the more commonly used latex microspheres, they exhibited higher sensitivity, superior
specificity, and shorter hybridization times than the solid spheres in initial assays of model
DNA sequences [174].
1.4 Outline of Thesis
The purpose of this work is to enhance the utility of graphically-encoded hydrogel
microparticles so that they may be employed for the sensitive, specific, and high-throughput
detection of microRNAs and potentially other medically-relevant biomolecules. The
organization of this work is as follows:
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Chapter 2 describes the materials and methods employed in the synthesis, use, and
analysis of the gel particles.
Chapter 3 details a parametric study of the factors that govern the flow alignment of soft
gel microparticles in microfluidic devices.
Chapter 4 describes the construction of a microfluidic particle scanner, as well as the
development of a 12-plex assay for a panel of clinically significant miRNAs.
Chapter 5 details the creation of a signal-amplification scheme that enables the
visualization of single-molecule binding events on the surface of the gel particles. The
development of a serum-based miRNA assay is also described.
Chapter 6 describes the development of lysate-based miRNA assays and a microwell
approach to analyze the miRNA profiles of single cells and small groups of cells.
Chapter 7 summarizes the findings of this thesis and discusses future work.
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Chapter 2
General Ma terials and Experim en tal Methods
This portion of the thesis provides a consolidated overview of the various chemicals, buffers,
and methods frequently used in experiments. The materials and general techniques
described here are referenced throughout the thesis, and in the event that alterations were
made to these protocols during the course of research, those changes are explicitly detailed
in the appropriate chapter.
2.1 Materials
2.1.1 Chemicals and Buffers
For the sake of brevity, acronyms and chemical trade names will be used throughout the
thesis instead of full chemical names. The abbreviations are given in Table 2.1 below.
Oligomers and Elastomers
PDMS Polydimethylsiloxane (Sylgard 184, Dow Corning)
PEGsoo Poly(ethylene glycol), n = 200 g/mol (Sigma)
PEGeoo Poly(ethylene glycol), n = 400 g/mol (Sigma)
PEG-DA7oo Poly(ethylene glycol) diacrylate, n = 700 g/mol (Sigma)
Fluorescent Molecules
Rhodamine-acrylate Methacryloxyethyl thiocarbonyl rhodamine B (Polysciences)
SA -PE Streptavidin-R-phycoerythrin (Invitrogen)
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Miscellaneous Chemicals
Darocur 1173 2-hydroxy-2-methylpropiophenone (Sigma)
SDS Sodium dodecyl sulfate (Invitrogen)
Tween -20 Polyoxyethylenesorbitan monolaurate (Sigma)
PK Proteinase K (New England Biolabs)
Buffers
TE (1x) 10mM Tris pH 8.0 (USB) and 1mM EDTA (USB) in nuclease-free water
TET 1x TE buffer with 0.05% Tween-20
PTET 5x TET buffer with 25% PEG 4oo
PBST Phosphate buffered saline (PBS, Cellgro) with 0.05% Tween-20 (pH 7.4)
NEB2 New England Buffer #2 (New England Biolabs)
R50 TET with 50mM NaCl
Prepolymer Mixtures
DA20 20% PEG-DA7oo, 40% PEG2oo, 35% 3x TE, 5% Darocur 1173
DA30 30% PEG-DA7oo, 30% PEG200, 35% 3x TE, 5% Darocur 1173
Code Monomer 35% PEG-DA7oo, 20% PEG200, 40% 3X TE, 5% Darocur 1173
Inert Monomer 35% PEG-DA7oo, 20% PEG200, 40% 3X TE, 5% Darocur 1173
Table 2.1: List of frequently used acronyms and chemical trade names. All percentages represent v/v
concentrations.
2.1.2 Oligonucleotides
All oligonucleotides used in this work were purchased form Integrated DNA Technologies
(IDT) and stored in buffers prepared from nuclease-free water. There are two main
classifications for the oligonucleotides used: (1) "probes" are DNA oligonucleotides that are
covalently incorporated within particles for the capture of specific biomolecules and (2)
"targets" are the DNA or RNA oligonucleotides that are to be detected by the particles in
solution. DNA probes were purchased as lyophilized films in 250 nmol quantities with
HPLC purification. They were ordered with an AcryditeTM modification on the 5' end to
facilitate incorporation into the hydrogel network and with an inverted dT modification on
the 3' end to prevent incidental ligation of labeling sequences to the untethered end. After
suspending and appropriately diluting the DNA in 1x TE, the oligonucleotide probes were
stored at -200 C in snap-top 0.65-mL tubes in aliquots of 5 pL at either 500 ptM or 1 mM in
labeled cardboard sample boxes. Meanwhile, targets were purchased as lyophilized films in
250 nmol quantities with RNase-free HPLC purification. Targets were suspended in the
stock tube in 1x TE at a concentration of 100 pM, and then at least four 100-jL "mini-
stocks" were created at a concentration of 10 jiM in separate 0.65-mL snap-top tubes. One
of these mini-stocks was then used to create aliquots of 5 pL at 10 ptM. All targets were
stored at -200 C in labeled cardboard sample boxes. To maintain integrity, all aliquoted
targets and probes remained frozen at -200 C until 10-20 min prior to use in experiment.
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2.2 Equipment Setup
2.2.1 Configuration of Microscope for Polymerization
PDMS synthesis devices were mounted on a Zeiss Axio Observer microscope equipped with
a Zeiss Plan Neofluar 20x objective (NA 0.50) and a Chroma 11000v3 UV filter. A UV
source (Lumen 200 at 100% setting, Prior) was connected to a VS25 Uniblitz shutter
system, which in turn was attached to the rear port of the microscope either directly or via
a switching mirror box. Two neutral density filters (OD 0.05 and OD 0.4) were inserted in
series into a slider bar and placed in the aperture slot of the microscope to reduce UV
intensity to a level that enabled high-resolution polymerization with exposure times
between 50 and 100 ms. A power meter (Newport, Model 1815-C) and appropriate
adjustment of exposure time were used to ensure a consistent UV intensity. Transparency
masks with a diameter of 2.5 cm were ordered from Fineline Imaging and placed into a
second slider bar, which was inserted into the field stop slot of the microscope. To ensure
the transparency was flush with the back of the slider bar, the mask was sandwiched
between a circular cover glass (25 mm, VWR) and a blue spacer ring. A rubber 0-ring was
then inserted to hold the spacer ring down. The automated flow/stop/expose cycles required
for SFL were controlled by a custom-written Python script. A compressed-air flow control
system provided rapid dynamic response and precise control of multiple inlet streams; the
construction and operation of this system has been described extensively elsewhere [161].
2.2.2 Acquisition of High-speed Flow-focusing Movies
Flow devices with two inlets and one outlet were mounted on an inverted microscope
(TE2000U, Nikon) for visualization with 10x and 4x objectives. Prior to being loaded into
the flow device, particles were removed from the refrigerator, rinsed 4 times in PTET, and
allowed to sit at room temperature for 90 min. PTET was used to obtain better density-
matching between the particles and the liquid medium in order to minimize the effects of
sedimentation in the loading process. The PTET was sonicated for 1 min before use to
eliminate polymer agglomerations that could disrupt particle flow. Once the particles were
diluted to the appropriate concentration (10-20 particles/tL) with PTET, 20-30 pL of the
mixture was loaded into a pipette-capped length of Tygon tubing, and the pipette was
inserted into the central port of the device. Particle types were never mixed together; each
flow trial consisted of particles of identical shape and composition. A modified Eppendorf
tube containing a 2% (v/v) solution of food coloring in PTET was connected to the outer inlet
port via metal tubing. Tygon tubing was inserted through a hole in the Eppendorf cap to
provide driving pressure. The tubing from the inlets was then attached to two separate
pressure regulators (Omega) to provide independent control over the two streams. Flow
devices were able to be reused up to 25 times without any decrease in performance. The
compressed air source used to drive the flows was a plastic canister with a hand pump.
Upon sufficient pumping, a two-way valve connecting the canister with the regulators was
opened, thereby inducing flow. Pressures of 9 psi were able to be maintained for more than
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a minute using this simple setup. A high-speed Phantom camera (Vision Research)
captured images at rates ranging from 4,000 to 15,000 frames/s. Still images from the
movies were analyzed using the Phantom Cine Viewer software (2.24 pm/pixel for 1Ox and
12.44 gm/pixel for 4x). Detection zone measurements of velocity, position, and alignment
were made 750 pm from the outlet to ensure consistency.
2.2.3 Configuration ofMicroscope for High -throughput Scanning
PDMS focusing devices were mounted on a Zeiss Axio Observer microscope equipped with a
Zeiss Plan Neofluar 20x objective (NA 0.50) and an Omega XF101-2 filter (Figure 2.1). A
chrome-coated soda-lime glass mask (Advance Reproductions) was fitted into an iris slider
bar and inserted into the field stop of the microscope to limit the beam spot of a 100-mW,
532-nm laser (Dragon Lasers) to a thin excitation window of 4 x 90 Pm in the scanning
plane. Prior to each scanning session, laser alignment was calibrated with a power meter
(Newport, Model 1815-C). Using images captured from a Clara Interline CCD camera
(Andor Technology), the excitation window was oriented such that its long dimension was
aligned perpendicular to the flow direction approximately 750 Jm from the exit port of the
device. A switching box on the side port of the microscope was used to alternate between
the CCD and a photomultiplier tube (PMT, Hamamatsu H7422-40) used to record
fluorescence signatures of passing particles. The output current of the PMT was
conditioned using a homemade amplifier with a low-pass filter, and the resulting voltage
signal was captured at a rate of 600 kHz by a digital acquisition (DAQ) board (USB-6251,
National Instruments). A Python script was written to convert each scan to a binary text
file for off-line analysis. Single-chemistry particles with fluorescent rhodamine incorporated
throughout were scanned to optimize the performance of the scanning system, leading to a
combination of amplifier gain (22), cutoff frequency (100 kHz), slit width (4 pm), and PMT
control voltage (0.300 V) that produced the highest signal-to-noise ratio (SNR) and
frequency response possible.
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Figure 2.1: Equipment setup for particle scanning. (A) Image of the inverted
fluorescence microscope configured for scanning. The switching mirrors are used to
toggle between the different excitation (Lumen UV and laser) and detection (CCD and
PMT) instruments. (B) Image of the PDMS flow-focusing device, with fluid inlets and
outlet attached. (C) Schematic of the slit-scan process.
2.3 General Experimental Protocols
2.3.1 Soft Lithography andAssembly of Microfuidic Channels
Master molds for the production of PDMS devices were either created at the BioMEMS
Resource Center (BMRC) in Charlestown, MA or purchased from the Stanford Microfluidic
Foundry. For those molds fabricated at the BMRC, a clean silicon wafer was first spin-
coated at an appropriate speed with negative photoresist (SU-8 25, MicroChem). High-
resolution photomasks (10,000 dpi, CAD Art Services or Fineline Imaging) were then used
to selectively expose the coated wafers to UV light, thus creating the desired channel
patterns. Following treatment with SU-8 developer (MicroChem), the wafers were flood
exposed to UV light and baked. A profilometer (Dektak) was used to determine the heights
of features located on the left, right, and central portions of the wafer. The wafers were
then treated with a fluorosilane ((tridecafluoro-1,1,2,2-tetrahydrooctyl)1-trichlorosilane,
United Chemical Technologies, Inc.) by placing five drops of the silane in a vial next to the
wafer under vacuum for 60 min in a chemical fume hood. PDMS prepolymers (10 parts
base, 1 part curing agent) were poured over the molds to a depth of 5 mm, degassed in a
vacuum chamber for 60 min, and allowed to cure in an oven at 65"C for 12 h. Individual
channel designs were cut from the mold with a scalpel, and inlet and outlet holes were
punched with blunt 15-gauge luer stub adapters (Clay Adams). The devices were then
rinsed with water and ethanol, dried with argon gas, placed channel-side down on slides
coated with partially-cured PDMS (20-25 min at 65"C), and baked in an oven at 65'C for 12
h. Microchannels used for particle synthesis had heights between 37 and 40 pm, while those
used for flow-through particle analysis were between 38 and 40 pm in height.
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2.3.2 Preparation of Prepolymers
The porosity and detection properties of hydrogel particles depend on the composition of the
prepolymers from which they are synthesized. As a result, it was critical to ensure that the
prepolymer preparation steps were precise and reproducible. The necessary reagents (PEG-
DA7oo, PEG200, Darocur 1173, 3x TE, 1x TE, food coloring) were first aliquoted in separate
glass vials. In the prepolymer preparation, after the addition of each reagent to a 1.7-mL
snap-top tube, the solution was vigorously agitated on a vortex at the highest setting to
ensure complete mixing. In the initial step, PEG-DA7o was carefully added, followed by
PEG 200 and then Darocur 1173. For the pipetting of these three viscous reagents, it was
critical to draw up and dispense the liquid at a slow rate such that the main liquid front
and the secondary residue front traveled at the same velocity within the pipette. Failure to
do so resulted in residual liquid remaining trapped in the pipette and thus inaccurate
dispensing of reagent. 3x TE was added after the PEG-DAmoo, PEG200, and photoinitiator
were thoroughly mixed. Depending on prepolymer type, the monomer solutions were then
either added to a previously prepared aliquot of DNA probe ("probe" monomer) or
supplemented with additional reagents ("DA20", "DA30", "code" monomer, and "inert"
monomer) (Table 2.1).
For flow focusing experiments, DA20 and DA30 were mixed 9:1 with 1x TE to mimic the
prepolymer formulation used in previous nucleic acid detection experiments. For detection
experiments, code prepolymer was formed by combining code monomer with 1x TE and
rhodamine-acrylate (Rh-Ac, 1 mg/mL) to give final concentrations of 9.4% and 0.6%,
respectively. Inert prepolymer was formed by combining inert monomer with 1x TE and
blue food coloring to give final concentrations of 8.0% and 2.0%, respectively. Food coloring
was used to introduce contrast between neighboring streams for easier adjustment of
stream width during SFL. Probe regions on single-probe particles were polymerized from a
monomer that was added to acrydite-modified DNA probe sequences suspended in 1x TE to
give the desired concentration of probe in 18% PEG-DAoo, 36% PEG200, and 4.5% Darocur
1173; the remaining balance consisted of 3x TE. For multi-probe particles, certain probe
prepolymers were modified to allow for stream visualization during synthesis by replacing a
portion of the 3x TE with food coloring (final concentration of 2%). Once all reagents had
been added and thoroughly mixed, each prepolymer was centrifuged (VWR Galaxy Mini-
Star, 2,000 g) for 14 min prior to injection into the synthesis device to sediment any debris
or agglomerations that could clog the microchannels. Code and inert prepolymers could be
used for up to three weeks after preparation; probe prepolymer was prepared fresh on the
same day as the synthesis.
2.3.3 Particle Synthesis
Hydrogel microparticles with up to six different chemical regions were simultaneously
synthesized, functionalized, and encoded at rates up to 18,000 per h with 50-100 ms UV
exposures using the SFL method (Figure 2.2) [52, 160]. Exposure time was periodically
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adjusted to compensate for the aging of the UV bulbs used [175]. Code, inert, and probe
prepolymer solutions were loaded into microfluidic synthesis channels with 1-6 inlets using
modified pipette tips as delivery chambers. These tips were rinsed with water and ethanol
and then dried with argon gas prior to use; this practice was seen to dramatically reduce
the frequency of clogs in the synthesis channels. The modified tips were connected to an
adjustable pressure manifold with Tygon tubing, and forcing pressures of 3-4.5 psi were
used to drive flow [161]. As discussed earlier, when synthesizing particles with multiple
chemistries, food coloring was added to certain prepolymers to create a contrast difference
that could be exploited for stream visualization in the synthesis process using a CCD
camera (Hitachi KP-M1A or Andor Clara).
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Figure 2.2: Microparticle synthesis using SFL. (A) Schematic of the creation of
a single-probe particle in a four-inlet channel. (B) Image of a four-inlet device
mounted on an inverted fluorescence microscope for synthesis. C = Code, B =
Blank (Inert), P = Probe.
Following polymerization, particles were flushed down the synthesis channel and collected
in a 1.7-mL Eppendorf tube containing 950 pL of TET. Tween was used in the collection
buffer to prevent particle aggregation. Particles were next suspended in 200 pL of PEG200
for 5 min and then rinsed with 700 jiL of TET. This washing sequence was used to rinse the
particles of unreacted PEG-DAoo, probe, and rhodamine-acrylate. The wash sequence was
then repeated two more times and required manual aspiration of supernatant facilitated by
centrifugal separation of the dense particles. After two further washes with 500 pL TET,
particles were stored in TET at a final concentration of -12.5 particles/pL in a refrigerator
at 40C. Unless otherwise noted, particle dimensions cited in this work refer to the size
expected from the transparency mask used. Depending on buffer conditions, the size of the
particle could be greater or smaller than the original synthesis dimensions due to swelling.
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2.3.4 MicroRNA Assay with Ligation Labeling
For trials involving non-amplified ligation labeling of captured miRNA targets, particles
were brought to room temperature prior to use, and each target incubation was typically
carried out in a total volume of 50 gL in a 0.65-mL snap-top tube with a final salt
concentration of 350 mM NaCl and at least 30 replicates of each particle type (up to 500
particles/incubation tube). For calibration and specificity studies, a hybridization buffer
(TET with assay-specific NaCl molarity) was first added to the Eppendorf tube, followed by
all relevant target sequences appropriately diluted in 1x TE. Tween was excluded from the
dilution buffer to prevent inaccuracies in pipetting steps that can arise from surfactant-
induced changes in wettability. Depending on the assay type, either 1 gL of TET or 1 pL of
E. coli total RNA (200 ng/pL, Ambion) was introduced to simulate sample complexity.
For human tissue profiling studies, hybridization buffer was added directly to a tube
containing either 2.5 or 1.0 pL of previously frozen extracted total RNA (one individual per
tissue type; stored at 100 ng/pL). Primary pair samples consisted of total RNA isolated from
primary tumor and its adjacent normal tissue. Total RNA for all tissues was isolated by
TRIzol purification; integrity of isolation was confirmed by checking for intact 18S and 28S
ribosomal RNA. Lung sample (BioChain) was obtained from 50-year-old male with poorly
differentiated squamous cell carcinoma. Breast sample (BioChain) was obtained from 53-
year-old female with moderately differentiated invasive lobular carcinoma. Stomach sample
(BioChain) was obtained from 70-year-old female with poorly differentiated
adenocarcinoma. Pancreas sample (BioServe) was obtained from 65-year-old female with
well-differentiated acina cell carcinoma. For all assays, 1 pL of miSpike target
appropriately diluted in 1x TE was also introduced to give a total amount of 100 amol of the
synthetic sequence to measure consistency of scanning/labeling and for quantification
purposes. Prior to the addition of particles, incubation mixtures were heated to 95'C for 5
min in a thermoshaker (Biomega, 1500 rpm) and then brought back to room temperature
over a 7-min period. A previously prepared master mix of particles (18 per pL) was
thoroughly vortexed for 1 min, and 20 tL (-30 particles of each probe type) was introduced
to each incubation tube. Incubation with target was carried out at 55 0 C for 90 min in a
thermoshaker (1500 rpm).
Following hybridization with target, samples were rinsed three times with R50 solution.
Supernatant was manually aspirated from the tube following centrifugal separation of the
particles. All but 50 tL of solution was aspirated after the third rinse. Next, 245 PL of a
previously prepared ligation master mix (100 pL 10x NEBuffer #2, 900 gL TET, 250 nM
ATP, 40 nM universal adapter, and 800 U/mL T4 DNA ligase) was added to the tube. The
mixture was placed in a thermoshaker at 21.5*C for 30 min with a mixing speed of 1500
rpm. Following ligation, an identical three-rinse cycle was performed with R50. Adapter
molecules that were not ligated to captured target readily de-hybridized, while ligation
products remained bound to the particles. SA-PE (1 mg/mL) was diluted 1:50 in TET and
added to obtain a final dilution of 1:500. Samples were incubated in a thermoshaker (1500
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rpm) at 21.5"C for 45 min. After another three-rinse cycle, particles were additionally
rinsed in 500 ptL of PTET, and then suspended in a final volume of 50 ptL PTET for
scanning. Prior to use, all PTET was sonicated for 5 min to eliminate aggregations of
polymer.
2.3.5 Rolling Circle Amplification (RCA) of Reporting Signal
Typical RCA assays were conducted in 0.65-mL snap-top tubes using a total reaction
volume of 50 pL and a final NaCl concentration of 350 mM. For all preliminary experiments
and calibration trials, a hybridization buffer (TET with NaCl), -20 particles of each type,
and appropriately diluted synthetic RNA target sequences were added (in that order) to the
reaction tube. Depending on assay type, either 0.5 pL of TET or 0.5 pL of E. coli total RNA
(200 ng/pL) was also added. Circular template for RCA was prepared using CircLigase
(Epicentre Biotechnologies) and the protocol described in Schopf et aL. [176]. Briefly, 5 piL of
50 pM linear DNA was added to a solution containing 40 pL of nuclease-free water, 6 pL of
10x CircLigase buffer, 3 ptL of 1 mM ATP, 3 pL of 50 mM MnCl2, and 3 ptL CircLigase
enzyme. After heating the solution to 62 0C for 1 h, the circularization enzyme was
deactivated by raising the incubation temperature to 800 C for 10 min. Then, 1 pL of
Exonuclease I (New England Biolabs) was added, and the mixture was heated to 37"C for
90 min to remove any remaining linear DNA. Finally, the exonuclease was deactivated by
heating the mixture to 850C for 15 min. Following circularization, 7-ptL aliquots of template
were stored at -20 0 C for future use. The primer sequence and template used in this study
were based on the system described in Schopf et al, with an alteration made to the primer
site to reduce hairpin melting temperature and optimize performance [176]. For the best
results, circular template was used no more than six months after synthesis; template older
than this showed reduced spot counts and thus decreased the limit of detection.
Target incubation was conducted at 55 0 C for 2 h. After target capture, particles were
washed three times with R50, again using centrifugation to pull particles to the bottom of
the tube for manual aspiration and exchange of carrier solution. For all rinses in this study,
50 piL of solution was left at the bottom of the tube to ensure retention of particles. A
primer-modified universal adapter sequence was then ligated to all captured targets at
21.5 0C for 30 min using T4 DNA ligase (New England Biolabs) and New England Buffer #2
(NEB2, New England Biolabs). This ligation procedure was identical to that described in
Section 2.3.4, with the exception that the adapter in this case contained an additional
primer sequence component. Following adapter ligation, particles were washed three times
in R50 and circular template was added to give a final concentration of 50 nM. Template
was allowed to anneal to the primer site during a 1 h incubation at 45'C, after which
particles were washed two times in R50. Prior to the addition of the RCA reagents, particles
were also washed with 235 pL of a gel-customized RCA buffer consisting of 10% 1Ox NEB2
and 90% TET solution. Bovine serum albumin (BSA, New England Biolabs), dithiothreitol
(DTT, Epicentre), dNTPs (Epicentre), and Phi29 polymerase (Epicentre) were then added to
give final concentrations of 200 pg/mL, 5 mM, 150 pM (of each dNTP), and 400 U/mL,
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respectively. RCA was performed at 30"C for the desired extension time (usually 4 h),
followed by three washes in R50. Two biotinylated reporter sequences were added to give a
final concentration of 50 nM each and incubated with the particles for 1 h at 21.50C.
Particles were washed three times in R50 and incubated with 2.5 piL of a 1:50 dilution of
SA-PE (1 mg/mL) for 1 h at 21.50C. Finally, particles were washed three times in R50 and
one time in PTET to prepare them for imaging analysis. All incubations in this section were
carried out in a thermoshaker with a mixing speed of 1500 rpm.
2.3.6 Serum -based MicroRNA Assay
Sera taken from one healthy donor and from one donor with prostate cancer were obtained
from BioServe Biotechnologies (donors were matched by age, sex, and race). Aliquots (25
ptL) were prepared immediately upon receipt and kept frozen at -20 0C until assay. For all
assays, 22.5 pL of a modified TET incubation buffer was added to the serum to denature
background proteins as well as RISC-associated proteins known to sequester miRNAs [127].
Assuming standard physiologic NaCl concentration of 150 mM in human serum [177], the
TET incubation buffer was supplemented with appropriate amounts of NaCl, SDS, and
Tween-20 to give concentrations of 350 mM, 2% (w/v), and 0.05% (v/v), respectively, in the
final 50 gL reaction volume. To completely dissolve the SDS at this concentration, it was
useful to immerse the mixture in a hot water bath maintained at 600C, and to improve
particle clarity in post-assay imaging, it proved beneficial to pass the resulting incubation
buffer through a syringe-mounted 0.45-pm filter (Acrodisc 25 mm with Supor membrane,
Pall Corporation). Following addition of the buffer to the reaction tube, each sample was
heated to 900C for 10 min and then allowed to cool for 2 min. Next, SUPERase-In RNase
inhibitor (Applied Biosystems) was added to each sample to give a concentration of 0.5 U/pL
in the final 50 pL reaction volume. Particles and synthetic RNA target were then added,
and the samples were placed in a thermoshaker (1500 rpm) at 550C for 2 h. The remainder
of the assay was identical to the procedure described in Section 2.3.5. During optimization
of the serum assay, the 900C preheating step was found to be essential for eliminating
nonspecific adsorption of material during target incubation, presumably due to its effective
disruption and denaturation of background proteins.
2.3.7 Particle Analysis P Static Fluorescence Imaging
For the fluorescence imaging of stationary particles after assay, 13 PL of PTET containing
the processed particles was placed on a cover glass (24 x 60 mm, VWR), sandwiched with
another smaller cover glass (18 x 18 mm, VWR), and imaged using a CCD camera (Andor
Clara) attached to an inverted microscope (Zeiss Axio Observer) equipped with a 20x
objective (Zeiss Plan-Neofluar, 0.5 NA), UV source (Lumen 200 at 100% setting), and filter
set appropriate for the fluorescence imaging of SA-PE, rhodamine-acrylate, Cy3, and Alexa
532 (XF101-2, Omega). In order to obtain the best results possible, it was important to turn
off all ambient light sources during fluorescence image acquisition. For non-amplified
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labeling, the focus was adjusted to the mid-plane of the particle, the microscope's halogen
shutter was closed, the microscope's fluorescence shutter was opened, and the CCD
camera's acquisition was immediately triggered (0.05 s exposure time). The fluorescence
shutter was closed as soon as acquisition had ceased to avoid photobleaching the reporter
molecules. For RCA labeling, two primary image acquisitions were made for each particle:
one with the focus adjusted to the top face of the particle and one with the focus adjusted to
the bottom face. For completeness, a third image was also acquired with the focus set at the
mid-plane of the particle.
2.3.8 Particle Analysis I: Fluorescence Scanning
Using the microscope setup described in Section 2.2.3, PTET was injected from a reservoir
input into a PDMS device to serve as a focusing sheath stream for scanning analysis. For
each trial, particle-bearing fluid was aspirated into a modified pipette tip using a syringe
connected to the tip via Tygon tubing. With the illumination switching mirror directed
towards the laser and the capture switching mirror directed towards the PMT, the tip was
then inserted into the appropriate PDMS inlet port and a pressure of 8 psi was used to
drive the flow of both fluids. Immediately before the initiation of flow, the fluorescence
shutter on the microscope was opened and data acquisition was triggered with a custom
Python script. A typical scan of 50 pl of particle-bearing fluid lasted -30 s and used less
than 25 tl of sheath fluid, with particle throughputs ranging from 5-25 per second,
depending on the number of particles used in the assay. Devices were able to be used more
than 25 times without degradation. Following each scan, a rinse solution of 30 pl 1x TE was
flowed through the particle inlet to flush out stranded particles and thereby reduce inter-
run contamination. Additionally, the loading tip was rinsed in ethanol and water so that it
could be reused. As with the static imaging protocol, the best results were obtained when
ambient lights were turned off during the scanning procedure. Furthermore, to protect the
PMT sensor, it was important to keep the capture mirror directed towards the CCD (rather
than the PMT) at all times, except immediately before and during signal acquisition.
2.3.9 Hydrogel Encapsulation and Lysis of Cells
A set of protocols was developed for the handling and lysis of cells in the context of hydrogel
microparticle assays. For assays carried out in snap-top tubes, cells were introduced either
as (1) gel-encapsulated entities within the probe regions of encoded particles (Figure 2.3) or
as (2) groups of 500-50,000 cells that were added directly to the reaction tube in a manner
similar to that used for synthetic target spiking in Section 2.3.4. For these assays, cultured
HeLa cells were trypsinized, harvested, and stored at concentrations between 1 x 106 per
mL and 6 x 106 per mL in Dulbecco's Modified Eagle's Medium (DMEM) with 10% fetal
bovine serum (FBS). The cells were then washed with three 500-pL volumes of PBS with 1
mg/mL BSA. For the assay of large groups of un-encapsulated cells, 0.5-2 pL of the cell
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solution was added to a reaction tube containing lysis buffer and particles, with lysis and
target capture occurring simultaneously during the same 90 min incubation at 550C.
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Figure 2.3: Schematic of the cell encapsulation
strategy Cells were physically entrapped
within the probe regions of encoded gel
particles during SFL synthesis for subsequent
lysis during assay. Transparent regions
represent blank sections that contain neither
probe nor fluorophore.
For encapsulation studies, the cell solution was added to a 5-pLL aliquot of the appropriate
acrylate-modified DNA probe. Then, a monomer mixture consisting of PEG-DAoo, PEG200,
and Darocur 1173 was added to produce a final concentration of 50-100 pM DNA probe,
20-30% (v/v) PEG-DAoo, 30-40% PEG200, 5% Darocur 1173, and -2,000 cells per pL. It is
important to note that following centrifugation of cells during washing steps, it was crucial
to manually disperse the cell pellet that was produced by vigorous manual mixing of the
solution using a pipette; simply vortexing the pellet did not disperse it fully and led to
inaccurate cell dilution. In addition, the use of 1 mg/mL BSA in the wash buffer was found
to be important to prevent cell adhesion to tubes and pipette tips. Trypan blue staining was
used to monitor cell viability at each step in initial trials to ensure that the protocol was not
compromising the cell membrane prior to encapsulation with SFL [178].
Following the mixing of the cell-laden prepolymer, the solution was loaded into a modified
pipette tip. To ensure that cells were not clumped together, it was best to repeatedly draw
the solution up with a syringe and eject it back into the loading tube five times before
inserting the tip into the PDMS device. Synthesis devices with 50-pm and 100-pm wide
inlet channels were both used, and it was observed that the 100-jim inlets were
advantageous for the cell work as they did not clog nearly as frequently as the 50-pm inlets.
Although the cell loading concentration could be raised above 2,000 per pL, this would also
increase the chances of a clogging event. Aside from the use of a slightly different channel
geometry and the alteration of the prepolymer composition, the SFL protocol for the
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encapsulation of cells within the gel particles via UV-induced crosslinking was the same as
that described in Section 2.3.3. After particle harvesting and the standard TET and PEG200
rinses described earlier, the cell-laden microgel particles were loaded into a single well of a
filter plate (Whatman 96-well polystyrene plate with pore size of 25 pm and well volume of
800 pL), and a vacuum manifold was used to pull through the carrier liquid and any
unincorporated cells that remained, leaving only the microparticles in the dry well. The
well was then immediately rehydrated with 700 pL of TET and the filtration was repeated
two more times. Following the third rinse, the well was filled with 700 pjL TET, the solution
was manually mixed ten times with a pipette to remove particles from well surfaces, and
the entire liquid volume was transferred to a snap-top tube for further processing. This
filtration was found to be effective for separating the microgel particles from
unincorporated cells and was also observed to be very important for producing clean, non-
fouling particles during subsequent assay. Particles containing encapsulated cells were
added to snap-top tubes containing lysis buffer, and lysis and target capture were carried
out simultaneously during the same 90 min incubation at 55'C.
An optimized lysis buffer was developed to ensure rapid denaturation and digestion of
cellular protein so that miRNAs could be released from sequestration and captured on gel-
embedded probes with the labeling protocols described in Section 2.3.4 and Section 2.3.5.
The final formulation of this buffer consisted of TET with final concentrations of 350 mM
NaCl, 2% (w/v) SDS, 1% (w/v) BSA, 200 pg/mL proteinase K (PK, New England Biolabs),
and 0.5 U/tL Superase-In RNase inhibitor (Invitrogen). It was important to pass this buffer
through a syringe-mounted 0.45-tm filter to reduce the likelihood of clumps of debris in
later stages of the assay. When using SDS and PK in the lysis buffer with the RCA labeling
protocol, it was crucial to use biotinylated dNTPs (bio-dNTPs) rather than biotinylated
labeling oligonucleotides for the attachment of SA-PE in order to avoid non-specific fouling
on the particles (see Section 6.2.2).
In the modified bio-dNTP protocol, labeling was carried out in the same manner described
in Section 2.3.5 up to the point at which the RCA mixture is added. In the bio-dNTP
protocol, a master mix of unmodified dNTPs (New England Biolabs) and bio-14-dNTPs
(Invitrogen) was prepared with the following composition: 1 mM dGTP, 1 mM dTTP, 840
tM dATP, 840 pM dCTP, 200 pM biotin-14-dATP (Invitrogen catalog number 19524-016),
and 200 pM biotin-14-dCTP (Invitrogen catalog number 19518-018). After the addition of
BSA, DTT, and Phi29 enzyme, 1 ptL of this master mix was added to the 50-pL volume of
the reaction tube. Nucleotide concentrations and the ratio of labeled-to-unlabeled
nucleotides were chosen to match the vendor's suggested conditions for polymerase
incorporation. RCA was carried out at 30'C in a thermoshaker (1500 rpm) for 14 h, after
which the particles were washed three times with R50. A 6M urea solution in TET was
created, and 3 mL of the resulting solution was mixed with 7 mL of R50 to create a 30%
urea mixture. After passing this mixture through a 0.45-pm filter, 5 pL of the mixture was
added to the -50 pL volume in the reaction tube, and the contents were incubated at 37'C
for 1 h in a thermoshaker (1500 rpm). Upon removal from the thermoshaker, the particles
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were washed twice with R50, and SA-PE (1 mg/mL) was diluted 1:50 in TET and added to
obtain a final dilution of 1:1000. The particles were then processed for fluorescence imaging
in the same manner as described in Section 2.3.5.
2.3.10 Microwell Confinement Assay
PDMS microwell arrays with well depths of 46 and 113 pm were produced from
separate master wafers made at the BMRC. To facilitate magnetic manipulation, molds
were only poured to a depth of about 1.5 mm (as opposed to the 5 mm depth used for
other molds) by using a mixture of 1 g PDMS curing agent and 10 g PDMS base. Molds
were typically used for assay within three days of their creation, and incubation buffers
were always made fresh for each detection experiment. Buffer M1 (TET with 350 mM
NaCl, 1% BSA, 2% SDS, and 200 gg/mL PK) and buffer M2 (TET with 350 mM NaCl,
1% BSA, 4% SDS, and 400 ptg/mL PK) were created in 15-mL Falcon tubes and used for
calibration and cell-based trials, respectively. To completely dissolve the SDS at these
concentrations, it was useful to immerse the mixture in a hot water bath maintained at
60 0C, and to improve particle clarity in post-assay imaging, it proved beneficial to pass
the resulting incubation buffer through a syringe-mounted 0.45-pm filter (Acrodisc 25
mm with Supor membrane, Pall Corporation). For calibration studies, a dilution series
of appropriate synthetic targets was prepared using buffer M1 as the diluent. The
desired microwell design was excised from the wafer mold with a scalpel and placed
feature-side upwards on a clean glass slide (24 X 60 x 1 mm, VWR) that was then
inserted into a plasma oven. A vacuum pump was used to evacuate the oven for 60 s, at
which point a 45-s UV treatment at the low Rf setting was performed. Although this
degree of plasma treatment only slightly improved the wettability of the PDMS surface,
higher Rf settings or longer treatments at the low setting were observed to create an
irreversible bond between the PDMS surface and the hydrogel microparticles, thus
preventing particle collection after assay.
For calibration trials with synthetic spikes, the wells were immediately transported to
an inverted microscope following plasma treatment, where 7 IL of buffer M1 and 0.3 pL
of Superase-In were deposited on the center of the thin PDMS slab. With the halogen
lamp at the lowest possible setting to prevent evaporation of the deposited liquid, the
wetting of the microwells was monitored with the 5x objective. After 5 min, 0.5 ptL of
magnetically-functionalized particles (stored at -12.5 particles/pLL) were gently added to
the wetted portion of the PDMS, and a thin rectangular hand magnet attached to the
end of a screwdriver was maneuvered underneath the stage to direct particles into
wells. By controlling the angle of the magnet, particles could be dragged through
solution with their broad faces or their thin edges lying flush with the PDMS surface
[179]. All particles were typically inserted into wells within 2 min of particle injection.
For the introduction of synthetic miRNA targets, 7 pL of target appropriately diluted in
buffer M1 was repeatedly injected into and withdrawn from the droplet lying on the
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PDMS. This process was repeated at least ten times to mix the delivery and wetting
fluids for even dispersal of target. After the tenth cycle, the fluid in the pipette was
emptied onto the PDMS, and the slide was removed from the microscope and placed into
the bottom holder of a microarray hybridization chamber (Agilent). A second glass slide
(24 x 60 x 1 mm) was placed on top of the PDMS, the chamber's top holder was inserted,
and the chamber was then secured tightly with the thumb screw. For a tight seal
without deforming the wells, it was best to turn the thumb screw only until resistance
was encountered. The chamber was then placed in a small oven kept at 55'C for 90 min
for target capture.
Following incubation, the thumb screw and top holder were removed, and the glass-
PDMS-glass assembly was transferred to the microscope stage. Once the top glass slide
was removed, 15 pL of R50 was immediately deposited onto the PDMS surface, and 15
piL of R50 was also placed onto the underside of the glass slide. This was done to
maintain hydration of the particles so that they would not stick to the substrates. For
particles remaining in the wells, 15 tL of R50 was pipetted into the wells to eject
particles, which could then be collected by aspirating the liquid from the top of the
PDMS. For particles retained on the glass slide, it was often necessary to gently scrape
them from the surface with a pipette tip in order to aspirate them. All collected particles
were then deposited in a 0.65-mL snap-top tube containing R50, rinsed, and processed
either with non-amplified ligation labeling or RCA as in Section 2.3.4 and Section 2.3.5,
respectively.
For cell assay within the microwells, cultured HeLa cells were trypsinized, harvested, and
stored at concentrations between 1 x 106 per mL and 6 x 106 per mL in Dulbecco's Modified
Eagle's Medium (DMEM) with 10% fetal bovine serum (FBS). Depending on the desired cell
density, 5-60 tL of cell solution was added to 2-4 mL of TET with 150 or 350 mM NaCl and
1% BSA. Then, 7 p.L of this mixture and 0.3 ptL of Superase-In were deposited onto a clean,
plasma-treated PDMS slab. After waiting 5 min for the wells to wet and for the cells to
settle, 0.5 pL of particles (stored at -12.5 particles/ptL) was gently added. Next, 7 iL of
buffer M2 was manually mixed into the deposition droplet in a manner identical to that
described above for the synthetic target. Thorough mixing was crucial to ensure even
distribution of the lysis agents contained within buffer M2. Subsequent well sealing,
incubation, and particle extraction/processing for the cell-based assays proceeded exactly in
the manner described earlier for calibration trials. It should be noted that the two protocols
(one for calibration with synthetic spikes and one for cell-based assays) and the two buffers
(M1 and M2) were designed to produce the same final concentration of reagents within the
sealed wells (350 mM NaCl, 1% BSA, 2% SDS, 200 ptg/mL PK, and 0.5 U/ pL Superase-In).
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Chapter 3
High-throughput Flow Alignment of Hydrogel
Microparticles
Suspension (particle-based) arrays offer several advantages over conventional planar
arrays in the detection and quantification of biomolecules, including the use of smaller
sample volumes, more favorable probe-target binding kinetics, and rapid probe-set
modification. In this chapter, we present a microfluidic system for the rapid alignment of
multifunctional hydrogel microparticles designed to bear one or several biomolecule probe
regions, as well as a graphical code to identify the embedded probes. Using high-speed
imaging, we have developed and optimized a flow-through system that (1) allows for a high
particle throughput, (2) ensures proper particle alignment for decoding and target
quantification, and (3) can be reliably operated continuously without clogging. A tapered
channel flanked by side focusing streams is used to orient the flexible, tablet-shaped
particles into a well-ordered flow in the center of the channel. The effects of channel
geometry, particle geometry, particle composition, particle loading density, and barcode
design are explored to determine the best combination for eventual use in biological assays.
Particles in the optimized system move at velocities of -50 cm/s and with throughputs of
-40 particles/s. Simple physical models and CFD simulations have been used to investigate
flow behavior in the device.
3.1 Introduction
The ability to accurately detect and quantify biological molecules in a complex mixture
59
is crucial in both basic research and clinical settings. Advancements in the fields of
genomics and proteomics require robust technologies that can obtain high-density
information from biological samples in a rapid and cost-effective manner [2, 4-6]. High-
throughput screening for genetic analysis, combinatorial chemistry, and clinical
diagnostics benefits greatly from multiplexed analysis, which is the simultaneous
detection of several target molecules [7, 8]. This approach significantly reduces the
required assay time, sample volume, and cost. However, it requires an encoding scheme
that can be used during analysis to identify immobilized probe species.
Particle-based assay platforms exhibit several advantages over planar arrays in
applications that involve the detection of low to medium target densities (1-1000),
demand rapid probe-set modification, or necessitate high-throughput processing of
samples [26]. Compared to planar arrays, the use of micrometer-sized particles leads to
faster probe-target binding kinetics due to mixing during incubation, more efficient
separation and washing steps, and higher degrees of reproducibility [31, 32]. The vast
majority of particles used in suspension arrays are optically encoded latex microspheres
with diameters between 0.3 and 10 sim that can be interrogated and decoded with laser-
based flow cytometry. Optical encoding is accomplished by swelling the spheres with
fluorescent organic dyes with different emission spectra. Although used extensively, this
scheme requires multiple excitations and is limited to the multiplexed sensing of only
-500 analytes due to spectral overlap of encoding and analyte-detection fluorescence
[27, 50]. Submicrometer rods with multiple metal stripes that serve as a graphical code
for multiplexing have also been developed, but the high density of such rods leads to
rapid settling in solution and thus requires the rods to be vigorously mixed during
assays, a procedure which can damage fragile biological molecules like antibodies [33,
48]. Moreover, a feasible high-throughput quantification and decoding strategy for the
rods has never been introduced, thereby significantly limiting their applicability in
clinical or research settings.
Recently, innovations in gel-based microchips were combined with suspension array
technology to create multifunctional, graphically-encoded hydrogel microparticles for
biomolecule analysis [23, 52]. Implementing photolithography and microfluidic-based
techniques, geometrically and chemically complex microparticles were rapidly
synthesized (104 per hour) with high reproducibility from co-flowing streams of UV-
curable monomers [160]. Synthesis, encoding, and functionalization of the particles
occurred in a single step, with unpolymerized holes in the wafer structure used to
construct a 20-bit fluorescent "barcode" region. Multiplexed detection of fluorescently
labeled DNA oligomers was demonstrated with high specificity, high sensitivity, and
short hybridization times. Nonspecific binding in multiplexed assays was minimized
through the use of a biocompatible and non-fouling PEG polymer scaffold. Compared to
the surface immobilization strategies employed with planar arrays and latex
microspheres, the immobilization of probe molecules in a three-dimensional gel
structure leads to more favorable hybridization kinetics due to the hydrated
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environment, high probe-loading densities, and decreased steric hindrance [174, 180].
Furthermore, the physical separation of code and probe regions on each particle enables
the use of a common fluorophore for all signalling purposes, thus avoiding the spectral
issues that limit the multiplexing capacity of the optical encoding schemes discussed
earlier and also reducing the costs associated with detection equipment. Although flow-
through scanning was demonstrated for a limited number of encoded hydrogel particles,
the processing rate was low (<1 particle/s) and therefore not suitable for high-
throughput applications [52]. Robustness of the device was also not explored.
Originally developed in the 1950s to count cells, flow cytometry has become a versatile
tool for the rapid interrogation of the synthetic microparticles used in suspension arrays
[51, 56, 181]. Compact and inexpensive molded microfluidic cytometers made of the
silicone elastomer PDMS have been developed for particle sizing, as well as single-line
fluorescence detection [60, 61]. The ability to achieve well-ordered flows with uniform
particle velocity and passage time is essential for accurate detection and
characterization in such devices. The most common method of directing the particles
through the channel involves the hydrodynamic focusing of the particle-bearing stream
with secondary sheath flows [63, 67]. Recent advances have led to high-throughput and
high-resolution cytometers capable of three-dimensional hydrodynamic focusing [62, 64].
In order to extend the barcoded hydrogel platform to real-world applications in high-
throughput screening, we seek to develop a robust microfluidic approach to the rapid
interrogation of each particle. We present a parametric study to understand the various
geometric, mechanical, and operating factors that govern the system's performance. The
inclusion of properly-spaced side-focusing streams, the use of a sufficiently wide detection
zone, the modulation of particle cross-link density and morphology, and the choice of
particle loading concentration were identified as the most crucial elements. We
demonstrate here a new system that implements the design principles distilled from this
study and thereby is capable of reliably manipulating the relatively large and flexible
hydrogel particles into a single-file, high-velocity procession without clogging or
deformation. The ability to align particles in the channel with high precision will enable
PMT-based detection with a simple one-dimensional line scan that integrates fluorescence
intensity along a thin excitation beam established perpendicular to the flow direction of the
particle. The resulting profile could then be used to reconstruct the identity of the particle
as well as the extent of the binding events on the various probe and control regions.
3.2 Theory
The tablet-shaped hydrogel particles investigated here are substantially larger (250 x
80 x 35 pm, Figure 3.1) and more flexible than the latex microspheres commonly used in
other suspension arrays. This introduces additional design considerations regarding
flow velocity and mechanical stress. Pressure-driven flow is used to carry the particles
through rectangular PDMS channels, while sets of side streams and abrupt contractions
61
in width serve to orient the particles prior to their entrance into a narrow "detection
zone." In a rectangular channel with a high cross-sectional aspect ratio, it is expected
that a parabolic velocity distribution will develop along the small dimension. This flow
profile can inhibit the performance of cytometers by generating nonuniform particle
velocities. Although the short dimension can be further reduced to physically confine the
particles, this lowers flow velocity and throughput. Higher driving pressures could be
used to counteract these decreases, but such an approach may lead to deformation of the
channel and/or the particles. While the velocity distribution in the long cross-sectional
dimension will be nearly uniform in the center of the channel, large gradients will
develop in a boundary layer near the wall. Particles passing through this layer will be
slowed significantly. Focusing streams and periodic contractions in channel width could
be used to disturb the developed flow along the walls and eject particles into the central
flow region for better cytometric performance. It has previously been shown that rapid
decreases of channel cross-section can enhance the focusing of deformable blood cells by
introducing regions of high shear rate adjacent to the walls that produce strong
hydrodynamic lift forces [182].
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Figure 3.1: Particle flow in rectangular channels. (A) Image from high-speed movie of model
particle flowing "lengthwise" at 30 cm/s from left to right in 150-pm wide channel. Columns of
coding holes run in the y-direction, while rows run in the x-direction. (B) Cross-sectional
schematic of the particle in (A). The height gap is ~1-2 pm in the studies presented. The larger
side gap permits significant bypass flow, thus leading to bulk fluid velocities that are higher
than particle velocities. (C) Schematic of pertinent variables for application of the lubrication
approximation to analyze lift forces and torques on misaligned particles in channel regions
where side-gap flow is nearly unidirectional.
The pressure-driven flow of both rigid and flexible disk-shaped bodies in parallel plate
channels has been used to model the behavior of red blood cells in certain microvessels
in which cell and passage heights are nearly equal [183, 1841. Although the mechanical
properties of cells and hydrogels differ in some aspects, many of the effects observed in
these studies are relevant to the current investigation. For flexible bodies that deform
at constant volume and surface area, it was found that the pressure in the thin "height
gaps" above and below the body (Figure 3.1 B) will be uniform. Small deformations in
the body height were shown to produce a gap distance that varied with spanwise (y)
position only; the gap distance was constant along lines parallel to the flow. Cell velocity
was predicted to be much less than that of the bulk fluid for channels with small height
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gaps and with spans much larger than cell width. This effect can be attributed to the
ability of the fluid to easily bypass the cell by moving through the relatively large "side
gaps." In contrast, for tightly fitting bodies in cylindrical tubes, the driving pressure is
concentrated across the particle, leading to bulk fluid velocities that are lower than body
velocities and even "leakback" of fluid [185].
A thorough understanding of the hydrodynamic forces that act on the particles in the
channel is crucial for the development of an effective cytometry system. For the narrow
detection portions of the channel a lubrication approximation can be utilized to determine
the lift forces on a particle that arise from the bypass flow in the side gaps just described
(see Section 3.6 for full derivation). This analysis can be used to rationally design a particle
and a channel that will give rise to forces and torques that most effectively position and
align the particle for proper scanning. In a reference frame moving with the particle, the
fluid velocity and pressure drop in the side gap are given by:
v (x, y)= _L (y - h(x))+ U, -1 Equation 3.1
2pu dx (h(x)
dP= 12pq 6iU, Equation 3.2
dx h(x) h(x)2
where p is the dynamic viscosity, P is the dynamic pressure, U" is the wall velocity, and q is
the volumetric flow rate per unit width (see Figure 3.1 C for other definitions). The
geometric and dynamic criteria required for application of the lubrication analysis become
tan a << 1 and (q/v) tan a << 1 [159]. Neglecting deformation and any three-dimensional
effects from flow in the height gap, these conditions are met by the nearly unidirectional
bypass flow established in the side gaps when an oblong particle is passing through the
relatively narrow regions of the channel at small a. In analyzing the stress exerted by the
fluid on a rigid particle surface, the normal viscous stresses are zero, and the components of
the stress vector are thus given by:
dh a~v
s = -- P - p * Equation 3.3dx Oy
Sy = P. Equation 3.4
The torque (per unit width) about ro can be calculated as
G = (r -r)x s(n) dx. Equation 3.5
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Meanwhile, the rotational and translational tendencies of particles in the wider regions of
the channel (i.e., upstream) are best understood by the principle of gradient minimization,
which dictates that the oblong particles will tend to rotate until the velocity gradient across
their rear surface can no longer be reduced. For rectangular particles with high aspect
ratios, this condition will be met once the short and long dimensions have been oriented
perpendicular and parallel, respectively, to the flow direction. The large particles used in
the study are expected to impact the time scale of this orientation process by altering local
velocity profiles and generating significant wake flows in areas of high particle
concentration.
3.3 Process Design
The success of high-throughput microparticle scanning depends on both the fluidic channel
design and the particle morphology. We took a three step approach to independently study
these two facets of the project and optimize the process. First, using a canonical
microparticle design we explored a variety of operating conditions and channel designs with
the aim of minimizing clogging and disruptive particle-particle interactions in the detection
zone. Next, particle size and composition were varied to explore the impact on alignment
tendency and mechanical stability. Finally, the operational limits of a revised particle
design suitable for bioassays were studied to maximize throughput and success rate while
also maintaining a high degree of reproducibility; additional modeling and analysis of these
particles were conducted to further understand the complexities of their behavior in high-
speed flows. A "successful" scan was defined to be one in which the horizontal distance
between the center of any two holes in a given column of the code region was less than 5
gm. In addition, particles with any measurable lateral (y-direction) drift were deemed
"unsuccessful" passages. This conservative definition of success is based on the PMT
sampling rates (0.1-1 MHz) and excitation beam width (1-5 pim) required for fluorescence
scanning procedures. Quoted throughput values include both successful and unsuccessful
particles, and unless otherwise noted, each flow trial involved the measurement of 100
particles.
3.3.1 ChannelDesign
The effects of detection-zone width (Wd), side-stream number (N), side-stream spacing
(Lf), and forcing pressures were studied for a fixed particle design (Figure 3.2). All
particles used in channel optimization were photopolymerized from DA20 prepolymer
(Table 2.1), had dimensions of 270 x 90 x 33 ptm, and featured 10 x 10 ptm code holes
spread evenly throughout the particle (Figure 3.1 A). The composition was selected
based on its performance in earlier assay optimization studies [52], while the hole
design was chosen for its symmetry and for its use in alignment measurements. Loading
concentration was fixed at 10 particles/ptL.
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Figure 3.2: Particle flow device. Schematic of a "4-focus" device, with four
sets of side streams (N = 4), each separated by L4 = 1000 pm. Sections of
constant width (450, 350, 250, 150, and 125 pm) are broken up by abrupt
contractions. Sheath flow is introduced through inlet 1, while the particle-
bearing fluid is introduced through inlet 2. The detection zone is the region
in which the particle velocity, alignment, and position are evaluated to
determine if a passage is successful. The measurement point was 750 pm
from the outlet for all flow trials.
Initial trials were performed with a simple channel design with one set of side streams
("1-focus device," N = 1). The central channel decreased in width from 500 to 100 ptm at
the meeting point of the side streams, producing a large velocity gradient in the flow
direction. The detection zone was 2.3 mm in length, with Wd = 100 pim. The forcing
pressures of the particle and sheath streams were matched, and they varied between 4
and 9 psi. Average particle velocities for this pressure range were between 10 and 30
cm/s. Analysis of the detection region revealed a tendency for particles to appear in
clusters with poor alignment and slight deformations of the leading and trailing particle
edges. Moreover, flow in the channel would temporarily decrease at times, producing
wild variations in particle velocities over short periods of time.
These observations implied that the particles were jamming at the contraction point of
the channel. Subsequent investigation of this region revealed periodic instances in
which groups of 2-5 particles traveled closely together and lodged tightly in the
contraction zone, thus impeding flow and leading to an accumulation and compression of
particles. After 100-1000 ms, the elastic hydrogels would eventually squeeze past one
another and eliminate the blockage, producing the clumps observed further
downstream. It should be noted that the clogging never led to permanent (plastic)
deformation. Particles collected in an exit reservoir did not exhibit any substantial
structural abnormalities. Seeking a more gradual contraction with improved particle
conditioning, additional trials with 2- and 3-focus devices with Wd = 100 pm and Lf= 400
ptm were performed. The frequency and duration of the blockage events were reduced,
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but only by small amounts. Observations of the flow patterns in the 500-pm width
region of 1-focus devices revealed a tendency for some particles to travel slowly along
channel walls. Such behavior is consistent with the flow profile of a channel with a high
aspect ratio, as discussed earlier. Although the same observations were made in the
500-gm wide regions of the 2- and 3-focus devices, the "wall-huggers" in these channels
were reliably coerced off the wall prior to the detection zone by the local velocity
increase created by the impinging side streams.
It was postulated that increasing L from 400 to 1000 pm would better enable particles
to adopt a lengthwise flow orientation prior to the shorter contraction points at which
clogs were ocurring. This was based on the belief that rotation into the lengthwise
orientation arose from a tendency for the particle to minimize the velocity gradient of
the flow impinging upon it. The disordered flow patterns in the wakes of particles
severely limited this effect, making congested areas less likely to produce well-aligned
particles. Trials with larger Lf seemed to confirm this hypothesis. Based on observations
of both upstream and detection zones, the longer residence time of the particles in the
wide portions led to a nearly complete elimination of blockage events and drastic
velocity variations in a modified 3-focus device with Lf = 1000 pm. However,
deformations of particles traveling through the detection zone persisted, especially at
higher forcing pressures. Particles approaching the final width contraction (200 to 100
pm) in the 3-focus device were seen to distort violently if they approached the
contraction from a position far from the centerline of the channel. Furthermore, the
small side gap between the particle and channel walls (5 pm on each side) led to a large
pressure drop across the particle length and introduced substantial lift forces that
compressed the particle in the direction perpendicular to flow and elongated it in the
direction parallel to flow (-10% increase in length). Although such deformation could
potentially increase the resolution of the proposed line scans, it was determined that
future channels would have detection zones roughly twice as wide as the particle to
preserve particle morphology by increasing bypass flow and lowering the pressure drop.
In short, this study revealed the need for multiple sets of side streams separated by a
sufficient distance, as well as a detection zone width that permitted substantial bypass
flow for shape preservation.
3.3.2 Particle Design
The control over hydrogel morphology and composition permitted by SFL is a valuable
tool for design. The alignment of the tablet-shaped particles observed in initial
experiments was far more reliable than that of additional morphologies that were also
investigated (oblong particles with pointed ends, as well as tear-drop and bullet shapes).
As a result, the 3-focus design with Lf = 1000 ptm was adopted for the parametric study
of the tablet-shaped particles. All studies detailed in this section were performed with
Wd = 150 jim and a pressure of 9 psi for both inlets, leading to particle velocities of 25-35
cm/s.
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Figure 3.3: Primary failure modes of DA20 particles in detection zone with wd = 150 Pim. (A) 190 X 90
pm particle (AR = 2.11) with poor alignment. (B-D) 270 X 90 pm particles (AR = 3.00) with drastic
deformations that would preclude reading of the barcode. Scale bar in all images is 50 pm.
Aspect Success Mean Dist From Main Failure Mode
Ratio Rate Centerline (pm)
DA20 2.11 91% 4.5 Lateral movement
2.56 95% 2.6 Front deformation
3.00 82% 3.2 Front/back deformation
3.44 99% 1.4 None
DA30 2.11 82% 9.2 Lateral movement
2.56 94% 6.9 Lateral movement
3.00 88% 6.5 Poor alignment
3.44 100% 3.6 None
Table 3.1: Effect ofAR on particles in device with N = 3 and wd -- 150 Um.
The effect of particle aspect ratio (AR) was explored by flowing 90-tm wide particles
(DA20 composition) with four different lengths: 190, 230, 270, and 310 pLm. Flow trials
involved measuring the lateral position and success rate of 100 particles of each type
(Table 3.1). The position was calculated as the distance from the center of the particle to
the centerline of the channel. It was observed that several of the shortest particles, AR
= 2.11, exhibited significant lateral movement and had slanted front and rear edges
upon reaching the detection zone (Figure 3.3 A). Particles with AR = 2.56 flowed more
closely along the centerline of the channel and with virtually no lateral movement, but
several had leading edges that were slightly blurred or compressed at driving pressures
of 9 psi. Particles with AR = 3.00 exhibited drastic deformations (Figure 3.3 B-D),
leading to the lowest success rate of the four particle types. In many instances, the front
edge of the particle was bent towards one of the walls, thereby disrupting the alignment
of the holes in the code region. This phenomenon is qualitatively similar to the
deformations of tightly fitting red blood cells in two-dimensional channels. In the case of
cells, the bending arises to reduce the driving pressure needed to sustain a certain cell
velocity [186]. Several particles (10%) with this AR also exhibited curved side walls. The
particles with AR = 3.44 suffered from none of the problems that plagued the other
designs. The sole failure in this trial was one particle that was twisted into a U-shape.
The results of these trials indicated two potential sources of failure. At low AR, there
was a reduced tendency to orient into and maintain a flow alignment that was
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conducive to scanning. As discussed earlier, the generation of lateral forces in the small
side gap between the channel wall and the particle edge will tend to rotate the particle
into an orientation such that the major axis of the particle is aligned with the centerline
of the channel. This effect becomes more pronounced as the particle length-to-channel
width ratio (b) becomes larger. Longer particles experience a larger net torque, and
smaller side gaps generate greater lift. Meanwhile, failures of a different nature arose
at more moderate AR. Particles with mid-range AR achieved the desired orientation and
position within the detection zone, but they were more susceptible to deformations of
their leading edges. A visual inspection of the particles entering the final contraction in
the 3-focus device revealed that many of the particles of mid-range AR were poorly
oriented and thus forced to bend significantly to enter the more narrow detection width.
In contrast, particles with the lowest AR resisted such deformation and were able to
enter with imperfect alignment due to their smaller size. Particles with the highest AR
were already aligned sufficiently so that they did not experience distortion upon their
entrance into the detection zone.
It is well known that the mechanical strength of a hydrogel depends to a great extent on the
number and nature of the cross-links present [173]. By using a prepolymer with a higher
proportion of crosslinking monomer (PEG-DA), it should be possible to generate hydrogel
particles with higher cross-linking densities that are more resistant to deformation. The AR
study was thus repeated with particles polymerized from DA30 prepolymer (Table 2.1) to
investigate effects on flow characteristics. Atomic force microscopy (AFM, Agilent
Technology) was used to probe the mechanical properties of the particles. An optical
microscope (IX 81, Olympus) was employed to position AFM cantilevered probes above
particle samples. Calibration of AFM cantilevers of nominal spring constant k = 0.01 nN/nm
and probe radius R = 25 nm (Veeco) was conducted. Briefly, inverse optical lever sensitivity
(nm/V) (InvOLS) was measured from deflection-displacement curves recorded on rigid glass
substrates. For each measurement of elastic modulus, at least 25 replicate indentations
were acquired to maximum depths of 20 nm. Acquired probe deflection-displacement
responses were converted to force-depth responses using measured spring constants and
InvOLS (Scanning Probe Imaging Processor, Image Metrology). Elastic moduli, E, were
calculated by applying a modified Hertzian model of spherical contact to the loading
segment of the force-depth response with the scientific computing software Igor Pro
(Wavemetrics).
From AFM measurements on particle regions without coding holes, the elastic modulus
of the DA20 hydrogel was found to be 10.1 + 0.4 kPa, while that of the DA30 hydrogel
was found to be 19.6 ± 1.2 kPa. The impact of the added rigidity of the DA30 particles
was noticeable, with significantly less deformation at all values of AR (Table 3.1). DA30
particles did not exhibit the bent leading edges, curved side walls, or compressions that
plagued the softer DA20 particles. Observations of the final contraction revealed
particles with no perceptible shape changes, in sharp contrast to the DA20 case.
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While the higher cross-linking density solved one flow problem, it seemed to exacerbate the
other. The stiffening of particles with ARs of 2.11 and 2.56 led to an increase in poorly
aligned particles that were also more susceptible to moving laterally in the detection zone
(Figure 3.4). The use of DA30 raised the success rates of the two higher ARs, but actually
led to a decrease in the success rates of the two lower ARs. In the case of DA30 particles
with ARs of 2.11 and 2.56, the additional rigidity arising from higher cross-link density,
when combined with the compact morphology, leads to a regime of rigid-body motion within
the channel. This effectively eliminates the temporary hydrogel deformations induced by
the surrounding focusing flow that play a significant role in coercing the particle into the
preferred position and alignment. Any attempt to tune the flow behavior with this design
parameter must balance the desire for structural integrity with the need for efficient
focusing and orientation by hydrodynamic forces. Thus, the best particle design will have a
high aspect ratio and a stiff gel network.
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Figure 3.4: Lateral position of particle (W = 90 pm) in detection
zone with wd= 150 pm. This plot demonstrates the difference in
position for particles of different lengths and compositions. At all
lengths, the softer DA20 particles exhibit superior positioning
and a reduced tendency to move laterally. Longer particles are
observed to settle into stable flow trajectories closer to the
centerline than shorter particles. Each point represents 100
particles, and all measurements were made from channel
centerline to the cen tral-most point of the particle.
3.4 Barcoded Particle Optimization
The channel and particle motifs with the best performance characteristics were selected to
create a flow-through system that could be operated reliably at high-throughput with
hydrogel designs that were capable of extracting and displaying information from
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bioassays. Three different channel designs (A, B, C) were used (Table 3.2), each with L4=
1000 pm. The shape and composition of the hydrogel particle were altered to ensure proper
alignment, durability in high-velocity flows, and compatibility with bioassays. Using new
masks and SFL, 9 pm X 9 pm holes were limited to one half of the particle, thus creating a
"probe" region and a "code" region (Figure 3.5 A). Columns and rows of holes were
separated by 9 pm. This design allows the capture and quantification of target(s) on one end
and the display of probe identity on the other[52]. To create "bifunctional" particles, the
code region was polymerized from DA30 to ensure mechanical stability, while the probe
region was polymerized from DA20 to produce a pore size consistent with that featured on
particles employed in high-sensitivity assays in previous work [52, 174]. Furthermore, the
use of DA20 imparted a flexibility that would aid in orientation within the channel, as seen
in the earlier particle study. The new particles were 235 X 65 x 35 pm and featured a
redesigned hole setup capable of 3,072 distinct codes. The AR of this design (3.62) was
higher than any used in previous flow trials.
Name Wd (pm) Side stream sets, N Upstream widths (sm)
A 100 4 450, 350, 250, 150, 100
B 125 4 450, 350, 250, 150, 125
C 150 3 450, 350, 250, 150
Table 3.2: Channel parameters for optimization study.
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Figure 3.5: Bifunctional barcoded particles. (A) Image from high-speed movie of bifunctional
barcoded particle flowing "robe-first" at 55 cm/s from left to right in a channel with wd - 125 pm.
The dotted box around the first column of holes is drawn to indicate the thin excitation beam that
will be employed in 1 -D line scans. Column and row spacings are 7 and 9 pm, respectively. (B) Plot
showing superior performance of bifunctional design. Each point represents 100 particles. (C)
Histogram of detection -zone velocities of 1,000 bifunctional particles in devices B and C. The small
spread of velocities for each device indicates a high degree of order and repeatibility. Results are
compared from trials run in five B and five C devices with five different particle batches. The tails on
the left side of each spike can be attributed to the small percentage (15-20%) of particles that flowed
'ode -first." For the bifunctional design, these particles were typically 10% slower than their probe -
first counterparts.
3.4.1 Bifunctional Design
To evaluate this new design, bifunctional particles were flowed through the three channel
types at loading concentrations of 10 particles/pL, and their performance was compared to
that of particles with probe and code regions both synthesized from DA30. Higher success
rates were recorded for the bifunctional particles in all three channels (Figure 3.5 B).
Bifunctional particles also flowed more closely along the centerline than their pure-DA30
counterparts in all channel types, with the best positioning achieved in design C. With the
asymmetric morphology, a preference for "probe-first" flow was observed, with 91% of
bifunctional and 79% of pure-DA30 particles doing so. In addition, higher velocities (35-60
cm/s) were recorded for these slender particles. Compared to the previously used 90-pm
wide design, the 65-pm wide design provided larger side gaps that effectively reduced the
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pressure drop across the particle, thereby diminishing the tendency to deform in the
detection region. For the 600 total hydrogels analyzed, probe-first particles traveled -10%
faster than code-first particles, with a larger difference being measured for the pure-DA30
design.
3.4.2 Hole Spacing
The effect of hole spacing was investigated, again using the same three channel designs.
Seeking to increase throughput, the loading concentration was increased from 10 to 15
particles/pL for these trials. Bifunctional particles with column spacings of 9, 7, and 5 ptm
were studied (all row spacings remained 9 tm). Shorter column spacings reduce the particle
area needed for coding and thus increase the area available for probe immobilization.
However, the desire to minimize the code area must be balanced by the need to maintain
structural integrity. Nine trials with bifunctional particles of the three spacings in the
three channels revealed a noticeable reduction in success rate for holes with 5-pm spacing.
For the 900 hydrogels studied, the average success rates of the 9-, 7-, and 5-pim spacings
were 97%, 99%, and 88%, respectively. Most failures of the smallest spacing were due to
large compressions of holes in particles traveling code-first. Mean throughput at the higher
loading concentration was 29 particles/s, while mean velocity was 51 cm/s.
3.4.3 Repeatibility
The high success rates achieved in devices B and C (100% and 99%, respectively) with 7-pim
spacing were explored further by conducting additional trials. Five new batches of
bifunctional particles with the spacing were synthesized, and five devices of each type were
constructed. To investigate the reproducibility of the earlier results, each batch was sent
through one of the five sets of devices (i.e., batch 1 through B-1 and C-1, batch 2 through B-
2 and C-2, etc.) at a loading concentration of 15 particles/pL. The results of these trials
(Table 3.3) indicated a high degree of repeatibility, including inter-trial CVs less than 4%
for the mean velocity, as well as mean success rates over 99%. This uniformity of particle
speed (Figure 3.5 C) is crucial for high-fidelity signal analysis and signifies the
establishment of well-ordered flows with minimal particle-particle interactions. As in
earlier trials, particles preferentially adopted a probe-first orientation by the time they had
entered the detection zone, with 76% flowing in this manner in B compared to 80% in C.
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Loading Channel Number Mean Mean Mean Inter-trial Percentage
Concentration Type of Trials Success Throughput Velocity Velocity Probe-first
(particles/sL) Rate (81) (cm/s) CV
15 B 5 99.8% 30.2 46.3 3.29% 84.4%
C 5 99.2% 24.9 35.0 3.91% 84.6%
17.5 B 5 98.4% 40.2 48.1 2.02% 75.6%
C 5 98.8% 35.4 35.4 1.44% 79.8%
20 B 1 92% 47.4 50.8 NA 86%
C 1 91% 40.3 38.5 NA 71%
Table 3.3: Optimized particle results for channels B and C at various loading
concentrations. All results represent bifunctional particle design with AR = 3.62 and 7-
,um column spacing. Each trial involved the measurement of 100 particles, and thus,
the total number ofparticles represented in this table is 2,200.
3.4.4 Loading Concentration
In order to maximize throughput, an attempt was made to determine the highest loading
concentration that could still produce well-ordered, single-file flows. A reproducibility study
similar to the one just described was conducted at a loading concentration of 17.5
particles/pL. Once again, a high degree of repeatibility was achieved (Table 3.3), with a
minor success-rate decrease that was outweighed by a noticeable increase in mean
throughput. As in the previous study, device B performed slightly better, with a higher
mean throughput. Trials were then performed at 20 particles/pL. At this concentration, a
more significant drop-off in the success rate occurred (Table 3.3), with crowding in the
channel significantly disrupting the upstream focusing and even leading to the partial
overlap of particles in the detection region. It was concluded that the increase in
throughput at 20 particles/piL was not worth the decrease in success rate, and the
maximum concentration was set at 17.5 particles/tL.
3.4.5 Tapered Channel Designs
Additional flow trials were conducted in two channel designs that did not use sheath
streams (N= 0). These designs featured only a central channel (of the same length as the
central channel in A, B, and C) that gradually tapered to a final width of either 100 pm (D)
or 150 pm (E). The final width persisted for 2.6 mm in D and 3.4 mm in E. Bifunctional
particles with 7-pm column spacing were used for these trials. At throughputs of only -20
particles/s, success rates were lower (83% for D, 97% for E) than those in channels with side
streams and abrupt contractions. A throughput of -40 particles/s in E led to a 92% rate of
success. Analysis of the upstream behavior in these simple tapered channels revealed a
disordered flow of tumbling particles, as well as particles that slowly traveled along the
walls of the channel (a behavior that was seen earlier in single-focus devices). While many
of these particles were able to eventually adopt a proper orientation further downstream,
the chaotic upstream tendencies led to a flow pattern and velocity distribution in the
detection zone that exhibited more variability than those of designs with sheath flow.
Indeed, for comparable throughputs, the standard deviation of particle velocity in D was
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40% greater than in A and the deviation in E was 47% greater than in C. In many
instances, consecutive particles in the detection zone in D and E were touching one another,
with some even wedging a small portion of their probe region under the code region
traveling ahead of it. These observations indicate poor conditioning of the particles in the
upstream region and underscore the importance of side streams for the reliable
establishment of well-ordered, single-file particle flows.
3.5 Barcoded Particle Flow Analysis
The hydrodynamic forces acting on the barcoded particles in the detection region of
device B were explored by applying Equations 3.1-3.5 to the nearly unidirectional side-
gap flow to determine the torque involved in lengthwise alignment. As expected, the
torque about a central point on the particle's trailing edge increased as the deviation
from lengthwise orientation grew (Figure 3.6 A). This torque always acted to restore the
lengthwise orientation, and its magnitude was greater for particles with higher values
of b (particle length-to-channel width ratio). This trend reinforces earlier observations
regarding alignment tendencies and particle dimensions. For the case b = 1.88, results
of the lubrication approximation agree well with the torques calculated for various
values of 6 using 2-D COMSOL simulations (Figure 3.6 B).
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Figure 3.6: Hydrodynamic forces on misaligned particles. (A) Plot of torque magnitude calculated for
misaligned particle centered in detection zone with wd = 125 pm. Torque is calculated about the
central point on the trailing edge of the particle (marked by black x in (B)), based on experimental
observations of particle rotation. As expected, higher deflection angles and higher values of b lead to
larger torques that restore the particle to a lengthwise orientation. Lubrication analysis shows
excellent agreement with torques calculated using 2-D COMSOL simulations of flow profiles (B) for
the commonly investigated situation of b = 1.88 (i.e., particle length of 235 pm and channel width of
125 pm). Calculations are based on a 1.5 psi drop across a 700-pim long detection zone containing a
single particle. Re of the flow upstream of the particle is ~~ 15.
COMSOL Multiphysics' Incompressible Navier Stokes module was used to model the two-
dimensional fluid flow in the microfluidic devices for particle focusing. For all simulations,
a stationary nonlinear solver was used with the Direct (UMFPACK) linear system solver.
Relative tolerance for the solver was at least 1.0 x 104 for all converged flow profiles, and
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high mesh densities were used to increase resolution in areas of particular interest. Based
on a "full-device" simulation without particles present, it was determined that devices with
wd 125 ptm and N = 4 had a mean fluid velocity of 6.79 m/s at the point of particle
measurement in the detection region. This full-device simulation specified no-slip boundary
conditions at all walls of the channel except the inlet port (normal pressure condition set at
9 psi) and the outlet port (neutral condition set). With a channel Reynolds number defined
as Rec = UDh/v (U is mean flow velocity, Dh is hydraulic diameter of channel, v is kinematic
viscosity of fluid), these simulations demonstrate that Rec ~ 40 for typical detection-zone
geometries. The same module was also utilized for the study of hydrodynamic forces on
particles in the detection region of the channel (Figure 3.6). Using pressure estimates from
the full-device simulation, flow profiles were solved for a 1.5 psi drop across a 700-pm long
detection zone with Wd = 125 ptm that contained a single particle with various values of 0.
No-slip boundary conditions were set at the two side walls, a normal pressure condition was
set at the inlet, and a neutral condition was set at the outlet. In addition, a normal flow
velocity condition was set at the boundary of the particle to match the typical velocity of the
particles in the detection region (50 cni/s). To determine the forces acting on the particle
surface, the post-processing feature of COMSOL was used to export data on drag and lift
forces at each point of the line segments used to construct the particle. This data was then
combined with Equation 3.5 to numerically calculate the torque with a MATLAB script.
To further understand the flow in B, the orientation of particles was recorded by
measuring the acute angle between the major axis of the particle and the centerline of
the channel (0) as particles moved through the upstream contraction points (Figure 3.7
A). An indication of alignment tendency can be obtained by measuring the standard
deviation in this angle at the end of each constant-width region for a collection of 85
particles (Figure 3.7 B). The results indicate a nearly linear decrease in deviation as the
channel width decreases for both of the orientations. The larger deviations in 0 for code-
first particles suggest this orientation is not driven to alignment in the flow as strongly
as probe-first particles. Indeed, of the 85 particles studied, four switched from code-first
to probe-first during flow, while none made the transition from probe-first to code-first.
A closer examination of one particle of each orientation reinforces this hypothesis. For
each frame of video, the full angle (i.e., 0*-3600) between the long axis and the centerline
(p) was measured to preserve orientation information, with code-first corresponding to (P
= 0' and p increasing in the counter-clockwise direction (Figure 3.7 C). Despite starting
only 200 from a lengthwise orientation, the code-first particle nearly moves into a
widthwise orientation before rotating back into a code-first alignment that oscillates
quite dramatically as the channel width approaches 150 pim. Meanwhile, the probe-first
particle behaves in a much more controlled and predictable manner, with a rapid
transition from widthwise to lengthwise orientation before a relatively mild oscillation
about q = 180'.
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Figure 3.7: Upstream rotation analysis in device B. (A) Schematic depicting the two angles of
interest. (B) Plot of deviation of 0 with channel width in the upstream region for particles that flow
code- or probe-first. The larger deviation exhibited by the code -first particles suggests that such an
orientation is less stable than the probe -first orientation. Measurements were taken at the end of the
corresponding constant-width region prior to contraction. (C) Plot of qp over the course of the travels
of two particles through the upstream region. The probe -first orientation is seen to be achieved in a
smoother and more predictable fashion than the code-first orientation, again suggesting that the
probe-first orientation is more stable. While the probe-first particle experiences limited disruptions
in the regions of constant width (shaded boxes), the code -first particle experiences two sharp
alterations in alignment. From left to right, the constant-width regions measure 350, 250, and 150
pm, respectively.
These analyses provide insight into the preferential orientation that was observed in every
trial with the half-probe/half-code particles, including those in which both regions were
polymerized from DA30. Of the 3,200 bifunctional particles analyzed in A, B, and C devices,
83% flowed probe-first, compared to 79% of the 300 pure-DA30 particles. This indicates that
the flexibility difference in the bifunctional design plays, at most, a minor role in the
preference. The measurements of rotational tendency in the upstream region imply that the
resistance to fluid flow in the thin height gaps (each -1-2 pm) above and below the code
region is different from the resistance in the height gaps above and below the probe. This
disparity can be observed directly by comparing the lateral wobbles of a code-first particle
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to the smooth, settled flow of a probe-first particle in the upstream regions of a channel
(Figure 3.7 C). While it is tempting to attribute this resistance difference to the relative
stiffness of the code region, the data from the pure-DA30 trials refute this claim. The holes
that constitute the graphical code are the only other source of asymmetry in the particle
and thus appear to give rise to the resistance difference. It seems that the flow pattern and
the resulting pressure gradient along the length of the particle in the height gap depend on
whether the holes are on the leading or the trailing edge of the particle. This hypothesis is
supported by the observed velocity disparity between code- and probe-first particles noted
earlier for bifunctional particles as well as pure-DA30 particles.
3.6 Derivation of Lubrication Approximation
To better understand the hydrodynamic forces acting on the particles, a lubrication
approximation was developed to describe the bypass fluid flow in the side gaps in the
narrow detection portions of the channel. In this section, a full derivation of the equations
from Section 3.2 is provided for completeness. Based on the negligible deformation of
particles in the optimized design, the particles are assumed to be rigid bodies for this
analysis. Building off previous observations of deformable red blood cells in rectangular
channels, the bypass flowrate in the larger side gaps is assumed to be much greater than
the flowrate through the small height gaps, leading to the neglect of any three-dimensional
flow effects in the side gaps (i.e., flow only in the xy-plane) [183, 184]. The side gap is
essentially a long, narrow channel, and as a result, the flow within it can be regarded as
nearly unidirectional (x-direction) and dominated by viscous stresses. For the lubrication
approximation to be valid in this situation, both geometric and dynamic requirements must
be met [159]. Using the physical setup depicted in the schematic in Figure 3.1 C and
assuming a constant volumetric flowrate in the detection region of the channel, the
geometric requirement becomes:
h -hj| L sin aLos - Lcsa = tan a <<I Equation 3.6
Lcosa Lcosa
and the dynamic requirement becomes:
= - tan a <<1 Equation 3.7
S)(L cos a v
where u(x) is the mean velocity at a given x position in the channel, V is the kinematic
viscosity of the fluid, and q is equivalent to u(x)h(x). Upon entrance into the detection region
of the optimized channel, the observed angle of deflection, a, for a typical particle is
between 00 and 50, thereby giving a maximum value of 0.087 for tan a and satisfying the
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geometric requirement. Meanwhile, based on a typical volumetric flowrate per width, q, of 2
x 10-5 m 2/s and a kinematic viscosity, V, of 1 x 10-5 m 2/s for the PTET carrier fluid, the q/v
prefactor in Equation 3.7 has a value of 2 and thus the maximum value of the central
expression in Equation 3.7 is 0.174. These values suggest that the use of the lubrication
approximation is indeed valid within this side gap region.
A reference frame moving with a particle with a center of mass located at the center of the
channel was adopted to simplify calculations (Figure 3.1 C). Considering only the lower half
of the channel and assuming the particle has a constant velocity, U, in the +x-direction, the
no-slip boundary conditions are
vX (x, 0) =-Uw
vr(x, h(x)) = 0
Equation 3.8
Equation 3.9
h(x)= ho + ( ax. Equation 3.10
The lubrication approximation reduces the Navier-Stokes equation to
a 2 v 1 dP
y 2 PdX
Equation 3.11
where P is solely a function of x. As discussed elsewhere, the distinction between dynamic
pressure, P, and the regular pressure, p, is quantitatively insignificant within thin layers of
fluid that have large pressure variations [159]. Integrating twice with the boundary
conditions gives Equation 3.1.
When this expression is used to evaluate the mean velocity in the channel, it is found that
dP h(x) 2  U
dx 12p 2
Equation 3.12
Upon rearrangement, this provides Equation 3.2. When this expression for dP/dx is used in
the expression for the velocity in the x-direction, the following result is obtained:
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where
vxy) = - y + 3Uy - 6q - 3Uh(x) + UJ -1 .
h(x)2 h(x) ) h (x))
Equation 3.13
In order to determine the force (per unit width) which the fluid exerts on the surface of the
particle, it is necessary to calculate the stress vector, s:
s= n-a Equation 3.14
n(x) = 1 Ae 
-elg dx
( dh 2  -1/2g(x)= +1I
Equation 3.15
Equation 3.16
where n is a vector normal to the particle surface, a is the stress tensor, g(x) is a
normalization factor, and e, and ey are the unit normal vectors in the x- and y-directions,
respectively. The nonzero components of the stress vector are then given by
s, = - a -C, =--r, P - r x
g d1x g dx dx
1 dh A = dhr,+_s, =- -x,-,,j=F + - r' ]
g dx g dx
Equation 3.17
Equation 3.18
where T is the viscous stress tensor. Because the particle is assumed to be a rigid body, both
of the normal viscous stresses are zero. Moreover, in the nearly unidirectional flow in the
gap, the normalization factor, g, can be approximated as unity, and the avx/8y term will be
much larger than the av/ax term in the calculation of the remaining viscous stress
component (Txy = [yx). With this approach, Equation 3.3 is recovered, and further it is found
that
dhiav
s =A + P.
dx ay
Equation 3.19
In calculating the y component of the stress vector, it is permissible to neglect the shear
stress term. The ratio of the pressure to the shear stress is ~ L cos a/|h]-hol = cot a, and since
a is not usually more than 5' in the detection region, it is estimated that the pressure
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contribution will always be at least ten times greater than the shear stress contribution.
This reasoning allows us to reduce to Equation 3.4.
For calculation of the drag and lift forces (per unit width) involved in orientation and
alignment, these stresses can then be integrated along the surface of the particle using the
following equations:
F -( AP+Pa | dx Equation 3.20
x( yx h"x)
F, = P dx. Equation 3.21
X1
For the curves plotted in Figure 3.6 A, the stress expressions derived above were used to
calculate the torque that the gap flow exerted on particles in the detection region. The
pressure field was calculated by integrating Equation 3.2 and using boundary values that
matched the bulk flow ahead of and behind the particle [159]. Torque (per unit width), G,
was calculated about the central point on the trailing edge of the particle, ro (Figure 3.6 B),
using numerical integration in MATLAB and Equation 3.5. The torque was calculated
about this point because high-speed videos of poorly aligned particles in the upstream
portion of the detection region were observed to most often rotate about this point in their
movement into a properly-aligned orientation. For all calculations with this lubrication
approximation, the effect of the upper gap was modeled in an analogous fashion to that just
described for the lower gap and the contributions summed for the determination of the total
force and torque. The primary difference between the two situations is that the lower gap
involved a contraction while the upper gap involved a symmetric expansion.
3.7 Summary of Results
We have shown that a plurality of sufficiently spaced side-focusing streams, a detection
zone of ample width, and a moderate particle loading concentration are crucial for the
high-throughput flow alignment of graphically encoded hydrogel microparticles. In
addition, the reliable alignment of soft particles in high-speed flows (without
deformation or clogging) is greatly enhanced by simultaneously optimizing the
mechanical properties and morphology of the particles to ensure efficient focusing by
hydrodynamic forces while still maintaining overall structural integrity in areas of high
shear. The high throughputs achieved in the optimized design of our microfluidic system
(40 particles/s) compare favorably with those of currently available technologies for
analyzing hard-sphere suspension arrays. The use of multiple probe strips on each
particle in our setup has the potential to greatly augment this processing capacity in
future work.
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The next step in the development of this platform is the implementation of a PMT for the
detection of the fluorescence emitted by the passing particles. The single-color detection
scheme made possible by the graphical encoding of probe identity should make the platform
easier and less expensive to operate than existing suspension array cytometers.
Furthermore, the large code library of the method described here permits the pooling of
samples prior to scanning, a step which can greatly reduce processing times for assays.
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Chapter 4
Rapid MicroRNA Profiling on Encoded
Hydrogel Microparticles
The work presented in this chapter establishes the encoded gel particle system as an
efficient miRNA profiling platform through the introduction of a ligation-based fluorescent
labeling scheme and a microfluidic scanning instrument that can decode particles and
quantify the amount of target bound to probe regions at rates up to 25 particles/s. This
platform's unprecedented combination of sensitivity, flexibility, and throughput offers
exciting possibilities for discovery and clinical applications, particularly in the rapid
quantification of low-abundance miRNA and other biomolecules for cancer diagnostics.
4.1 Introduction
MicroRNAs are short non-coding RNAs that mediate protein translation and are known to
be dysregulated in diseases including diabetes, Alzheimer's, and cancer [117, 125, 187].
With greater stability and predictive value than mRNA, this relatively small class of
biomolecules has become increasingly important in determining disease diagnosis and
prognosis. However, the sequence homology, wide range of abundance, and common
secondary structures of miRNAs have complicated efforts to develop accurate, unbiased
quantification techniques [134, 188]. Applications in the discovery and clinical fields
require high-throughput processing, large coding libraries for multiplexed analysis, and the
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flexibility to develop custom assays. Microarray approaches provide high sensitivity and
multiplexing capacity, but their low-throughput, complexity, and fixed design make them
less than ideal for use in a clinical setting [12, 138]. PCR-based strategies suffer from
similar throughput issues, yet offer highly sensitive and specific detection for genome-wide
miRNA expression profiling [139]. Alternative bead-based systems provide a high sample
throughput, but with reduced sensitivity, dynamic range, and multiplexing capacities [35,
41, 59]. miRNA profiling by deep sequencing is emerging as a powerful tool for small RNA
analysis; however, the high cost of implementation and need for large amounts of input
RNA currently limit its utility [149]. The ideal system for miRNA quantification would offer
the detection performance of array and PCR-based methods, the throughput of bead-based
systems, and improved reproducibility with a user-friendly workflow.
The Doyle lab has previously reported the synthesis of chemically and geometrically
complex hydrogel microparticles using flow lithography [52, 153, 166]. By polymerizing
across laminar co-flowing streams of monomer, multifunctional particles with distinct
chemical regions can be rapidly (>104/h) produced with high degrees of reproducibility.
Separate "code" and "probe" regions are used to identify particles and capture targets,
respectively [52]. The bulk-immobilization of probe molecules in the bio-inert, PEG-based
gel scaffolds provides solution-like capture kinetics and high degrees of both specificity and
sensitivity, leading to significant advantages over surface-based immobilization strategies
employed in microarrays and existing particle systems [180]. Patterns of unpolymerized
holes in the code portion of the particle serve as the basis for a graphical multiplexing
barcode to identify the probe(s) in a particular particle.
Despite rapid developments in the synthesis of information-rich encoded micro- and
nanoparticles, there has been little progress in the creation of high-throughput systems for
analyzing these complex entities [44, 46]. The majority of emerging bead-based systems
lack a method for rapid decoding and target quantification, while commercially available
flow-through scanning systems constrain multiplexing capacity and provide only simple
intensity measurements for inefficient, gate-based analysis [41, 44, 189, 190]. Unlike bead
systems that optically encode spheres and use arrays of lasers and PMTs, our particles
have multiple distinct regions, making single-color, morphology-based scanning possible,
with only one excitation source and one detector required. This setup significantly reduces
the cost and complexity of analysis. Furthermore, the coding library can easily be expanded
to accommodate high levels of multiplexing or parallel processing of samples. The flexibility
of our synthesis method also allows for embedding living entities such as cells in the probe
region of particles, or for incorporating multiple probe regions on a single particle for
intrabead multiplexing [52, 163].
4.2 Microfluidic Scanning System
Here, we describe the performance of a gel particle scanning system and an accompanying
post-hybridization labeling scheme for use in high-throughput multiplexed miRNA
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quantification (Figure 4.1 A). We constructed a slit-scan system that uses a thin laser
illumination window to sequentially excite passing portions of precisely oriented particles,
thus producing a temporal fluorescent signature from which code identity and bound target
amount can be determined (Figure 4.1 B,C) [191, 192]. A polydimethylsiloxane (PDMS)
focusing chamber bonded to a glass slide was mounted on a fluorescence microscope for
analysis procedures. To align the soft gel particles, the sample and sheath streams were
injected into the device with 8-psi forcing pressure, creating a single-file flow of particles
traveling at velocities of -0.5 m/s. Slit illumination was created with a 532-nm laser
spatially filtered through a chrome-coated glass mask inserted into the field stop position of
the microscope. As particles passed through the illumination window, fluorescent
signatures were captured with a PMT and the resulting signals were processed using a
homemade amplifier with a low-pass filter.
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Figure 4.1: Encoded gel particle assay system. (A) Workflow of platform includes () hybridization of
particles with target, (ii) incubation of particles with universal labeling adapter, ligation enzyme,
and fluorescent reporter, and (iii) scanning of particles to determine code identity and amount of
target bound. A typical particle consists of a fluorescent barcoded region and a probe -laden region
flanked by two inert sections. Central-most hole has a fixed value to indicate particle orientation. (B)
Actual PMT fluorescence signatures of 75 flow-aligned particles. (C) Magnified signatures of
individual particles. As probe-target reaction rate is observed to be faster than target diffusion
through gel matrix, the increased fluorescent intensity on the sides of the particle in image can be
attributed to binding of target near the side faces of probe region [1801. Scale bar is 50 pm.
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The fluorescent signal obtained along each particle is integrated across the particle width
by the detector. The sizes of the holes in the code region determine the depths of the
fluorescence troughs in the signature and thus indicate the particle identity. We optimized
the particle architecture and hole design to find that four distinguishable coding levels (0-
3) could be obtained for 70-pm wide particles, leading to 192 possible codes for a five-bar
particle (Figure 4.1 C). Multiplexing capacity could easily be augmented to >105 by adding
more bars, using multiple fluorescent levels for the code region, or incorporating multiple
probes on each particle (Figure 4.2 and Figure 4.3). Furthermore, by scanning particles
with various barcode designs, it was observed that a minimum spacing of 8 pm was
required between holes to prevent mechanical deformations of the soft hydrogels during
flow alignment. We developed and trained a decoding algorithm to accurately decode
particles and quantify targets. Particle orientation and velocity are determined to analyze
the coding holes and establish a first estimate of code identity. A revised assignment is
calculated by checking the consistency among holes identified as the same level, and a
decoding confidence score is then computed and used to accept or reject particles.
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Figure 4.2: High-throughput flow alignment device and code design. (A) Image of
PDMS focusing chamber attached to glass slide, with inlets and outlet attached.
Reservoir inlet on the left delivers sheath fluid, while central pipette tip delivers the
particle -bearing fluid. Reservoir outlet on the right serves as a collection point for
particles that have been scanned. The chamber is mounted on a standard inverted
fluorescence microscope for scanning runs. (B) Images of particles used to optimize
scanner performance. Simple plug particles were scanned to maximize signal-to-noise
ratio (SNR) and frequency response of detection circuit. Particles with holes of various
areas were used to determine the minimum differences in size required to distinguish
between coding levels. Scale bars are 50 pm. (C) In the final particle design, coding
holes were separated by 8 pm, and the lengths of the holes were 15, 27.5, and 40Opm for
levels 1, 2, and 3, respectively All holes had a width of 12 pm.
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Figure 4.3: Multi-probe particles. (A) Fluorescence image and accompanying scan of two-probe
barcoded hydrogel particles of the same dimensions (250 X 70 x 35 pm) as used in the 12-plex study.
The probe strip nearest the code region contains DNA capture sequence for let -7a, while the second
strip contains capture sequence for miR-155. Particles have been incubated for 90 min with 115 and
100 amol of the DNA analogs of let-7a and miR-155, respectively. Labeling has been performed with
the ligation scheme. Although the probe strips are ~50% smaller than those used in the 12-plex
study, single-probe particles with this reduced strip size were successfully implemented in the
sensing and scanning procedures. To demonstrate different encoding possibilities, these two -probe
particles were synthesized with four coding bars and with 75% as much rhodamine acrylate (Rh -Ac)
in the code region (0.45% (v/v) final concentration) as the 12-plex batches. Scale bar is 100 pm. Green
bar in schematic indicates position of excitation slit relative to particle. (B) A single -probe particle
from the 12-plex study incubated with 100 amol let-7a RNA is shown (blue curve) for comparison
purposes. Red curve corresponds to scan in A. (C) Overlaid scans comparing 6) particle incubated as
in A and particle incubated with 0 amol of both targets, and (ii) two particles incubated as in A and
scanned during different assay sessions. (D) Scans of two-probe particles incubated with 0-1000
amol of miR-155 DNA analog target. As in the 12-plex study, five different codes are featured for the
same probe set.
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4.3 Ligation-based Method for miRNA Labeling
To generate signal in the probe region of particles, we employed a unique ligation-based
scheme to fluorescently label bound miRNA targets. Existing approaches rely on the bulk-
labeling of RNA using chemical or enzymatic means [138, 193, 194]. These methods suffer
from high cost, sequence bias due to secondary structure [138], complicated protocols [138],
and in the case of microarrays, the need for small-RNA purification and clean-up [193, 194].
To overcome these issues, we implemented a two-step method to efficiently label targets
after hybridization in about one hour. We used T4 DNA ligase to link a universal
oligonucleotide adapter to the 3' end of targets captured on gel-embedded DNA probes
(Figure 4.4). For maximum fluorescent efficiency, we used a biotinylated adapter with
phycoerythrin-conjugated streptavidin reporter (SA-PE), though it is also possible to use
fluorophore-conjugated adapters directly.
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Figure 4.4: Post-hybridization miRNA labeling via ligation to a universal adapter. (A) DNA
probes, linked at their 5' end throughout the probe region of encoded hydrogel particles, contain
a miRNA-specific sequence adjacent to a universal adapter sequence such that the 3' end of a
captured target would abut the 5' end of a captured adapter oligonucleotide. The probe is capped
with an inverted dT to mitigate incidental ligation and the adapter has a poly(A) spacer to
extend its biotinylated 3' end a way from the hydrogel backbone for efficient reporting. (B) After
particles are hybridized with total RNA, T4 DNA ligase is used to link the universal adapters to
the 3' end of captured targets, unligated adapters are released using a low-salt rinse, and SA -PE
is used as a fluorescent reporter.
It was necessary to optimize several aspects of the labeling scheme, including probe/adapter
design, reagent concentrations, rinse buffer salt content, ligation time, and ligation
temperature. We show here the effects of ligation time and adapter tail length on labeling
efficiency. The nucleic acid probes, targets, and adapters (all from IDT) are given in Table
4.1:
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Oligo Name SequencefModifications
let-7a probe, DNA /5Acryd/GATATATTTTAAACTATACAACCTACTACCTCA/3InvdT/
let-7a target, RNA 5'-UGAGGUAGUAGGUUGUAUAGUU-3'
UA10-Cy3, DNA /5Phos/TAAAATATAT/3Cy3/
UA10-bio, DNA /5Phos/TAAAATATAT/3Bio/ poly(A) 0
/5Phos/TAAAATATATAAA/3Bio/ poly(A) 3
/5Phos/TAAAATATATAAAAAA/3Bio/ poly(A) =6
/5Phos/TAAAATATATAAAAAAAAAAAA/3Bio/ poly(A) 12
Table 4.1: Nucleic acid probes and targets used in labeling optimization studies. Blue represents
universal adapter-specific sequences, maroon represents target-specific sequences, and green
represents poly(A) tails.
Probes were designed to include a miRNA-specific region and an adapter-specific region,
such that when bound, the 3' end of the miRNA target would abut the 5' end of the adapter.
We chose to label the 3' end of miRNA targets because it has been demonstrated that when
using a DNA template, the action of T4 DNA ligase in joining DNA to RNA molecules
proceeds several orders of magnitude more rapidly at the 3' end of RNA versus the 5' end
[195]. The adapter sequence and length were chosen such that (1) the melting temperature
was between 10-20"C in ligation buffer, (2) the sequence was not self-complementary in
order to avoid adapter hairpin or homodimer formation, and (3) complete DNA probes (with
adapter and miRNA sequences) did not show appreciable hairpins for the miRNAs
investigated.
We performed studies to determine the minimum ligation time needed for our labeling
assay, using let-7a as a model system. Particles bearing a let-7a DNA probe region were
incubated with 5 fmol synthetic let-7a RNA at 55"C for 110 min. Particles were rinsed three
times with PBST and incubated with 250 pL of a ligation mix containing 200 U T4 DNA
ligase, 40 nM Cy3-modified adapter (UA10-Cy3), and 0.05% Tween-20 in T4 DNA ligation
buffer (NEB) for 10, 30, or 90 min at 16"C. After ligation, particles were rinsed three times
in 1x TE containing 0.025 M NaCl, deposited on a glass slide, and imaged using a CMOS
camera (Imaging Source). We measured the fluorescence intensity in the probe region of
each particle, subtracting the background fluorescence to get a target signal, which
indicated ligation efficiency. The results are shown in Figure 4.5. We calculated the relative
efficiency by normalizing each signal by that obtained for the 90 min sample. As can be
seen in Figure 4.5, ligation is >95% complete even after a short 10-min reaction. For the
experiments described in this work, we chose to use a ligation time of 30 min to ensure
nearly complete ligation.
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Figure 4.5: Relative ligation efficiency over time. Error
bars represent the standard deviation taken over
measurements from five particles.
The SA-PE reporter is a large protein structure that has a radius of gyration on the order of
-10-15 nm. As such, when using biotinylated adapters with the SA-PE reporter, we found
that it was beneficial to extend the biotin group away from the polymer backbone of the gel
matrix. To do this, we used a poly(A) tail at the 3' end of the adapter and investigated the
effect of tail length on target signal. In this experiment, we used the same let-7a particles
as in the previous section, incubating with 50 amol let-7a miRNA for 60 min at 50"C. The
particles were rinsed three times in PBST, and divided into four separate tubes. Particles in
each tube were incubated for 30 min at room temperature with ligation mix containing 200
U T4 DNA ligase, and 40 nM UA10-bio (with either a 0, 3, 6, or 12 bp poly(A) tail), in 1x T4
DNA ligation buffer (NEB) with 0.05% Tween-20. After ligation, particles were rinsed three
times in 1x TE containing 0.05 M NaCl and 0.05% Tween-20. Particles were deposited on a
glass slide and imaged. The target signals were compared to determine the effect of poly(A)
tail length. As can be seen in Figure 4.6, the length of the poly(A) tail has a large effect on
target signal obtained. From zero to 12 bp, the signal increases -5x but seems to level off at
that point. For the experiments described in this work, we chose to use universal adapters
with poly(A) tail lengths of 12 bp.
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Figure 4.6: Effect of universal adapter poly(A) tail length
on fluorescence signal when using biotinylated adapters
with a streptavidin -phycoerythrin reporter. Signals are
relative to that measured for a tail length of 12 bp.
Importantly, this labeling method was highly efficient, had no minimal input RNA
requirement, and showed no sequence bias for the targets used in this study. For each new
miRNA target species, we simply incorporated a target-specific sequence into the universal
probe template; complex modification and customization were not necessary.
4.4 System Characterization
We investigated the dynamic range, sensitivity, and specificity of the platform in the
context of a 12-plex assay featuring ten clinically relevant miRNA targets. Because of its
relative invariance across tissue types and disease states, RNU6B was used as an internal
control for normalization purposes. We also used 100 amol of miSpike (a synthetic 21-mer)
as an external control to validate the consistency of the labeling and scanning processes.
We synthesized twelve batches of single-probe particles for this study. To compensate for
discrepancies in target hybridization rates, we implemented a coarse rate-matching by
tuning the probe concentration for each target using previously determined scaling laws
[180]. In an effort to coarsely rate-match the binding of the targets used in the study, we
incorporated the probe sequences at different concentrations in the particles (Table 4.2 . As
the characteristic time for target depletion scales with the inverse square root of probe
concentration, a doubling of the binding rate for a given target will require a 4x increase in
the amount of probe incorporated in a probe region of fixed size. In this study all rates were
adjusted to match that of let-7a binding. It should be noted that higher sensitivities and
shorter assays could have been achieved by loading probe at maximum concentration, but
the goal of this study was to develop a 12-plex assay with broad dynamic range and -1 amol
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sensitivity for all targets. To fully demonstrate the versatility of the scanner, five separate
codes were correlated to particles of each probe type, thereby simulating a 60-plex assay
(Table 4.2).
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Figure 4.7: System performance in 12-plex assay. (A) Calibration curves for particle batches, with
background-subtracted signal plotted against spiked target amount. miR-210, -221, -222 and let-
7a were spiked into the same incubation mixes at the indicated amounts. The remaining seven
naturally-occurring targets ('+' symbols) were spiked into the 27- and 243-amol trials to validate
performance. For all trials, 200 ng of E. coli total RNA was also spiked in for complexity. Mean CV
of target level is 6.35% when considering target levels greater than 5 amol. Each point
represents, on average, 19 particles from a single run. (B) Specificity of let-7a probe in the
presence of sequences closely related to intended target. (C) Cancer profiling results for
dysregulated targets in four human tissue types. Error bars represent standard deviation in
triplicate measurements on aliquots of the same single-patient sample. Amount of total RNA used
in gel-particle assays is 250 ng, unless otherwise noted. See supporting information for details of
dysregulation analysis.
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7a 7b 7c 7d
Spiked Target
M Lung, 260 ng
N Lung, 100 ng
* Lung, qPCR
* Breas
* Stomach
SPancreas
C
0
Target Probe Sequence Hairpin Binding Rate Adjusted Identifying
Melting Relative to let- Probe Codes for Mock
Temps 7a (Probe at Conc. 60-plex
(aC) 50 pM) (PM)
let-7a 5Acryd/GAT ATA TTT TAA ACT ATA 38.0 1.00 50 31131, 32231,
CAA CCT ACT ACC TCA/3InvdT 31231, 32131,
miR-21 5Acryd/GAT ATA TTT TAT CAA CAT 60.4, 52.9, 0.45 247 31112, 32212,
CAG TCT GAT AAG CTA/3InvdT 49.3, 46.6 31212, 32112,
miR-29b 5Acryd/GAT ATA TTT TAA ACA CTG 45.9, 44.7, 0.63 126 31132, 32232,
ATT TCA AAT GGT GCT A/3InvdT 41.7 31232, 32132,
miR-181b 5Acryd/GAT ATA TTT TAA CCC ACC 58.4, 43.2, 0.89 63 32230, 31130,
GAC AGC AAT GAA TGT T/3InvdT 38.6 31230, 32130,
miR-143 5Acryd/GAT ATA TTT TAG AGC TAC 55.2, 51.1 1.04 50 31110, 32210,
AGT GCT TCA TCT CA/3InvdT 31210, 32110,
miR-145 5Acryd/GAT ATA TTT TAA GGG ATT 47.4, 43.0, 1.01 50 31121, 32221,
CCT GGG AAA ACT GGA C/3InvdT 36.6 31221, 32121,
miR-146a 5Acryd/GAT ATA TTT TAA ACC CAT 64.6, 49.4, 0.67 111 30001, 31101,
GGA ATT CAG TTC TCA/3InvdT 48.3, 43.4 32201, 31201,
miR-210 5Acryd/GAT ATA TTT TAT CAG CCG 68.4, 65.6, 0.90 62 31122, 32222,
CTG TCA CAC GCA CAG/3InvdT 59.7, 55.4 31222, 32122,
miR-221 5Acryd/GAT ATA TTT TAG AAA CCC 49.8, 43.6, 0.82 62 31111, 32211,
AGC AGA CAA TGT AGC T/3InvdT 42.2, 41.0 31211, 32111,
miR-222 5Acryd/GAT ATA TTT TAA CCC AGT 68.2, 68.1, 0.62 130 31120, 32220,
AGC CAG ATG TAG CT/3InvdT 58.1, 47.5 31220, 32120,
miSpike 5Acryd/GAT ATA TTT TAA GAC 66.5, 46.0 1.21 35 30002, 31102,
CGC TCC GCC ATC CTG AG/3InvdT 32202, 31202,
RNU6B 5Acryd/GAT ATA TTT TAA AAA ATA 64.4, 58.4, 0.95 55 30000, 31100,
TGG AAC GCT TCA CGA ATT TGC 56.9, 56.1 32200, 31200,
GTG TCA TCC TTG CG/3InvdT 32100
Table 4.2: Particle codes and probe information for batches synthesized for 12-plex study. Final
composition (v/v) of PEG DA roo, PEG20o, and Darocur 11 73photoinitiator in prepolymer stream
for probe were fixed at 18, 36, and 4.5%, respectively. Hairpin melting temperatures are listed
in descending order, as calculated for the DNA -RNA duplex by IDT's OligoCalc application for
the incubation conditions used in the study. For each miRNA, the relative binding rate was
calculated using the average of target signals from 30- and 60-min incubations with 500 amol
of target and ligation labeling. Short incubations were chosen to ensure the system had not
reached equilibrium. Quoted probe concentrations refer to prepolymer stream composition.
Approximately 11% of the probe in the prepolymer stream was covalently incorporated into the
particles [1801.
To assess sensitivity and dynamic range, we simultaneously spiked four of the twelve
targets into 50-pL incubation mixes at amounts ranging from 1 to 2187 amol. The four
targets used in calibration (let-7a, miR-210, miR-221, and miR-222) were chosen for their
diversity of 3' nucleotides, hairpin melting temperatures, and relative binding rates. We
observed a linear detector response over four logs, with sub-attomole sensitivity achieved
for three of the four targets (Figure 4.7 and Figure 4.8) and strong agreement between neat
samples and those spiked with 200 ng of E. coli total RNA to add complexity. By
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comparison, existing bead-based approaches have a 200-amol limit of detection and only
one log of range [41]. To assess specificity, we performed assays with let-7a particles and
four members of the let-7 family spiked separately at 200 amol into samples containing 200
ng E. coli total RNA. Scans revealed a maximum cross-reactivity of 27%, which is lower
than other systems [138] (microarray -50%) and can be dramatically improved with lower
hybridization salt concentrations (Figure 4.9). These assays were very reproducible, with
intra- and inter-run CV's of 2-7% (Table 4.3). Due to limitations in detection and particle
preparation, it is common for users of current bead-based systems to employ 4,500 copies of
each type of bead in an assay for high-confidence estimates of target level [2]. By contrast,
we found it sufficient to analyze only 10-15 hydrogel particles for each probe type (Figure
4.10).
1 amol 3 amol 5 amol 9 amol 27 amol 81 amol 243 amol 729 amol 2187 amol
miR-210 59.45 29.22 10.88 10.93 1.81 5.91 1.39 5.85 1.93
miR-221 36.71 9.95 21.80 18.41 4.11 7.20 2.79 6.81 2.01
miR-222 - 5.96 16.10 15.62 4.85 5.25 3.26 5.93 3.27
let-7a 87.99 19.18 26.77 18.83 5.20 5.83 3.13 5.53 2.93
Table 4.3: Intra -run CVs in target level for E. coli calibration curve. All entries are percentages
with each statistic calculated using 19 particles on average. miR-222 exhibited a limit of
detection over 1 amol. Inter-run CV in background-subtracted miSpike signal (100 amol) for
the nine represented scan sets was 6.84%. Inter-run refers to different detections with the
same batch ofparticles.
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Figure 4.8: Limit of detection calculations and calibration curves for neat samples. (A) Extrapolation
of SNR for determination of LOD. The LODs of the four calibration targets (see legend) were
calculated by finding the target amount at which the SNR was three. Regression lines with a mean
Pearson coefficient of 0.9965 (excluding miR-222) were used to extrapolate LODs. (B) Neat
calibration curves for particle batches incubated without spiked E. coli total RNA. Except for the
absence of E. coli RNA, conditions are identical to those used to construct Figure 4.7 A. The
remaining seven naturally-occurring targets (+ symbols) were spiked into the 27- and 243-amol trials
to validate performance. (C) Comparison of background-subtracted signals from neat and E. coli
calibration measurements. Clustering of points around the identity line (red) indicates highly
specific detection with no noticeable decrease in binding rates in more complex samples. For all
plots, all target levels (except miSpike) have been adjusted for comparison purposes by using the
background-subtracted signal from the 100-amol miSpike profiles.
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Figure 4.9: Effect of hybridization buffer salt
concentration on cross -reactivity between let-7d
miRNA and let- 7a probe. Particles bearing a let-
7a probe region were incubated with 500 amol of
synthetic let-7a or let-7d RNA for 90 minutes at
550C with varying amounts of NaCl. Particles
were labeled using the standard
ligation/reporter protocol Probe region
fluorescence was measured and scaled using the
let- 7a fluorescence signal for particles incubated
at 350mM Na Cl (as used in the 12-plex study in
the main text).
Number of Particles Analyzed
Figure 4.10: Coefficient of variation (CV) of target level as a function of number
of particles analyzed. The CV of the target level for let-7a in the E. coli
calibration scans was seen to stabilize to a nearly constant value in the 10-15
particle window for the five spike-in amounts presented above. More
information about intra -run target-level CVs can be found in Table 4.3.
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4.5 Dysregulation Analysis of Human Total RNA
As a further validation of the platform, we performed expression profiling across tumor and
adjacent normal tissue for several cancer types. As anticipated, we observed the
dysregulation of miRNA targets in all of the diseases investigated (Figure 4.7 C, Table 4.4,
and Table 4.5). Although we used 250 ng of total RNA for these samples, similar profiling
results were obtained for lung samples using only 100 ng, suggesting that less input RNA
would be sufficient. Aliquots of the lung samples were profiled with qPCR by the Dana
Farber Cancer Institute's Molecular Diagnostics Laboratory to independently confirm our
results. The two platforms exhibited strong agreement for the seven targets available for
comparison (Figure 4.7 C). With a simple workflow and a total assay time of only 3 h, the
profiling is far more efficient than microarray approaches (-24 h) [138] and recent
amplification schemes (-9 h) [196], and it exhibits sensitivity and reproducibility superior to
that of existing bead-based methods [41, 59].
Table 4.4: Mean target amounts and inter-run CVs
number in each entry is mean amount for replicate
in target amount for 250-ng tissue assays. Top
trials (amol); bottom number in parentheses is
the inter-run CV (%1). Amounts were determined by comparison to the background-subtracted 100-
amol miSpike signal from each run. Replicate assays were conducted on different days to rigorously
test reproducibility. Each statistic was calculated using 16 particles on average. Entry spots lacking
data indicate that target was not present above the 2-amol cutoff
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let-7 miR- miR- mm- mm- mm- mm- mm- mm- mLR- RNU6B
a 21 29b 181b 143 145 146a 210 221 222
Lung 594.81 1498.85 68.36 7.02 85.61 162.88 77.02 - 7.21 8.13 57.16
Tumor
Lung 368.08 141.70 31.80 2.69 59.79 189.07 6.95 6.45 10.84
Healthy
Breast 1094.19 808.08 65.88 3.71 32.48 73.53 9.26 - - 2.29 116.88
Tumor
Breast 912.95 302.39 32.87 2.65 59.01 149.06 12.90 - - 10.20 78.55
Healthy
Stomach 270.64 561.87 68.78 2.28 169.45 388.39 29.66 - 2.93 14.15 175.69
Tumor
Stomach 258.28 204.24 73.44 - 186.39 597.31 3.33 - - 7.83 78.45
Healthy
Pancreas 44.96 14.96 9.95 - 5.43 22.63 - - - - 9.49
Tumor
Pancreas 98.10 18.21 14.85 - 6.79 10.88 - - - - 10.33
Healthy I I I __
let-7a miR- miR- miR- miR- mi1R- miR- miR-
21 29b 143 145 146a 181b 222
Lung -0.5119 0.3020 -0.3911 -0.5670 -0.7870 0.3232 -0.3066 -0.6210
Breast -0.0942 0.2532 0.1378 -0.4318 -0.4801 -0.3168 -0.0266 -0.8253
Stomach -0.3310 0.0966 -0.3844 -0.3877 -0.5336 0.6007 0.3294 -0.0935
Pancreas -0.3023 -0.0198 -0.1402 -0.1251 0.3534 - - 0.1785
Table 4.5: Log-transformed expression ratios for 250-ng assays. Top number in
each entry is the mean of the log-transformed ratios of tumor amount-to-healthy
amount of the indicated target in the specified tissue over three trials; bottom
number in parentheses is the standard deviation. Entry spots in red indicate
dysregulation. Entry spots lacking data indicate that the ratio was not
calculated. miR-210 and miR-221 were omitted because they did not appear
above the 2-amol cutoff in both tumor and healthy samples in any of the four
tissues investigated.
In past work, gel particles were imaged with a CCD camera and then analyzed at rates <1
particle/min. For the mock 60-plex assay demonstrated here (i.e., five codes per probe type),
the scanner provided a decoding accuracy of -98%, with only -10% score-based rejection at
throughputs up to 25 particles/s. This represents a 1,500-fold increase in analysis rate.
With manual loading from Eppendorf tubes, eight 50-pL samples could be scanned and
analyzed in 30 min, leading to a projected throughput of -125 samples per 8-h workday. In
future applications of this technology, it is expected that automation of the particle-loading
and rinsing processes using well-plates and a liquid handling system will greatly augment
efficiency to levels that match or exceed state-of-the-art particle analysis systems used for
genotyping (>500 samples/day) [35].
4.6 Data Analysis
In this work, raw data files (20 million points/scan) produced by the scanning process were
analyzed with a custom MATLAB algorithm designed to isolate individual particle
signatures, identify the code displayed by each particle, and quantify the amount of target
bound. The algorithm processed scans of 50-pL samples in under 5 s, making the approach
suitable for high-throughput applications. In the initial filter step, the algorithm excised
portions of the scan that exceeded a threshold voltage and then interrogated each removed
segment for characteristics that identified it as a particle signature. Using specific
properties of the fluorescent code region as reference points, a high-confidence estimate of
the velocity of each particle was determined and utilized to pinpoint trough locations for the
five coding holes. The orientation of the particle (i.e., probe- or code-first) was established
using the fixed-value "3" hole that bordered the inert region. After an initial code identity
was calculated from the trough depths, a secondary review was conducted by measuring the
standard deviation in trough depths of holes designated to be of the same level and
corrective action was taken if necessary. In the final decoding step, a confidence score was
calculated for the particle by computing the linearity of the correlation between trough
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depth and assigned level. A particle decoding event was rejected if its Pearson coefficient
fell below 0.97.
In order to calculate the amount of target bound, the measured particle velocity was used to
infer the location of the center of the probe region. Briefly, a search window was used to
investigate the scan in this region, seeking to identify a local maximum that could be
correlated to a target-binding event. If a maximum was found, the position of the search
window along the scan profile was adjusted until the two endpoints were sufficiently close
in signal amplitude, thereby selecting a nearly symmetrical portion of the maximum over
which to average for quantification purposes. In the cases in which a maximum was not
found, the original estimate of probe center was used to calculate a mean signal without a
search window. To calculate the background for a given probe sequence and incubation
condition, particles from the same synthesis batch were incubated in the presence of only
100 amol of miSpike target according to the procedure described above. This method
provided a measure of the probe-dependent background that arose from the PEG scaffold
and the universal adapter used in the labeling process. Also, upon calculation of all code
identities and target levels, a particle would be rejected from consideration if its target level
was more than one inter-quartile range above the third quartile or below the first quartile
of the data set consisting of target levels associated with the probe in question. This
measure was taken as further protection against incorrect code assignments and inter-run
contamination.
For calibration and profiling studies, mean background-subtracted signals were computed
for each target at each incubation condition. For inter-run comparisons of calibration data,
signals were normalized by background-subtracted miSpike amplitude, with the null (0
amol) samples providing the reference 100-amol miSpike value for both neat and E. coli
investigations. miSpike target values displayed on the calibration curves (Figure 4.7 A and
Figure 4.8 B) were not adjusted to this reference in order to demonstrate the repeatibility of
the labeling and scanning process. For profiling studies, the background-subtracted
miSpike signal from the first scan of each healthy tissue type was used as the reference for
analysis of that tissue. Signals from a given profiling scan were further normalized by the
RNU6B amount in that scan to facilitate direct quantitative comparisons that were
independent of total RNA amount [197]. Repeat runs of tissue assays were conducted at
least one day after the original. Assays of 250-ng tissue samples were repeated in triplicate,
while assays of 100-ng samples were performed once to provide a basis of comparison. For
each calculated expression ratio, the healthy and tumor samples were assayed and scanned
in the same set of experiments for consistency. We required at least 2 amol of target to be
detectable in a tissue of a given disease state in order to calculate an expression ratio. As
we only used a single patient sample for each tissue type, we implemented a threshold
approach to determine dysregulation. For each target in each tissue, the three log-
transformed expression ratios from the three separate trials were used to calculate an SNR,
by dividing the mean of the set by the standard deviation. Targets with SNRs above 3 were
considered to be dysregulated. It should be noted that all 20 instances of dysregulation were
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able to be correlated to observations from the literature regarding the expression profiles of
either mature miRNA (16 of 20) [117, 125, 187, 198-200] or miRNA precursors (4 of 20)
(Figure 4.11) [201, 202].
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Figure 4.11: Dysregulation classification. A SNR was used to distinguish
dysregulated targets in tissue profiling. The mean and standard deviation
of the log-transformed expression ratio were calculated for each target in
each tissue for the triplicate assays. A SNR of three was chosen as the
threshold for dysregulation. All 20 instances of dysregulation matched
observations in the literature. miR-210 and miR-221 were omitted because
they did not appear above the 2-amol cutoff in both tumor and healthy
samples in any of the four tissues in vestiga ted.
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Chapter 5
Ultrasensitive MicroRNA Detection via
Rolling Circle Amplification
There is great demand for flexible biomolecule analysis platforms that can precisely
quantify very low levels of multiple targets directly in complex biological samples. In this
chapter we demonstrate multiplexed quantification of miRNAs on encoded hydrogel
microparticles with sub-femtomolar sensitivity and single-molecule reporting resolution.
Rolling circle amplification (RCA) of a universal adapter sequence that is ligated to all
miRNA targets captured on gel-embedded probes provides the ability to label each target
with multiple fluorescent reporters and eliminates the possibility of amplification bias. The
high degree of sensitivity achieved by the RCA scheme and the resistance to fouling
afforded by the use of gel particles are leveraged to directly detect miRNA in small
quantities of unprocessed human serum samples without the need for RNA extraction or
target-amplification steps. This versatility has powerful implications for the development of
rapid, non-invasive diagnostic assays.
5.1 Introduction
The growth of molecular diagnostics requires innovative tools that are sensitive, specific,
and precise enough to quantify low levels of multiple biological targets simultaneously in
complex media in a single assay. To minimize assay development time and cost, these
systems should be flexible enough to allow for rapid probe-set modification, standard post-
assay analysis methods, and the interrogation of diverse classes of clinically relevant
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biomolecules. MicroRNAs are small noncoding RNAs that have been shown to have
powerful predictive value in determining diagnosis and prognosis for several diseases
including cancer, diabetes, and Alzheimer's [117, 125, 187, 203]. It has proven difficult,
however, to accurately and efficiently quantify this increasingly important target set in
biological samples due to high levels of sequence homology, complex secondary structures,
and wide ranges of natural abundance [134]. Microarray, deep sequencing, and PCR-based
approaches for miRNA quantification provide high sensitivity but ultimately are ill-suited
for the high-throughput analysis of small, focused clinical target panels, an application
space that is quickly expanding due to interest in personalized medicine [12, 138, 139, 149].
With shorter, customizable workflows and rapid post-assay analysis options, particle-based
arrays offer a more economical solution for such applications, but the relatively poor
sensitivity of commercially available particles requires significantly larger sample amounts
[44, 59, 204, 205]. The ideal platform for the analysis of focused miRNA biomarker panels
would provide high sensitivity and specificity, scalable multiplexing with a simple
workflow, and the ability to directly interrogate easily-obtainable biological samples
without the need for RNA extraction.
It has recently been shown that miRNAs are remarkably stable in the RNase-rich
environment of blood because of their association with the Argonaute2 ribonucleoprotein
complex and membrane-bound vesicles [127, 128]. As a result, these small noncoding RNAs
have become an attractive target set for the development of non-invasive blood-based
bioassays and for the study of novel mechanisms of intercellular communication [127, 206-
208]. Unfortunately, the quantification of circulating miRNAs is particularly challenging
due to low levels of natural abundance, as well as the biological complexity of blood and its
derivatives (plasma and serum). While microarray and PCR-based methods have been
developed to profile serum-based miRNAs, all existing approaches require RNA isolation
and/or target amplification, which complicates assay workflow as well as quantification
[206-208]. The development of efficient diagnostic assays in this biological medium
requires a highly sensitive multiplexing platform capable of direct target detection in
minute amounts of sample without the need for complex, time-consuming processing and
purification steps.
In order to enhance the sensitivity of a biological assay, one can either amplify the number
of targets present in a sample or amplify the reporting signal produced by each of the
targets. Target-based amplification via PCR has been widely used as a means to profile low-
abundance miRNA [139]. However, great care must be taken in the optimization of primer
sequences to prevent amplification bias in multiplexed assays and to ensure accurate
quantification of target amounts. Signal-based amplification improves sensitivity without
augmenting the number of target molecules, and as a result, offers a more direct route to
biomolecule quantification, even allowing for single-molecule reporting resolution. Several
signal amplification strategies have been adapted for the quantification of miRNA,
including RCA and isothermal ramification amplification (RAM) [204, 209-212]. In these
approaches, the polymerase-mediated replication of a circular template is used to create
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long DNA concatemers either in solution or immobilized on a substrate that can be labeled
with multiple fluorophores or radioactive isotopes, thereby amplifying the signal generated
from a single target molecule to a level that can be observed using standard detection
instruments. Although significant enhancements in detection performance have been
achieved with signal-based amplification, the LODs demonstrated with such approaches
remain considerably higher than those obtained with quantitative PCR, preventing their
use in emerging applications such as the direct quantification of multiple miRNAs from
single cells or easily-obtainable body fluids [204].
We sought to investigate the use of RCA for multiplexed miRNA quantification on
graphically-encoded hydrogel microparticles [52, 180, 205]. In a typical assay, a custom mix
of particles bearing DNA probes complementary to the desired target miRNA sequences are
exposed to a sample solution, specific targets are captured on the immobilized probes, and
the captured miRNA molecules are then fluorescently labeled for quantification. The
selective labeling of only those miRNAs that have been specifically captured on immobilized
probes has several advantages over the bulk enzymatic and chemical methods used in the
majority of direct detection schemes, including higher efficiency, lower cost, and reduced
likelihood of labeling bias due to secondary structure [138, 193, 194]. In previous work with
these particles, we demonstrated a post-target-hybridization labeling procedure that ligated
a universal adapter sequence with a single fluorophore to each target captured on or within
the microgel particles for attomole-level miRNA quantification and rapid dysregulation
analysis in low-input human total RNA for cancer profiling [205]. Because the same
adapter can be used for all targets in a multiplex assay, this scheme provides a convenient
means for developing signal-based amplification without the risk of sequence bias.
In this chapter, an RCA-based signal amplification strategy is used to achieve sub-
femtomolar multiplexed quantification of miRNA on encoded microgels with single-
molecule reporting resolution. A primer site is incorporated into the 3' end of the universal
adapter, and then each ligated adapter (Figure 5.1) is extended through the introduction of
a circularized DNA template and Phi29 DNA polymerase, a highly processive enzyme
capable of more than 50,000 base insertions per binding event [213]. The enzyme's excellent
strand displacement allows for the use of small circular templates, the repeated 'rolling' of
which results in the production of extensions bearing hundreds of replicate sequences that
can each be fluorescently labeled through the hybridization of appropriately decorated
reporter oligonucleotides (Figure 5.1). This method greatly expands the utility of our
multifunctional gel particle platform by enhancing sensitivity to a level that allows for the
direct detection of miRNA in small amounts of serum without the need for RNA extraction
or potentially biasing target-amplification steps [52, 180, 205, 214]. With RCA and
fluorescent spot-based quantification, we achieve miRNA detection sensitivity superior to
that of existing particle arrays, RCA approaches, and conventional microarrays [204].
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Figure 5.1: Gel particle RCA workflow. A graphical barcode consisting of
unpolymerized holes in the wafer structure of the particle indicates the miRNA -
specific probe embedded within a different region of the gel. Particles are
incubated with sample, after which a universal adapter sequence with a primer
site is ligated to the 3' end of all captured targets and a circular template is
allowed to anneal Phi29 polymerase and dNTPs are incubated in a custom
reaction buffer at 301C to generate a DNA extension with repeat sequences, each
of which can be labeled with two distinct biotinylated oligonucleotides attached
to SA -PE.
5.2 RCA Optimization
Although RCA has been widely used to enhance signal transduction on solid surfaces [176,
215-217], there is limited information on the technique's performance on gel-based
substrates [22, 218]. Our hydrogel particle platform is highly advantageous for bioassays,
as it has proven to be both bioinert and non-fouling in complex biological media [2141.
However, careful optimization must be undertaken when introducing new labeling reagents
that can alter the environment of the stimuli-responsive microgels. To evaluate the
compatibility of RCA and our microgels, we created particles with a probe region embedded
with a previously described DNA sequence capable of capturing miR-210 target and our
universal adapter sequence (Table 5.1) [205]. Upon testing the detection of 10 amol of
synthetic miR-210 RNA with a primer-modified adapter and two commercial RCA buffers
from New England Biolabs (Ipswich, MA) and Epicentre Biotechnologies (Madison, WI), we
observed significant non-specific binding of fluorescent labels on all portions of the
particles. In an attempt to isolate the reagent(s) responsible, we prepared several
"knockout" buffers using NEB2, which had proven to be compatible with the gel particles
during earlier ligation studies. Each knockout buffer either eliminated one of the
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constituents of the commercial RCA buffers altogether or reduced it to the lower level found
in NEB2. When the Tris-HCl concentration was reduced from 40-50 mM to 10 mM in the
RCA buffer, the majority of the fouling was eliminated without negatively impacting the
amplification process, indicating that lower buffer pH was responsible for the non-specific
adsorption onto the gel matrix. The remaining noise was removed by supplementing the
customized buffer with BSA at a concentration of 200 pg/mL. In separate experiments,
incubation conditions and the concentrations of circular template, DTT, dNTPs, Phi29
polymerase, and reporter sequences were adjusted to ensure the highest possible signal-to-
noise ratio.
Sequence (5' to 3')
miR-141 Probe /5Acryd/ GAT ATA TTT TAC CAT CTT TAC CAG ACA GTG TTA /3InvdT/
miR-210 Probe /5Acryd/ GAT ATA TTT TAT CAG CCG CTG TCA CAC GCA CAG /3InvdT/
miR-221 probe /5Acryd/ GAT ATA TTT TAG AAA CCC AGC AGA CAA TGT AGC T /3InvdT/
cel-miR-39 Probe /5Acryd/ GAT ATA TTT TAC AAG CTG ATT TAC ACC CGG TGA /3InvdT/
Universal Adapter /5Phos/ TAA AAT ATA TAA AAA AAA AAA ATC AGA ACA GTC TCG GAA GGA
Circular Template /5Phos/ TAA GTC ATT CGC ACA GGA GCA ACA GAC GAG TCC TTC CGA GAC TGT TCT GA
Reporter Oligo 1 GCA CAG GAG CAA CAG ACG AGA AAA AA /3Bio/
Reporter Oligo 2 CGA GAC TGT TCT GAT AAG TAA AAA A /3Bio/
Table 5.1: DNA sequences used for RNA target capture and labeling. "5Acryd" refers to 5'
acrydite modification (for covalent incorporation into the PEG-DA gel matrix), "3InvdT" refers to
3' inverted dT modification (to prevent incidental ligation of adapter to the end of the probe),
"5Phos" refers to 5' phosphorylation (for ligation), and "3Bio" refers to 3' biotinylation (for
attachment of strepta vidin -phycoerythrin (SA -PE) reporter). Underlined portions of probes are
target-specific capture sites. Blue letters indicate sequence portions involved in universal
adapter binding. Red letters indicate sequence portions involved in circle binding.
5.3 Assay Optimization
The RCA protocol depicted in Figure 1 was optimized through a parametric study of
reagent types and concentrations. Commercially-available RCA buffers from Epicentre
Biotechnologies and New England Biolabs proved to be incompatible with our gel-particle
system, and thus we explored the use of other solutions. NEB2 buffer had been successfully
used in previous ligation-labeling studies. In addition, it contained the same concentration
of MgCl2 as the commercially-available RCA buffers (but less Tris-HC1, DTT, and
(NH4)2SO4) and was thus chosen for further study (Table 5.2). The use of NEB2 as an RCA
reaction buffer led to reduced signal from 10 amol miR-210 spike-ins when compared to the
commercially available buffers, but it also produced clean particles that were not plagued
by non-specific adsorption of fluorescent label and particulate debris. As a result, NEB2
was supplemented with Tris-HC1 and DTT to match levels used in the commercially
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available buffers in an attempt to recover Phi29 enzyme activity and eliminate non-specific
adsorption.
NEB2 Buffer Phi29 Reaction Buffer Phi29 Reaction Buffer T4 DNA Ligase Buffer
(1x, NEB) (1x, Epicentre) (1x, NEB) (1x, NEB)
50 mM NaCl 50 mM KC1 50 mM Tris-HCl 50 mM KC1
10 mM Tris-HCl 40 mM Tris-HC 10 mM MgC12 50 mM Tris-HC
10 mM MgC12 10 mM MgC12  4 mM DTT 10 mM MgC12
1 mM DTT 4 mM DTT 10 mM (NH4)2 SO 4  10 mM DTT
pH 7.9 at 25oC 5 mM (NH 4)2 SO 4  pH 7.5 at 250C 1mM ATP
pH 7.5 at 250C pH 7.4 at 250C
Table 5.2: Buffer compositions for RCA optimization.
It was observed that supplementing the NEB2 buffer with only enough DTT to raise the
concentration to 4 mM rescued the activity of the enzyme, restoring it to a level that was
comparable to that seen in the commercially available buffers while noticeably reducing
non-specific adsorption. The Tris-HCl supplement, meanwhile, did nothing to increase the
RCA performance, and it produced "sticky" particles that non-specifically adsorbed
fluorescent labels and particulate debris (similar to the commercial buffers). Further
experiments with NEB4 buffer and T4 DNA ligase buffer from New England Biolabs
seemed to confirm the hypothesis that higher Tris-HCl content and lower pH were
responsible for non-specific adsorption, while elevated DTT concentration was essential for
efficient polymerase activity. Additional parametric experiments eventually led to the use
of an NEB2 buffer supplemented with DTT, BSA, TE, and Tween-20. During optimization,
we found that high levels of Tris-HC1 (>10 mM), DTT (>5 mM), Phi29 (>400 U/mL) and
dNTPs (>150 pM each) in the RCA incubation mix promoted non-specific binding of the
reporter oligonucleotides, which in turn produced high levels of fluorescent background on
all regions of the hydrogel microparticles. We also observed higher background and
occasional particle aggregation when concentrations of circular template greater than 75
nM were used; in future work, an additional step to purify/isolate the circularized template
from the solution in which it was synthesized could potentially eliminate this.
For the low target amounts considered in this study (<50 amol), the vast majority of the
target-binding events occurred on probes immobilized near the surface of the hydrogel
particle. This can be attributed to the probe-target reaction rate being relatively fast
compared to target diffusion through the gel matrix, as well as the fact that the collection of
probes near the surface will avoid saturation [52, 180, 205]. Because of this binding pattern,
we imaged the top and bottom faces of each tablet-shaped particle in order to quantify the
fluorescent signal arising from target-binding. For higher target amounts, fluorescence was
integrated over the top and bottom faces of each probe region and then averaged. For lower
amounts where individual DNA-reporter coils could be distinguished, fluorescent spots on
the top and bottom faces of each probe region were summed.
106
We investigated the effect of RCA extension time on signal intensity by incubating 5 amol
of synthetic miR-210 with -20 particles bearing an appropriate probe (Figure 5.2). The
number of discernable spots increased over the first 4 h of extension, but there was no
noticeable difference in spot count between RCA times of 4 and 8 h. However, the
fluorescence intensity of each spot increased throughout the examined time range, with
evidence of a plateau emerging by hour 16. The higher signal intensity seen at the sides of
the particle beginning at 4 h (Figure 5.2) is due to the labeling of targets bound to the side
faces of the particle's probe region. RCAs were also performed in the absence of miR-210
target for the extension times seen in Figure 5.2 to generate appropriate control
measurements for each time point. Signal arising from these particles was subtracted from
the 5 amol spike signals to generate background-subtracted measurements. Although
background fluorescence levels increased slightly over time, the low spot count on the 16-h
control particles and the absence of non-specific binding of debris suggests that overnight
extension for intense amplification is feasible for the gel-particle system. To shorten assay
time, ensure that all target-binding events were detectable, and minimize signal variability,
we chose to extend for 4 h for all subsequent RCA trials in this study.
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Figure 5.2: Background-subtracted target signal as a function
of RCA extension time for 5 amol spike of synthetic miR-210.
Five distinct groups of particles were exposed to target and
five distinct groups of particles were incubated without target
to obtain appropriate background measurements. For each
time point, one batch with target and one batch without target
were processed with the specified RCA extension time and
then labeled using the methods detailed in Section 2.3.5.
Fluorescence was integrated over the probe region, with each
data point representing the mean of at least five top and five
bottom faces. Error bars represent standard deviation of
signal.
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5.4 Detection Performance
The optimized protocol was used to investigate the detection of miR-210 over a
concentration range of three orders of magnitude. Previous miRNA multiplexing
experiments with gel particles and ligation-based labeling determined 350 mM NaCl to be
optimal for achieving highly specific target binding with short incubation times. To
simulate biological complexity and assess the specificity of the RCA scheme, 100 ng E. coli
total RNA was added to each 50 pL incubation volume. As illustrated in Figure 5.3 A, the
number of spots decreased as the target amount was reduced, and the code and other non-
probe-bearing portions of the gel particles exhibited very low levels of background. The low
spot count on the control (0 amol) particles demonstrated that only the intended target was
being captured and labeled even in the presence of a great excess of non-target RNA
sequences. It should be noted that 100 ng total RNA is sufficient for robust multiplexed
profiling with the non-amplified gel-particle protocol [205], and thus profiling in total RNA
with the RCA scheme would use far less input RNA (0.1-10 ng, depending on target set)
[204]. Figure 5.3 B shows stationary scans of particles exposed to either 0 or 5 amol of miR-
210, along with a magnified fluorescence image of the probe region and the coils of
reporting DNA that have formed on its top face. To assess the scheme's suitability for
efficient multiplexing of low-abundance miRNA targets, we next created a batch of multi-
probe particles with spatially segregated capture sequences for miR-141, miR-210, and
miR-221, a panel of human miRNAs known to be frequently dysregulated in cancer
profiling studies [125, 203, 205]. When the three targets were added in different amounts to
an incubation mix containing the multi-probe particles, the expected signal pattern was
obtained upon particle analysis (Figure 5.3 C).
To more fully characterize multiplexing performance, we developed an assay with three
separate particle types designed for the detection of the three aforementioned human
sequences as well as a fourth particle type for the detection of a C. elegans miRNA (cel-miR-
39) commonly used as an external control for quantifying RNA recovery in detection
protocols that require nucleic acid extraction [127, 128]. For single-probe particles, stream
widths were adjusted during synthesis procedures to create code and probe regions that
spanned 140 and 45 pm, respectively, of the length of the particles. Inert regions accounted
for the remaining 65 pm of the length. Synthetic human miRNA targets in amounts
ranging from 50 zmol to 35 amol were spiked into 50 pL incubation volumes containing -20
particles of each type and 100 ng E colitotal RNA. With the exception of the 35 amol spike,
the three human miRNAs were introduced simultaneously; separate spikes were performed
at 35 amol to verify that target capture was probe-specific. Integrating signal intensity on
the faces of the probe region provided a linear calibration curve for target amounts of 100
zmol or greater (Figure 5.4 A). Meanwhile, counting the number of amplification spots was
an effective means of calibrating the detection for all sub-attomole amounts investigated
(Figure 5.4 B-D). Importantly, particles bearing probe for cel-miR-39 exhibited consistently
low spot counts for all calibration trials (Figure 5.4 A,E), indicating a high level of
specificity of target capture and signal amplification.
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Figure 5.3: Results with optimized RCA protocol. (A) Fluorescence
images of binding events on top face of particle for detection of 10, 1,
and 0.1 amol of synthetic miR -210 in buffer spiked with 100 ng E. coli
total RNA. (B) Overlaid stationary scans of particles exposed to
solution containing either 0 or 5 amol of miR-210, with magnified
color image ofprobe region. Each scan represents the mean of five top
and five bottom faces. (C) Multi-probe particle exposed to solution
containing 5 amol miR-141, 1 amol miR-210, and 0.2 amol miR-221.
Scale bars are 20 pm.
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Figure 5.4 Calibration of RCA method. (A) Calibration curve for multilexed assay. Fluorescence
was integrated over probe region for target spikes of 100-35,000 zmol. Particles bearing probe for
cel-miR-39 were used as a negative controL (B-D) Fluorescent spot counts for target spikes of 0, 50,
100, 250, 500, and 1000 zmol in a multiplexed assay. The measurement resolution demonstrated
here is suitable for dysregulation profiling of targets in the sub -attomole range. (E) Fluorescent spot
counts on cel-miR -39 particles for the calibration trials. In all trials depicted in Figure 5.4, 100 ng E.
coli total RNA was added to incubation buffer to simulate complexity and demonstrate specificity of
assay. Error bars represent in tra -trial standard deviation.
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We observed high reproducibility in detection performance at the low target levels
investigated in this study. The gel particles were fabricated, encoded, and functionalized
with probe in a single step using a high-fidelity microfluidic synthesis process that provides
a greater degree of reproducibility and uniformity than the multi-step batch synthesis
processes used to create and functionalize similar particle systems. The mean intra-trial CV
of target signal for sub-attomole detection with spot-counting was 14% when measuring five
gel particles of each type in a given trial. By comparison, the mean intra-trial CV for
attomole detection with the non-amplified scheme was 62% [205], while competing particle
systems require the analysis of thousands of particles for high-confidence estimates of
target levels 5,000-fold higher [2]. With RCA on the gel particles, an inter-trial CV of 15%
was calculated for three separate detections of 500 zmol miR-210 on three separate days.
LODs for each of the human miRNAs were calculated from the calibration curves in Figure
5.4 B-D. The lowest LOD was that of miR-141, which was detectable down to 15 zmol
(-9,000 copies or 300 aM in 50 pL incubation volume). This level of sensitivity is superior to
those demonstrated by existing particle arrays, blots, RCA schemes (dumbbell, padlock
blotting, branched), and conventional microarrays, and it should be sufficient for the direct
profiling of highly-expressed miRNAs from single cells [204]. The unique hydrogel
composition of our particles provides a hydrated, non-fouling scaffold that minimizes
background signal from non-specific interactions and enhances nucleic acid hybridization
relative to solid surfaces. As discussed elsewhere [10, 25, 180, 219], the three-dimensional
immobilization of probe within a gel provides solution-like hybridization thermodynamics
that lead to lower probe-target dissociation constants (and thus higher sensitivity) than can
be obtained with solid particle systems and microarrays. Furthermore, the ability to
immobilize probe within the gel microparticles concentrates the captured targets and
resulting fluorescence signal within a relatively small volume for image analysis, leading to
higher sensitivity than existing RCA approaches that use well-based spectrometer
measurements and Northern blots for quantification.
We also calculated the percentage of spiked-in target miRNA molecules that were captured
and labeled with this optimized assay. We determined this percentage by multiplying the
background-subtracted spot count per particle by the number of particles in the reaction
tube and then dividing by spiked amount. Assuming 20 particles per probe type in each
incubation volume and using the spot counts for the 1,000 zmol spike trials in Figure 5.4,
we arrive at capture percentages of 0.28%, 0.43%, and 0.40% for miR-141, -210, and -221,
respectively. It should be noted that capture percentage can be improved by increasing the
duration of the target hybridization step, decreasing the incubation volume used, and
increasing the probe concentration within the particle.
5.5 Serum Assay
We sought to leverage the high sensitivity and specificity of the gel-particle RCA scheme for
the detection of low-abundance miRNAs in complex biological media. Recent studies have
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identified miRNAs as valuable blood-based biomarkers that could potentially be used for
rapid, non-invasive determination of disease diagnosis and prognosis [128, 207, 208].
Unfortunately, the low target abundance and complexity of blood have hindered progress in
developing accurate and efficient plasma- and serum-based assays, requiring target-
amplification steps and time-consuming RNA extraction protocols that complicate
quantification and introduce technical variability [207]. In an attempt to detect miRNA
directly in 25 gL aliquots of human serum, we modified our assay protocol by adding SDS
and RNase inhibitor (SUPERase-In) to an incubation buffer that would be combined with
the serum. By measuring the recovery efficiency of synthetic cel-miR-39 spikes under a
variety of conditions, it was determined that the optimal reaction mix should contain 2%
SDS and 0.5 U/pL SUPERase-In to ensure the denaturation of both background and RISC-
associated proteins, as well as the inhibition of serum-based RNases [127, 128]. We spiked
5 amol of cel-miR-39 into 50 ptL mixes containing 25 pL of either normal or prostate-cancer-
associated serum and observed recovery efficiencies comparable to those measured for
spikes into our previous neat incubation buffers (Figure 5.5 A). Importantly, there was little
evidence of non-specific binding on the surfaces of the bioinert, fouling-resistant PEG-based
gel particles.
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Figure 5.5: Serum-based miRNA Assay. (A) Synthetic cel-miR-39
recovery efficiency for 5 amol spikes into normal and cancer-associated
serum. (B) Upregulation of miR-141 was observed in prostate-cancer-
associated serum. Data reflect the mean spot counts for three replicate
trials. Error bars represent the inter-trial standard deviations.
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We also investigated the endogenous miR-141 levels in the two serum types, seeking to
confirm a previous PCR-based study that found miR-141 to be upregulated in the serum of
prostate cancer patients [128]. The results obtained with our gel particles for three
technical replicate measurements of each serum type revealed a similar dysregulation, with
mean spot counts of 0.78 ± 0.13 on particles exposed to normal serum and 14.53 ± 2.34 on
those exposed to cancer-associated serum (Figure 5.5 B). The observed copy numbers of
miR-141 (<400 copies/pL normal, 2,000 copies/pL cancer) also agreed with the ranges
determined for the two serum types in the earlier study [128]. Unlike existing detection
methods, our assay required neither RNA extraction nor target-amplification steps, leading
to simple and direct quantification of targets in serum without the need for data
normalization using external control measurements or primer optimization [207].
Furthermore, our method required only 25 pxL of unprocessed serum for each assay. By
comparison, microarray techniques that profile without target-amplification typically use 1
mL of serum to generate enough RNA extract for assay [206].
5.6 Data Analysis
Because target binding occurred predominantly on the surface of the gel particles, we
acquired fluorescence images of the top and bottom main faces of each of the tablet-shaped
particles (250 x 70 X 35 pim) for data analysis. For fluorescence integration, we used
custom-written ImageJ macros and MATLAB scripts to process and analyze images.
Following image alignment and cropping, signal intensity was summed pixel-by-pixel over
the probe region for each face of a particle, and then the two resulting values were averaged
to give a raw net value. For preliminary trials and calibration experiments, signal was also
acquired in the same manner from a group of control particles (incubated in the same
conditions but without spiked target). For each particle type, the mean signal from five of
these control particles was then subtracted from each raw net value to obtain background-
subtracted values for the integration analysis. Reported integration values in Figure 5.4
represent the mean of at least five particles. For spot-counting, a separate custom-written
MATLAB script was used to process images. This script utilized a spatial bandpass filter
and a local optimization algorithm (bpass.m and pkfnd.m, respectively; publicly available
from http://physics.georgetown.edu/matlab/code.html) to automatically locate and count the
number of RCA spots on each particle face. "Total spot count" refers to the sum from the
two faces, and spot-counting values reported in Figure 5.4 and Figure 5.5 represent the
mean of at least five particles. To estimate the limits of the spot-counting method, we
calculated the probability of two probes with captured target being so close to one another
that optical detection cannot resolve them. Assuming a resolution of X/(numerical aperture)
~ 1 im for our optical detection system, the probability that a second binding event will fall
within a distance that is not resolvable from a single existing binding event is:
Area of Non-resolvability/Area of Probe Region = [n)(1 pm/2)2]/[(70 pm)(45 im)] = 0.025%
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This indicates that it is statistically unlikely for two single-molecule reporting events to
overlap within the probe region of the particle. Although we chose 1 amol as the target
amount at which to switch from spot-counting to integration for quantification, it should be
possible to continue to spot-count for higher amounts without the risk of significant rates of
overlap. In addition, better resolution could be obtained in future work by using an
objective with a higher magnification and a greater numerical aperture.
In the discussion of reproducibility, "inter-run" refers to variability over different detection
trials (i.e., among groups of particles in different reaction volumes), while "intra-run" refers
to variability within a single detection trial (i.e., among the group of particles within one
reaction volume). For the calculation of the LOD of each target, the intra-trial standard
deviation of the 0 zmol (control) spot count was multiplied by three and added to the mean
control spot count to determine a threshold count (corresponding to the signal-to-noise ratio
of three frequently used in the field [205]). A linear regression was performed on the 0, 50,
and 100 zmol spot-count results for each target, and the target amount at which the
extrapolated curve passed through the threshold was taken to be the LOD. The LODs (in
terms of molar amount, copy number, and molar concentration) are provided in Table 5.3. It
is important to note that all incubation volumes in this study were 50 pL.
Molar Copy Molar
Amount Number Concentration
miR-141 15 zmol 9,000 copies 300 aM
miR-210 37 zmol 22,000 copies 740 aM
miR-221 31 zmol 19,000 copies 620 aM
Table 5.3: Limits of detection for RCA -based detection on gel microparticles.
We have demonstrated the RCA of a universal adapter sequence selectively ligated to
targets captured on encoded gel microparticles for the ultrasensitive, multiplexed profiling
of miRNA (Figure 5.6). We have developed an optimized protocol that allows for the highly
specific detection of sub-femtomolar miRNA target concentrations in complex media,
thereby expanding the dynamic range of the particle platform to over six orders of
magnitude (300 aM to 40 pM) and introducing the possibility of direct single-cell profiling
[204, 205]. Our ability to assay directly in minute amounts of readily-accessible biological
media could potentially be leveraged for the creation of rapid, non-invasive diagnostic tests
for the profiling of focused panels of miRNAs. The incorporation of fluorescent nucleotides
for reporting binding events could streamline future iterations of the assay and simplify
workflow [220], while the implementation of branched RCA could be explored for digital
quantification [221-224]. It should also be straightforward to adapt the RCA scheme to a
recent protein sandwich protocol developed for cytokine quantification on gel particles,
enabling the quantification of low-abundance miRNA and proteins in the same assay and
perhaps even on the same particle [175, 214].
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Figure 5.6: Schematic of the three primary length
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Chapter 6
MicroRNA Analysis in Ra w Cellular Lysa te
In the development of biological assays, improvements in detection sensitivity allow the use
of smaller sample inputs, thereby reducing the technical and physiological burden of
sample collection while also enabling more targeted analysis of specific sample subdomains
(i.e., tissue isolated from a particular region of a tumor). The ultimate goal for many
bioanalytical researchers is a flexible and scalable analysis system that is capable of
interrogating the molecular profiles of individual cells. While the miRNA detection
performance we have demonstrated in previous chapters is superior to existing direct
detection schemes, the LODs we have achieved are not suitable for the robust, multiplexed
miRNA profiling of single cells. In this chapter, we describe the development of techniques
for the miRNA analysis of individual cells and small groups of cells using hydrogel
microparticles and arrays of PDMS microwells.
6.1 Introduction
The ability to directly measure miRNA from single cells is of great interest to the biological
community. Evidence continues to mount that miRNAs are less susceptible to temporal
fluctuations than mRNAs due to their stability and association with RISCs, making them
ideal candidates for biomarkers of single-cell state and for stratifying cell populations [225,
226]. Although there are a number of technologies available for the profiling of mRNA
transcripts and proteins from individual cells, there has been a noticeable lack of progress
in adapting the same methods for the analysis of miRNAs [92, 99, 109, 227-229]. The copy
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number of a given mature miRNA sequence depends primarily on cell type and state, with
values as high as 500,000 per cell and as low as 10s per cell. Reliance on population-
averaged measurements of miRNA levels prevents the interrogation of cell-to-cell
expression heterogeneity, which can potentially be used to identify cell subtypes that
respond to external stimuli in notable ways [230]. Techniques that require large inputs of
cells also preclude the study of miRNA-mRNA correlations in rare cell types such as
circulating tumor cells and embryonic cells. MicroRNA analysis on a single-cell basis allows
for targeted profiling that cannot be skewed by the presence of other unknown or poorly
understood cell types. The ideal system for this analysis would enable the rapid
measurement of multiple miRNA levels in hundreds to thousands of cells in a single trial
without the need for cumbersome sample preparation steps, RNA extraction, or target
amplification. An optimal scheme would provide quantitative results from an input of crude
cellular lysate with an efficient "one-pot" workflow that avoids the transfer or dilution of
sample through multiple processing steps or modules.
An important consideration in transitioning from bulk to single-cell miRNA assays is the
method by which the target molecules will be isolated and conditioned for capture. Unlike
protein targets which are often actively secreted from cells, mature miRNAs are
predominantly found complexed with carrier proteins within the cell, requiring careful yet
thorough disruption of the cellular environment to facilitate binding to complementary
probes. As RNA extraction at this scale is inefficient and technically challenging, the most
practical analysis approach involves cell lysis (typically through heat shock or chemical
treatment) and direct interrogation of the crude product. Several single-cell studies of
miRNA content have been performed in this way with modified stem-loop RT-qPCR
methods, but the majority are not amenable to high-throughput processing due to the need
for manual handling and manipulation of individual cells with pulled capillaries prior to
the lysis step [140, 141, 225]. The notable exception is the microfluidic approach introduced
recently by White et aL. in which -300 cells can be analyzed in a highly-multiplexed fashion
in a single run [226]. While this work represents a leap forward in single-cell miRNA
analysis, it relies on a target amplification scheme within a relatively complex microfluidic
network that may be difficult to scale-up cost-effectively in future applications. In addition,
PCR reaction efficiency is highly sensitive to lysate concentration in the nanoliter chambers
used and thus must be closely controlled and optimized for accurate results. It should also
be noted that there has been some progress in the development of fluorescence in situ
hybridization (FISH) for miRNA detection, but the protocol for this method requires
multiple days of processing and is severely constrained in multiplexing capacity [231].
In this chapter, we present a suite of methods that moves our gel particle platform closer to
a regime in which multiple miRNA targets can be measured directly (without target
amplification) from hundreds to possibly thousands of individual cells with a simple
workflow. Our strategy focuses on localizing probe-bearing particles and cells to nanoliter-
sized PDMS wells for highly efficient capture of miRNA targets that have been liberated
from cells and carrier proteins using detergent-based chemical lysis and protein digestion.
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6.2 MicroRNA Detection in Lysate Produced from Collections of Cells
The vast majority of methods for miRNA quantification in tissue, cultured cells, blood, and
serum first require the isolation of total RNA from the sample. In the case of PCR-based
detection, this step is required to remove proteins and other entities that may interfere
with the activity of the polymerase used for reverse transcription. In direct detection
schemes that do not employ such enzymes, this purification is carried out to reduce the
complexity of the input mixture so that subsequent incubation with probe-coupled
substrates such as particles or microarrays will not lead to fouling. The ability to detect
miRNAs in crude cellular lysate without a total RNA extraction procedure greatly
simplifies workflow and allows for more direct quantification without the need to consider
extraction efficiency.
6.2.1 Buffer Optimization and Analysis of HeLa Cells
Encoded hydrogel microparticles synthesized from PEG-based monomers and
functionalized with capture probes are well-suited for direct miRNA profiling in complex
mixtures due to their high sensitivity, high specificity, and resistance to non-specific
adsorption of biological molecules. To investigate the compatibility of the particles with
crude lysate inputs, we modified our assay protocol and carried out a series of experiments
to gauge the effect of adding detergent, protease, and RNase inhibitor to our hybridization
buffer. As described in Section 2.3.9 and Section 2.3.10, we added freshly trypsinized and
washed HeLa cells to reaction tubes containing gel particles as well as various amounts of
SDS and proteinase K (PK). These additional buffer agents were employed to disrupt the
cellular membrane and to denature and digest undesirable protein content that could
potentially sequester miRNA targets.
In initial trials with particles bearing probe for let-7a, -2,000 HeLa cells were spiked into
each reaction, and a small yet consistent signal was observed in the probe region of the
particles after 90 min of lysis/target capture at 55'C in a reaction buffer of TET with 350
mM NaCl. Depending on buffer conditions, signal intensity was comparable to that
observed for synthetic let-7a spikes of -5-30 amol. Importantly, combining the lysis and
capture steps did not lead to non-specific adsorption or fouling of the gel particles. In the
concentration range of 0.5-4% SDS (w/v), it was observed that raising SDS levels (at a fixed
concentration of PK, 200 ptg/mL) led to an increase in target capture, although the
difference between 2% and 4% was only slight (Figure 6.1 A). At SDS levels greater than
4%, signal was seen to be lower than that obtained with 2% and 4% SDS. Seeking to
investigate possible benefits from heat shock, we subjected a sample to a 95'C preheat for 5
min prior to particle addition but only observed a slight increase in target capture
compared to a sample with the same amount of SDS and PK (Figure 6.1 B). This contrasts
sharply with assays in 25 ptL unprocessed serum in which a preheat step was crucial for
denaturing background proteins and for minimizing non-specific binding to the gel particles
[232]. Furthermore, it was observed that levels of PK higher than 200 ptg/mL led to loss of
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signal, presumably from the introduction of higher amounts of the glycerol-based buffer in
which the enzyme was stored (Figure 6.1 B). There seemed to be no additional benefit from
introducing RNase inhibitor to the reaction mixture, with lower signals observed for 0.2 U
(4 U/mL in final reaction mixture) and 20 U (400 U/mL) additions than for the case in
which inhibitor was not used (Figure 6.1 C). To explore the effect of blocking agent in the
washing solution used to prepare the cells for assay, we carried out a cell preparation
without BSA (normally at 0.1% (w/v) in cell wash buffer). This test resulted in a lower
signal than preparations with BSA (Figure 6.1 D), underscoring the importance of using
BSA to block tubes and pipette tips in the cell washing process. It was postulated that
failure to block led to undesirable cell adsorption and loss on tube and tip surfaces, an effect
also seen in preliminary work with cell encapsulation studies (Section 6.4).
Additional trials with 600 amol of synthetic let-7a RNA target further elucidated the effects
of adding SDS and PK. As Figure 6.2 demonstrates, there was only a small decrease in
capture and labeling efficiency when using detergent and protease at levels suggested by
the initial trials. Moreover, the increased complexity of the buffer did not affect
reproducibility, with intra-trial coefficients of variation (CVs) of only 3-4% for buffers
containing both SDS and PK. These results indicated that the lysis buffer components were
effectively washed out of the gel particles prior to the addition of T4 DNA ligase for
labeling. From these experiments, it was determined that subsequent assays would employ
2% SDS and 200 pg/mL PK to maximize target capture and labeling efficiency. With the
signal generated by the 600-amol synthetic let-7a RNA spike in 2% SDS and 200 pg/mL PK,
it was estimated that the fluorescence previously observed for the assay of 2,000 HeLa cells
in the same buffer corresponded to -30 amol of endogenous target, implying a let-7a copy
number of -9,000 per HeLa cell. This figure is in rough agreement with a previously
published estimate that quantified miRNA expression using a modified Invader assay
(4,200 per HeLa cell, Allawi et a]. [233]).
Trials with 600-amol additions of synthetic miSpike sequence into reaction mixtures
containing 2,000 HeLa cells and the optimal lysis buffer showed -105% recovery efficiency
of the spiked target when compared with the same conditions but without cell inputs. This
result indicated that the presence of the raw lysate did not significantly interfere with the
binding conditions required for sensitive miRNA detection, although it should be noted that
the miSpike was not initially sequestered in protein complexes as endogenous miRNA
targets would be.
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Figure 6.1: Parametric study of buffer and operating conditions on let-7a detection in raw HeLa
lysate. For each condition, -2,000 HeLa cells were injected into the reaction mixture prior to
incubation. (A) For a fixed concentration of proteinase K (PK), target capture increased with
increasing SDS concentration up to 4% (w/v). (B) Preheating the reaction mix and cells to 950C for 5
min prior to particle introduction provided only a small boost in signal, while raising the PK
concentration from 200 to 800 pg/mL led to a slight decrease. (C) There was no noticeable benefit
from the use of an RNase Inhibitor (RNaseOUT, Invitrogen), with signal actually decreasing at
higher levels of inhibitor. (D) The exclusion of BSA from the buffer used to dilute and wash the cells
led to lower signal, presumably due to the loss of cells from sticking to tubes and pipette tip surfaces
during manipulation. All reactions were run at 550C for 90 min with 350 mM NaCl, and particles
were labeled using the standard non -RCA ligation/reporter protocol. Each measurement represents
the mean of 4-7 particles; error bars represent standard deviation. Background measurements were
taken from particles incubated in buffer with 350 mM NaCl, 2% SDS, and 200 ,ug/mL PK without
cells.
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Figure 6.2: Effect of buffer composition on the detection
of synthetic let-7a RNA target. Particles bearing a let-
7a probe region were incubated with 600 amol of
synthetic let-7a RNA for 90 minutes at 55"C with
varying amounts of SDS and PK Particles were labeled
using the standard non -RCA ligation/reporter protocol.
Probe region fluorescence was background-subtracted,
integrated, and scaled using the let-7a fluorescence
signal for particles incubated without SDS and without
PK Each measurement represents the mean of 4-6
particles. Background measurements were taken from
particles incubated in buffer with 350 mM NaCl, 2%
SDS, and 200 ug/mL PK without target.
Throughout the lysis buffer trials, the background exhibited by "negative control" particles
(for which there was no expected target present) was seen not to vary noticeably with
changes in SDS, PK, or inhibitor. Thus,.for simplicity, the background measurements used
to analyze the experimental data in Figure 6.1 and Figure 6.2 were taken from let-7a
particles in the most frequently used lysis buffer: TET with 350 mM NaCl, 2% SDS, and
200 gg/mL PK without cells. Furthermore, a brief investigation of running the lysis/capture
step for 150 min (as opposed to the normal 90 min) yielded only a slightly higher signal,
and as a result, incubations were kept at 90 min to streamline workflow. The parametric
study presented here was conducted with a fixed cell input amount of -2,000 HeLa cells. In
future work it may be necessary to adjust detergent or protease concentration to
accommodate the lysing of more cells. The data included in this section provides a basis for
predicting how the addition of more SDS or PK will affect the target capture and labeling
processes.
6.2.2 Modifed RCA for Labeling in Lysis Buffers
While there was little difficulty in adapting the non-amplified, ligation-based labeling
approach to protocols with SDS/PK-based lysis buffers, it was found that the RCA process
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could not as easily be ported onto the new workflow designed for direct detection in lysate.
Specifically, it was observed that exposure to buffers containing SDS and PK led to
subsequent fouling of all regions of the gel particles during the use of RCA. We postulated
that this fouling arose from the non-specific clumping of the biotinylated oligonucleotides
used for labeling the long DNA concatemers. Seeking other methods of introducing
fluorophores to the concatemers, we began to use modified nucleotides in the RCA process
that were conjugated to either biotin or Alexa dye. Incorporation efficiency for modified
nucleotides depends on polymerase type, modification type, and the relative concentration
of modified and unmodified nucleotides. However, there is little known about how to
rationally design a system around these factors. As a result, reagents and conditions seen
to work in previous studies were first systematically evaluated in neat buffers (no SDS or
PK) to test compatibility with the gel particles. Initial work with the Phi29 enzyme and an
Alexa-488-labeled dUTP (ChromaTide@ Alexa Fluor@ 488-5-dUTP) at concentrations of 25-
50 ptM failed to produce signal for 4-h RCA extension times in assays spiked with 10 amol of
miRNA target. In addition, there was significant fouling of particles, even in neat buffers
not containing SDS and PK.
In the next experiment, a commercially available biotinylated nucleotide mixture (1 mM
dCTP, dGTP, dTTP, 0.84 mM dATP, 0.16 mM biotin-14-dATP with biotin attached at the 6-
position of the purine base with 14-atom spacer, New England Biolabs) was tested with the
same extension time and target amount. The addition of 5 pL of this mixture to the RCA
reaction produced less fouling than the oligonucleotide labeling method, but again, there
was no noticeable signal, even with RCA temperature adjustments (30-37'C) and the use of
DMSO (15% (v/v), incubation at 37 0C for 1 h) to denature concatemers for more efficient
labeling with SA-PE. A second attempt with this nucleotide mixture and the vendor-
recommended reaction buffer for Phi29 (with an additional 200 gg/mL BSA to reduce non-
specific binding of debris to particles) produced a low signal (-15% of that seen for
complementary oligo labeling method) for a 10-amol target spike and a 4-h RCA at 30C.
Further attempts to denature the concatemers with urea treatments for more efficient SA-
PE binding to modified nucleotides [220] yielded little improvement in signal but
eliminated nearly all remaining non-specific binding. These results suggested that
incorporation of the biotinylated nucleotides was occurring, although at a very low rate.
Seeking to increase the number of biotinylated nucleotides in each concatemer, we began to
run the RCA reaction overnight (14 h) at 30"C in our gel-customized RCA buffer. In
addition, a new nucleotide mixture was created by combining unmodified nucleotides (New
England Biolabs), biotin-14-dATP (Invitrogen), and biotin-14-dCTP (biotin attached at the
N4-position of the pyrimidine base with 14-atom linker, Invitrogen). This approach
provided two different biotinylated nucleotides for more efficient labeling. Various input
amounts of the dNTP master mix described in Section 2.3.9 were tested in the RCA
mixture, with 1 ptL providing the lowest fluorescent background while still providing
sufficient signal intensity for spot discrimination (Figure 6.3). Further tests indicated that
the post-RCA addition of 5 ptL of a urea/TET mixture (30% (v/v) 6 M urea in TET and 70%
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R50) and incubation at 37'C for 1 h greatly reduced fouling tendencies when compared with
5 pL of 6M urea treatments used previously. It was also observed that filtering the
urea/R50 mixture as well as the SDS/PK lysis buffer improved assay results by reducing
the amount of debris in the reaction volume. The final optimized protocol described in
Section 2.3.9 provided the ability to carry out RCA in complex lysis mixtures that featured
both SDS and PK, a crucial achievement for the application of this signal amplification
scheme in assays featuring crude lysate inputs. Although the intensity of the RCA spots
was not as high as that seen with the complementary oligo labeling approach, there was
still sufficient signal to discriminate individual binding events, allowing for single-molecule
reporting resolution.
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Figure 6.3: Images of probe regions of miR-141 and cel-miR-39 particles following assay in lysis
buffer containing 2% SDS, 200 pg/mL PK, 1 amol miR-141, and 0 amol cel-miR-39. The lowest
background and cleanest particles were obtained when using 1 ,uL of biotinylated dNTP master mix
and a 30% 6M urea/70% R50 treatment following RCA. Volume of bio-dNTP represents amount of
master mix added to reaction tube prior to RCA. Images in yellow boxes were taken from assays with
incubation buffers that did not contain SDS or PK Scale bar in bottom -right image is 15 pm.
6.3 Well-based Approaches for Single-cell Analysis
The development of an effective lysis buffer and a compatible high-sensitivity labeling
scheme enabled us to investigate new cell-based detection schemes that previously would
not have been possible. While earlier detection trials with the gel particles were carried out
in 50-pL reaction volumes contained within snap-top tubes, it was postulated that capture
efficiency could be greatly augmented with the lysis of cells in small volumes [102, 234].
Prior to lysis, the miRNA content within a cell is relatively concentrated, and the release of
that content into a nanoliter-scale volume would lead to a much higher effective target
concentration than would be achieved with release into a 50-pL reaction volume. We sought
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to leverage our ability to capture and lyse in a single reaction step to generate a microwell-
based "confinement assay" in which particles and cells are co-localized to nanoliter-scale
volumes for detection. This approach allows us to significantly reduce the scale of the input
required for analysis, potentially enabling the direct detection of miRNA from lysate
generated from individual cells.
Single-layer SU-8 master wafers were created at the BMRC for the production of PDMS-
based well substrates. In the confinement assay protocol, probe-laden gel particles and
target input (either cells or appropriately diluted synthetic RNA spikes) were deposited
onto the face of the PDMS slab featuring relief-generated features, at which point the wells
could be sealed off from one another by placing a glass slide on top of the PDMS (Figure 6.4
and Section 2.3.10). Particles could be inserted into wells either by (1) a gradual
settling/sifting process or, in the case of magnetically functionalized particles, by (2) using a
hand magnet to rapidly rotate and translate particles into the wells [179]. For the trials
described in this section, wetting and lysis buffers were supplemented with 1% (w/v) BSA to
minimize the undesirable adhesion of biomolecules to well surfaces. Superase-In RNase
inhibitor was also added to the deposition droplet (final concentration of 0.5 U/pL) to
prevent degradation of RNA. As discussed in Section 2.3.10 and Section 7.1, it was observed
that intense plasma treatment of the PDMS substrates (to increase substrate hydrophilicity
and thereby aid in the spread of aqueous deposition buffers) led to strong binding between
the gel particles and the PDMS surfaces, preventing the harvesting of the particles from
the microwells after assay. As a result, only mild plasma treatments were employed, a
protocol requirement which hindered the wetting process and prevented the use of the full
complement of wells on each PDMS substrate.
Table 6.1 summarizes the dimensions and volumes investigated for the confinement assay.
It was found that the particles and cells were retained with much higher efficiencies during
the mixing and sealing procedures when using the deeper set of wells (113 im in height).
To minimize the reaction volume, it was desirable to use the smallest wells possible. Wells
3a and 3b proved too small to fill efficiently with the standard 250 x 70 pim gel particles
even when using magnetic manipulation. Wells la, ib, 2a, and 2b were large enough to fill
using both particle addition methods, though the filling of the smaller 2a and 2b wells was
much less efficient with the settling process than with magnetic manipulation. It was
decided that subsequent studies would focus on well type 2b (300 x 100 x 113 [Lm, 3.4 nL),
which provided the best overall balance of particle retention, filling efficiency, and volume
characteristics.
In order to confirm that the wells were fully sealed by the application of the cover glass and
insertion into the screw-clamp hybridization chamber, an experiment was performed in
which gel particles bearing photocleavable Cy3 fluorescent groups were sealed within the
wells and then exposed to UV light to release the reporters [237]. Because the hybridization
chamber covers the wells, it was necessary to expose the wells and cleave the Cy3 groups
after the full incubation had been performed and after the glass-PDMS-glass construct had
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been removed from the chamber. As a result, the test could only provide information on the
sealing status at the end of the 90 min, 55"C incubation. Figure 6.5 demonstrates that the
cleaved fluorescent- groups were retained within the bounds of the PDMS well and thus the
wells were fully sealed by the end of the incubation.
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Figure 6.4: Workflow of well loading for confinement assay. PDMS well height was
dictated by the feature height on the corresponding master wafer. After depositing a
wetting liquid and allowing the wells to fill, particles (and cells if desired) were
deposited in a TET-based buffer without SDS or PK. For calibration experiments,
synthetic targets were diluted in lysis buffer and manually mixed into the deposited
droplet with a pipette to ensure even dispersion. For cell experiments, pure lysis
buffer was mixed into the droplet. In both cases, wells were immediately sealed with
a cover slide following manual mixing to prevent mass transport between
microwells. Pipette and hybridization chamber images adapted from [235] and [236,
respectively.
The sealing confirmation allowed us to then explore the detection performance of well-
immobilized gel particles. After depositing particles into wells, a lysis buffer containing
appropriately diluted synthetic RNA targets was manually mixed into the deposition
droplet and particles were immediately sealed and incubated at 55 0 C for 90 min (Figure 6.4
and Section 2.3.10). Next, particles were extracted from wells, deposited in R50 contained
within snap-top tubes, and labeled with the standard protocols described in Section 2.3.4
and Section 2.3.5. To estimate target amount within each well, the concentration of
synthetic target within the deposition droplet was multiplied by the well volume (3.4 nL for
well type 2b). It should be noted that this calculation neglects the volume displaced by the
hydrated gel particle and thus likely represents an overestimate of target amount (i.e.,
actual target amounts within each well were most likely lower than those quoted).
Magnetically-functionalized, shape-encoded particles bearing four distinct probe types were
used for this study to simplify particle loading and to maximize the amount of data that
could be collected in each experiment [1791. During particle synthesis, each of the probe
types was loaded into its respective 20% PEG-DA prepolymer solution at a concentration of
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250 pM, providing an eventual particle concentration of -25 pM (assuming -10%
incorporation efficiency [174, 180]). In a typical experiment, ten magnetic particles could be
loaded into type 2b wells in under 2 min using a hand magnet. Figure 6.6 illustrates the
relative dimensions of the particle and well and also demonstrates the relative signal
intensity observed for separate 500-amol spikes of each of the four target types in typical
snap-top tube experiments with 50-pL incubation volumes.
Table 6.1: Dimensions and
confinement assays.
A
volumes of microwells investigated for
B
Figure 6.5: Results of well-sealing test. (A) Brightfield image of gel particle (outlined
in yellow) in 300 X 100 X 113 pm well after incubation at 55"C for 90 min but before
cover glass had been removed. Particle was irradiated with UTV light for 5 min. (B)
Fluorescent image of gel particle 15 min after UV irradiation. The cleaved Cy3
groups have diffused away from their particle source but seem to have been retained
within the bounds of the PDMS well, indicating that wells have indeed been
effectively sealed. It should be noted that the cleaving wavelength was sufficiently
different from the fluorescence excitation wavelength to avoid photobleaching. Scale
bars are 100 um.
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Length (tm) Width (pm) Height (pm) Volume (nL)
Wel la 500 500 46 11.5
Well lb 500 500 113 28.3
Well 2a 300 100 46 1.4
Well 2b 300 100 113 3.4
Well 3a 275 80 46 1.0
Well 3b 275 80 113 2.5
A500 amol
mIR-141
500 amol
mIR-210
500 amol
mIR-221
Capture Target Ligate Adapter
Figure 6.6: Magnetic particle scheme for well-based assays. (A) Depiction of 4-probe magnetic
particle (250 x 70 x 30 pum) in PDMS micro well. Each probe region was embedded with a DNA probe
bearing a miRNA -specific region (blue) and a universal adapter region (red). (B) Fluorescence images
of magnetic particles incubated with 500 amo] of the indicated RNA target in a 50-pL reaction
volume. Scale bar in B is 30 pim.
The detection performance of gel particles in SDS/PK lysis buffers in the confinement assay
is summarized in Figure 6.7. As shown in Figure 6.7 B, fluorescent signal with the non-
amplified labeling scheme scaled with input amount for the simultaneous spike of four
different sub-attomole amounts of the four RNA targets of interest. Significantly, the
fluorescence from a 60-zmol spike of miR141 was easily distinguished without the need for
signal amplification. By comparison, the LOD for RCA-based labeling in 50-prL incubation
volumes was previously determined to be 15 zmol. A further test with the bio-dNTP RCA
scheme showed strong signal from a 50-zmol cel-miR-39 spike and faint signal from a 10-
zmol miR-210 spike that seemed to be above the background registered on the neighboring
"control" regions (Figure 6.7 C). To assess the well-to-well variation within a given trial,
250 zmol and 500 zmol of miR-141 and miR-221, respectively, were spiked into the wells,
and the fluorescence intensities of six well-immobilized particles were examined (Figure 6.7
D). Upon integration of the background-subtracted fluorescence from each probe region, the
intra-trial CVs were calculated to be 15% and 13% for the 250- and 500-zmol spikes,
respectively. This result indicated that spiked target was being evenly distributed to the
wells through the manual pipette-mixing process. For the RNA targets with the greatest
binding rates (miR-141 and cel-miR-39), it was roughly estimated from these trials that the
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confinement assay LOD was -10 zmol (-6,000 molecules) for the non-amplified scheme and
-0.5 zmol (-300 molecules) for the RCA-based scheme.
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Figure 6.7: Detection of synthetic RNA targets with magnetically functionalized gel particles (250 x
70 x 30 fpm) and the confinement assay. (A) Image of 4-probe magnetic particles after well loading
with hand magnet. (B) Fluorescence image of particle incubated within well with the indicated
target amounts and then labeled using the non -amplified scheme. (C) Fluorescence image of particle
incubated within well with the indicated target amounts and then labeled using the bio-dNTP RCA
scheme. (D) Fluorescence image and width-averaged intensity profiles for six particles incubated in
six separate wells with 500 zmol miR-221 and 250 zmol miR-141. Dotted black curve represents
mean profile. All experiments in this figure performed with type 2b wells and target capture
incubations of 90 min at 55"C in lysis buffer containing 2% SDS, 1% BSA, and 200 ,ug/mL PK. Scale
bars in A, B, C, and D are 100, 30, 30, and 25 pm, respectively.
It is important to note that the binding patterns observed on the magnetic particles with
the non-amplified labeling scheme differed slightly from those seen with earlier particle
types. This was attributed to the fact that most of the probe region interfaces border other
probe regions synthesized from 20% PEG-DA prepolymer and not from the normal 35%
PEG-DA prepolymer that was used as an inert spacer chemistry in the majority of previous
trials. This chemistry difference allows for more rapid diffusion of targets within the more
porous gel and leads to increased binding on the internal interfaces between probe regions.
Next, the suitability of this scheme for HeLa cell analysis was investigated. HeLa cells were
trypsinized, harvested, and stored at concentrations between 1 x 106 per mL and 6 x 106 per
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mL in Dulbecco's Modified Eagle's Medium (DMEM) with 10% fetal bovine serum (FBS)
prior to assay. As described in Section 2.3.10 and Figure 6.4, cells were diluted and then
deposited onto the well surface along with gel particles bearing probe for miR-21, after
which the lysis buffer was manually mixed into the deposition droplet with a pipette, the
system was immediately closed with a glass slide, and the well setup was incubated within
the hybridization chamber. Care was taken to always deposit cells and particles in solution
with 150-350 mM NaCl to ensure cell viability and to avoid swelling of gel particles. In the
event that the deposition buffer contained less than 350 mM NaCl, the lysis buffer was
adjusted such that its addition to the deposition droplet produced a final NaCl
concentration of 350 mM for efficient target capture [205]. Although the results presented
here reflect experiments in which more than two cells were loaded into each well (Figure
6.8 A and Figure 6.8 B), it was possible to dilute the cell suspension such that addition to
the well substrate produced roughly 1-2 cells in 50-75% of the microwells. This optimal
dilution was approximately 7,000 cells per mL of deposition buffer. To measure the
background associated with the target incubation step, additional "control" particles were
incubated without cells in non-agitated 50-tL reaction mixtures in snap-top tubes in the
same buffer and at the same temperature as used on the PDMS chip.
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Figure 6.8: Confinement assay with HeLa cells. (A) Image of deposition droplet containing HeLa
cells and eight encoded gel particles (250 x 70 x 30 ,um) bearing probe for miR-21. Cell density
within wells can be tuned by adjusting the concentration of cells in deposition buffer. (B) Enlarged
view of three particles co-localized with several HeLa cells within type 2b PDMS wells prior to the
introduction of lysis buffer. (C) Gel particle after target incubation and removal of glass-PDMS-
glass construct from hybridization chamber. Note that the particle has slightly contracted due to
high incubation temperature (550C) and that cells have been fully lysed. Scale bars (in yellow) in
A, B, and C are 300, 150, and 100 pm, respectively.
The absence of cells upon removal of the PDMS from the chamber indicated that complete
lysis had indeed occurred (Figure 6.8 C), and the majority of the particles were seen to be
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hydrated and intact after incubation. Upon removal from the wells and insertion into snap-
top tubes, cell-exposed particles were labeled with the non-amplified ligation scheme and
analyzed with static fluorescence imaging; control particles were processed in an identical
manner. Figure 6.9 summarizes the results obtained for miR-21 detection from small
groups of HeLa cells incubated within wells in lysis buffer at 550C for 90 min. The ability to
localize and then lyse cells within a sealed, particle-occupied well produced noticeable miR-
21 signal with inputs as small as 2-5 cells. Given an estimated copy number of 12,000
copies/cell for miR-21 in HeLa [238], this translates to approximately 40-100 zmol within
the well upon lysis. Experiments with synthetic RNA targets showed this range to be
within the limit of detection when using the non-amplified labeling scheme.
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Figure 6.9: Width -averaged fluorescence profiles of probe region of miR-21 particles in
confinement assay. Solid curves represent particles incubated within a type 2b well with
the indicated range of HeLa cells and lysis buffer. Dotted curves represent control
particles incubated without cells in 50 pL of the same lysis buffer and at the same
temperature. Yellow box over the image represents the area of analysis depicted in plots.
Cell ranges rather than absolute numbers are provided for well occupancy due to the
inability to correlate each analyzed particle's identity with original well condition. Each
quoted range reflects the minimum and maximum number of cells in particle -occupied
wells in a specific trial prior to well sealing. Particle width in image is 70 pm.
Additional HeLa cell trials were run with longer lysis/capture times (2 h and 24 h) at 37 0 C
(to prevent dehydration of the PDMS wells). Compared to the results in Figure 6.9, there
was a slight signal reduction in the 2-h trial, while the 24-h trial was largely inconclusive
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due to poor particle recovery (although wells remained hydrated throughout the long
lysis/capture step). Overall, the cell-based confinement assays demonstrated the feasibility
of directly detecting miRNA from small numbers of cells, an achievement which can be built
upon with the application of RCA as well as the development of more efficient methods for
particle and cell loading.
It should be noted that there were several limitations in the protocol that prevented the
collection of larger quantities of data. For example, roughly 50% of the well-immobilized
particles would leave the PDMS and become stuck to the top glass slide upon removal of the
slide, requiring the soft gel particles to be scraped from the glass surface and thereby
increasing the risk of particle deformation. Furthermore, for the use of non-magnetic gel
particles, loading efficiency was not as high as that observed with the four-probe magnetic
particles, and as a result, 20-40% of particles deposited onto the PDMS failed to enter wells
and were crushed upon placement of the top glass slide. In future iterations of this
procedure, it would be greatly beneficial to use only magnetic particles and to develop a
chemical treatment or blocking process that prevents particles from sticking to the top glass
slide.
6.4 Cell Encapsulation Strategies
It has previously been shown that cells can be encapsulated within hydrogel microparticles
during the SFL procedure by suspending them within the prepolymer mixtures prior to the
loading of the microfluidic synthesis device [163]. We sought to leverage this ability in order
to explore the possibility of lysing cells within a probe-laden gel region for enhanced miRNA
capture efficiency. Based on previous observations of the relative rates of reaction and
diffusion of miRNAs, it was postulated that released targets would bind to surrounding
DNA probes before diffusing out of the gel, allowing for highly efficient target capture. As
described in Section 2.3.9, the SFL procedure was modified to allow for the high-throughput
encapsulation of cultured HeLa cells within encoded gel particles. By optimizing cell
loading density, BSA concentration, and channel design, it was possible to achieve stable
synthesis at throughputs of 5 particles/s, with approximately 20-30% of particles
containing a single cell encapsulated within a probe-laden region.
In initial trials, particles incorporated with cells and probe for let-7a were harvested from
the SFL device, filtered to remove unincorporated cells, incubated for 90 min at 55 0C with a
lysis buffer (TET with 350 mM NaCl and 2% SDS), and fluorescently labeled with the non-
amplified ligation scheme. The lysis of the cells within the gel produced noticeable cavities
that could be used to determine cell position within the particles during signal analysis
(Figure 6.10 A). For cell-laden particles exposed to lysis buffer containing SDS, a relatively
strong fluorescent signal was observed in the vicinity of the cavity, typically with a semi-
circular appearance that disappeared about 10 pm from the edge of the cavity (Figure 6.10
B). This fluorescent signal was seen to be strongly retarded by the less porous gel regions
synthesized from inert monomer (35% PEG-DA) (Figure 6.10 C), suggesting that the
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labeled entities were larger than discrete miRNA targets (which would be expected to
rapidly diffuse through the gel produced from the inert monomer). Furthermore, in many
instances, the fluorescence was not symmetric about the cavity but rather exhibited a
tendency to appear towards the interior of the particle (Figure 6.10 D). Importantly, the
fluorescent signal was not observed in trials in which SDS was omitted from the incubation
buffer, indicating that the signal was being generated by the labeling of intracellular
contents that had been spilled out of the cell and not from cellular autofluorescence.
However, further tests in which particles were immobilized and lysed in gel regions bearing
no probe also exhibited fluorescence, a result which showed our signal was not being
generated by labeling of the intended target.
A B
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Figure 6.10: Gel encapsulation of HeLa cells. (A) Image of the cavity left by a single cell
within the gel particle after the lysis procedure. (B) Fluorescence image of the area
surrounding a cavity after cell lysis and ligation labeling of lysis products. In this case, the
PEG-DA gel is incorporated with DNA probe for let-7a. (C) Encoded gel particle with an
encapsulated cell that was lysed and produced a spread of fluorescently-labeled material that
was abruptly retarded by the particle's less porous 35% PEG-DA region. (D) Example of the
the tendency for cells to lyse and spill fluorescently-labeled material towards the interior of
the gel particle. Fluorescent signal on the left side of the particle is from Rh -Ac incorporated
during synthesis to serve as an orientation marker. Scale bars in A, C, and D are 50 ,um; scale
bar in B is 20pm.
To determine the source of the fluorescent signal, we performed additional experiments
that modulated the lysis buffer and labeling conditions in a knockout fashion (i.e., one
deviation from standard protocol per trial). No signal was observed when SA-PE was
omitted from the protocol, nor was signal observed when only universal adapter was
excluded in a separate trial. In a third trial, the exclusion of T4 DNA ligase produced the
previously observed levels of cell-based fluorescence. Finally, a considerable reduction in
fluorescent signal was seen when NaCl concentration within the lysis buffer was reduced
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from 350 to 250 mM. Together, these results suggested that the fluorescent signal was
arising from the salt-mediated, non-specific binding of the biotinylated universal adapter to
some entity that was being released from the cell upon lysis. Because fluorescent signal
dropped significantly near less porous regions of the gel, it was postulated that these
unknown entities were large agglomerations of proteins and possibly nucleic acids that had
not been sufficiently denatured or disrupted by the use of only SDS.
A further experiment was performed in which PK was added to the lysis buffer at 200
ptg/mL in an effort to digest undesirable protein complexes that could be soaking up the
labeling reagents. Although the addition of this reagent seemed to eliminate the majority of
the non-specific fluorescent signal when combined with an Alexa-dye-modified adapter
(rather than the biotinylated adapter), there was no conclusive proof that miRNA target
was being efficiently labeled with the ligation scheme. It is possible that the majority of the
small miRNA targets diffused out of the particle and into the bulk solution before they were
liberated from their carrier proteins. This would have prevented immediate binding with
the gel-embedded probes, leading to considerable dilution in the surrounding 50-pL reaction
volume. While the encapsulation experiments did not produce the desired detection results,
they did establish a new route to populating microwells with particles and cells. It was
clear that cells remained intact within the gel structure, and thus this should be a feasible
way of simultaneously delivering cultured cells and gel particles to the nanoliter volumes of
the confinement assay.
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Chapter 7
Outlook
The work presented in this thesis has transformed the gel particle motif into a practical
research tool that can be exploited for a variety of future studies. Although the experiments
detailed in this thesis focus on the detection of miRNA, a number of significant advances
have also recently been made with the gel particle platform in the analysis of other classes
of biological molecules, namely proteins and mRNA transcripts [175, 214, 239, 240]. The gel
particle technology has now matured to the point at which it may be truly classified as an
"enabling tool", allowing for the elucidation of biological processes that are difficult if not
impossible to probe with existing technologies. The ability to rapidly profile focused sets of
diverse biological molecules directly in complex mixtures and physiological samples with
high sensitivity and specificity offers tremendous opportunities for the development of
streamlined assays that simplify research protocols in diagnostics, drug discovery, and
personalized medicine. In addition to opening avenues to discovery-based research in the
biological sciences, this work has generated several intriguing technological leads that can
be built upon for further advances in the fields of microfluidics and molecular analysis.
At this point, I would like to acknowledge Dr. Daniel Pregibon and Dr. David Appleyard for
their contributions to this thesis. In addition to initiating the encoded hydrogel
microparticle project, Dr. Pregibon conceived the idea of the microfluidic scanner and
contributed the majority of the initial research for the ligation labeling scheme. The
achievements made in this thesis would not have been possible without his help. Dr.
Appleyard was integral in the development and testing of the detection elements of the
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microfluidic scanner. He was responsible for the laser setup utilized for scanning, as well as
the optimization of the amplification circuit used to capture signal from the PMT. Finally, I
would like to acknowledge Vincent Auyeung for supplying HeLa cells during the lysate
experiments and for providing valuable advice on interpreting the results.
7.1 High-throughput Single-cell Analysis
Although we have demonstrated the isolation of cells and gel particles in microwells for
enhanced miRNA detection applications, the experiments to date have been simple proofs of
concept that analyze only small populations of 1-10 cells per trial. To fully realize the
potential of the confinement assay, it will be necessary to develop a more robust system for
loading wells with particles and 100-1000 cells for each trial. Previous work with
microengraving suggests that PDMS-based microwells can be rapidly loaded with cells by
simple deposition/settling processes [97, 112], but the efficient delivery of two entities (cell
and particle) to each of hundreds or thousands of wells will require substantial technical
innovation. The injection of cells and particles into wells with integrated microfluidic
channels and valves remains a possibility, although the addition of such features would
greatly increase the complexity of the process [96]. Recent unpublished work by Ki Wan
Bong in the Doyle lab suggests that particles can be photolithographically synthesized in
picoliter droplets. This synthesis route provides an isolated liquid-phase reaction volume for
each particle, which if properly combined with a cell input, could offer a more high-
throughput confinement strategy. Similarly, in recent work by the Mathies group, the dual
encapsulation of cells and sensing entities in microfluidically generated agarose emulsions
has been demonstrated for PCR-based gene detection with single cells [108]. In addition,
the incorporation of a dielectric material such as polystyrene into the particles could
potentially be used to guide well loading, as shown by work with dielectrophoretic trapping
within electroactive microwell arrays [107, 241].
One alternative strategy that would avoid the challenge of delivering two entities to each
reaction volume is the photolithographic fabrication of gel particles or structures within the
sensing wells themselves. With appropriate monomer rinsing cycles and precise
registration of photomasks with either a microscope-based system or a cleanroom mask
aligner, it should be possible to synthesize well-bound gels with multiple adjacent
chemistries for small-scale multiplexing of hundreds to thousands of cells. After exposure to
lysed cells, these gels could be labeled and imaged within the wells, or a chemical treatment
could be used to detach them from the wells so they may be processed in a manner identical
to that used for the particles in previous experiments. It should also be possible to pattern a
glass containment slide with gel pads containing multiple, spatially-segregated probe types
using a flow-through patterning method like that employed in the creation of single-cell
barcode chips in the Fan and Heath labs [96, 114]. This probe-laden slide could then be
placed over the wells during incubation to capture multiple miRNA targets lysed from
individual cells. Unlike the aforementioned dual delivery strategies, these two probe-
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patterning methods ensure that every well featured in the assay contains a sensing
element, thereby greatly augmenting the efficiency of the process.
In the exploration of new techniques for particle-based single cell analysis, there are
several features of the current experimental protocol that could be altered to enhance
performance. The design detailed in Chapter 6 should be regarded as a first attempt that
was optimized only with respect to those parameters that could be easily altered within a
limited timeframe (buffer conditions, incubation conditions, and workflow). It should be
possible to improve particle/cell loading by more carefully designing the master wafer from
which PDMS molds are produced. In particular, the spacing between wells can be reduced
significantly to improve loading efficiency, and the incorporation of drainage channels to
remove excess liquid could improve sealing and assay reproducibility [112]. Perhaps the
greatest challenge that was faced in experiments with microwells was the hydrophobicity of
the PDMS surface and the accompanying difficulty in spreading aqueous buffers to utilize
as many wells as possible. Although plasma treatment of the PDMS can temporarily render
the elastomer surface hydrophilic, only small doses of treatment could be used when
depositing the gel particles, and this weak treatment only marginally improved wettability.
Future work should explore and seek to eliminate the irreversible bond between plasma-
treated PDMS and the gel microparticles through the use of surface treatments or the
inclusion of more effective blocking agents in the incubation buffer [242]. Furthermore,
there are a variety of techniques for the controlled lysis of isolated cells (i.e., optical,
electrical, acoustic, and mechanical lysis) that may prove more useful than the current
chemical lysis, which is relatively slow and causes the denaturation of cellular proteins that
may be interesting to capture in native form in future assay schemes [243].
In addition to the analysis of the lysis products of cells, it is also important to consider the
design of sensing systems that can capture and quantify the molecular species that are
secreted from intact single cells or small groups of cells. Indeed, there are many
fundamental questions regarding the mechanism and purpose of miRNA exportation from
cells, with some researchers hypothesizing that exosomal transport of these biomolecules
may constitute a significant means of genetic exchange between cells [127, 132, 133]. The
use of arrays of well-immobilized gel particles could enable focused profiling experiments on
the frequency of exportation in different cell types, and the combination of miRNA and
protein probes in a single particle type or well could potentially enable an unprecedented
study of the stoichiometry of protein and nucleic acid secretion. Such a study would provide
valuable insight into the nature of the exportation process and could even determine
whether it is a controlled process that is directed by the cell for signaling purposes or
whether it is a more random event that is used to eject cytoplasmic waste material.
Preliminary work in encapsulating cells within gel particles during SFL may also provide
useful starting points for future single-cell analysis [163]. Localizing cells to gel
microparticles embedded with probe molecules enables the delivery of only one entity to
microwells for easier confinement assays, and cell-laden particles can be produced at
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relatively high throughputs (-1 particle with an encapsulated single cell produced each
second during modified SFL procedure). Although we focused solely on encapsulation
within PEG-based gels and used the gel as a medium for lysis and capture, it should be
possible to use other materials such as agarose and gelatin methacrylate to maintain long-
term cell viability for secretion, stimulation, or proliferation studies [158, 244]. With the
proper choice of materials and handling conditions, this approach could transform the
particles into miniature culture environments that could potentially be combined through
directed self-assembly to approximate more complex biological microenvironments.
Regardless of the confinement method, the direct and high-throughput detection of
biomolecules on a single-cell level provides a range of opportunities for biological discovery.
Leveraging our experience in the detection of miRNA, mRNA, and cytokines, it should be
possible to develop novel biomolecule assays that allow for the characterization of
expression and secretion heterogeneity over hundreds or even thousands of cells in a single
trial. This type of data would be tremendously valuable in the miRNA field, where very few
comprehensive studies of single-cell expression have been conducted [225]. Perhaps the
greatest opportunity for discovery lies in the application of such profiling technologies to
rare cell types such as circulating tumor cells (CTCs) [95]. Because of the cost and technical
difficulties in isolating rare cell types, technologies that can efficiently analyze single cells
without wasting sample in processing and preparation steps will play an important role in
future studies of rare cells. Preliminary experiments with well-immobilized gel particles
suggest that it is straightforward to analyze small numbers of cells (1-10), a practice that
can sometimes be cumbersome or cost-inefficient for systems designed only to handle
hundreds or thousands of cells.
7.2 Enhanced Techniques for miRNA Analysis
The detection sensitivity achieved in this thesis has proven sufficient for the direct analysis
of miRNAs from small quantities of raw prostate-cancer-associated serum (miR-141) and
from groups of 2-10 HeLa cells (miR-21). However, in both cases, this detection has been
restricted to miRNAs with abnormally high copy numbers. As mentioned earlier, miR-141
is significantly upregulated in the serum of prostate cancer patients, while miR-21 is the
most highly expressed miRNA in HeLa cells. To improve sensitivity and achieve robust
profiling in these clinically important sample types, it will be necessary to introduce further
innovation in the design of the particles and the reporting techniques employed for target
quantification. Such advances will provide the ability to probe the expression of a greater
variety of miRNAs (i.e., upregulated and downregulated species) and will potentially
provide better precision in measurement by minimizing non-specific binding and
experimental noise.
The RCA labeling procedure has enabled the quantification of single-molecule binding
events, and thus any future attempt to augment sensitivity should focus primarily on
improving the capture efficiency of the particles. The use of an LNA-based probe has the
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potential to lower the dissociation rate of the probe-target complex, thereby lowering the
dissociation constant and improving the affinity for the intended target. Aside from altering
the design of the probe species, there is also the option of capturing all RNA species in a
sample on boronic acid polymers and then releasing the captured molecules into a smaller
volume containing probe-bearing particles. This approach is similar to the confinement
assay described in Chapter 6 in that it concentrates the target molecules for better capture
efficiency. This so-called "bait" strategy would fit well into the current workflow of the
particle system, as the hydrophobic bait molecules could potentially be integrated into one
of the "blank" regions of the gel particle by loading them into oil-based nanoemulsions that
can then be encapsulated during SFL [237]. Even more sophisticated core-shell structures
and vertically-layered particles could be achieved through the use of hydrodynamic focusing
lithography (HFL) [166]. In addition, the pseudo-selective capture and release of the RNA
diol groups by the boronic acid groups of the polymer can be reversibly triggered by simple
temperature changes that are already encountered in the current assay workflow [245].
This baiting approach could be particularly valuable in concentrating low-abundance
miRNAs from whole blood, serum, urine, and other easily accessible biological fluids [246].
Although we have aimed for direct detection without target amplification in this thesis for
reasons of simplicity, it may be beneficial in some instances to employ stem-loop RT-PCR
methods for the augmentation of target copy number. The combination of PCR and gel-
particle detection should be straightforward, particularly if the primer sequences are taken
from previously optimized and validated multiplexing setups such as the 450-plex
Megaplex reaction [142]. While this approach will require extraction of total RNA, the
enhanced sensitivity that it provides may prove useful in applications in which sample is
severely limited. Furthermore, the exquisite detection specificity imparted by the use of
stem-loop primers could be helpful in improving discrimination of closely related sequences,
such as let-7 family members and precursor/mature molecules [139]. When implemented
with optimized sets of primers, this practice of "pre-amplifying" target with PCR for
subsequent capture on immobilized capture probes can offer an unprecedented combination
of sensitivity, specificity, throughput, and flexibility. The uncoupling of the PCR method
from the traditional plate and card formats and their accompanying reading instruments
has several advantages, many of which have been leveraged by Illumina in the
development of the BeadArray technology [35, 59]. This system leverages the advantages of
bead-based arrays (high-throughput processing of samples in parallel and rapid probe-set
modification) and PCR amplification for rapid miRNA profiling in as little as 100 ng of total
RNA input. However, it should be noted that the BeadArray's use of solid glass
microcarriers limits the capture efficiency of the PCR amplicons, and the development of an
analogous strategy for our hydrogel particles is likely to yield significantly lower limits of
detection.
To streamline the assay workflow, it may be beneficial to investigate additional reporting
methods. Although RCA provides single-molecule reporting resolution, it requires several
more steps than the non-amplified scheme and can significantly extend processing time,
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particularly with the bio-dNTP labeling strategy. It may be possible to achieve similar
gains in sensitivity with a shorter workflow by using enzymatic amplification. Preliminary
experiments with the use of a standard biotinylated adapter and streptavidin-conjugated
horseradish peroxidase (SA-HRP) showed that the Amplex UltraRed substrate could be
efficiently converted into a chemiluminescent species at a rate that appeared to scale with
the input miRNA target amount (Figure 7.1). While this strategy could be easily employed
in a single-plex, well-based format for colorimetric reporting, the ability to use such
amplification in a one-pot multiplexed reaction would require a more judicious choice of
substrate. In order for the luminescence generated by the SA-HRP attached to a particular
particle to remain associated with that particle (and its code), it would be necessary to
choose a substrate that will be converted into a product that will readily partition into the
gel network [47]. With the recent creation of mesoporous hydrogel particles embedded with
oil-based nanoemulsions [158], it should be possible to soak up hydrophobic conversion
products with high efficiency for rapid fluorescent signal localization. High-sensitivity label-
free reporting methods based on nanomechanical and electronic properties have also been
developed in recent years for rapid miRNA detection [12, 145, 247], and it would be
worthwhile to investigate the utility of such strategies in the context of the gel particle
system.
10 amol miR-145 10 amol miR-1 45
100 .mo mi 45 100 *mo mi14
Figure 7.1: Fluorescence images of particles exposed to different amounts
of synthetic miR-145 target, labeled with SA-HRP, and exposed to
Amplex UltraRed substrate. Fluorescence intensity was seen to rise in
the surrounding solution and within the hydrogel as target level was
increased. It is important to note that the low porosity regions of the
particle (code and inert) seem to capture the fluorescent enzymatic
product more readily than the probe region, suggesting that chemical
composition of the particle can be tuned to localize the reporter molecule
in future iterations of this assay. Scale bar is 50,um.
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The biotinylated dNTPs used for labeling in the second generation of the RCA detection
method provide lower background signal in complex samples and mixtures containing SDS
and PK. Unfortunately, these modified dNTPs are incorporated very inefficiently and thus
require overnight extension reactions to generate enough fluorescence for spot counting.
The workflow of the assay and the intensity of the RCA spots would be improved with an
alternative modified nucleotide chemistry that is more readily incorporated into the DNA
extension by the type B Phi29 polymerase. It has recently been shown that several other
type B polymerases incorporate 5-octadiynyl dUTP and 5-octadiynyl dCTP with high
efficiency [248, 249]. Once incorporated into DNA, these alkyne-modified nucleotides can be
easily linked to azide labels with high specificity via standard click chemistry methods. By
clicking fluorescently modified azides to the DNA concatemer, it may be possible to attain
higher levels of spot fluorescence with much shorter extension times. Furthermore, this
method of labeling nucleotides in long single-stranded DNA concatemers could be employed
for more fundamental studies of DNA stretching [250, 251]. The tethered RCA product
could be stretched through the hydrogel network with an applied electric field, and its
relaxation could be monitored with fluorescence microscopy to determine the gel pore size
and other information related to the stretching mechanics.
7.3 Mixed-content Assays
As mentioned earlier, the encoded hydrogel particle platform has been adapted for the
detection of a wide range of biomolecules, including DNA [52, 174], miRNA [179, 180, 205,
232], mRNA [240], and proteins [175, 214, 239]. For the development of next-generation
assays for diagnostics and discovery, it may be valuable to profile multiple types of
molecules in a single assay and perhaps even on the same particle. These "mixed-content"
assays would enable, for example, the simultaneous measurement of miRNAs and their
putative protein targets, allowing for more efficient profiling of biological function by
compressing workflow and reducing both reagent and sample consumption [252, 253]. This
approach would also offer more direct solutions in clinical diagnostics by enabling the
profiling of more diverse biomarker panels. For instance, a single particle bearing an
antibody probe for prostate-specific antigen and a separate DNA probe for miR-141 could be
used to more robustly analyze serum samples in the study of prostate cancer. Mixed-
content work could further elucidate the correlation of protein and miRNA content in
exosomes and the relationship between miRNA, mRNA transcript, and protein expression
in a variety of biological contexts. The highly focused set of virally-encoded miRNAs is
another excellent target ensemble for the multiplexing capacity of the gel particles, and the
ability to simultaneously measure 10-50 of these targets as well as their putative viral and
cellular mRNA targets could provide insight into viral pathogenesis [123, 124].
Although there are established protocols for the sensitive detection of multiple classes of
biomolecules on the gel particles, there are several notable differences between the methods
used, particularly in the incubation temperatures and buffer conditions. It should be
possible to reconcile temperature differences by using the lowest temperature from a group
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of protocols (to avoid denaturation and/or melting of probe-target complex) and then
increasing the duration of the incubation to enable the most complete capture possible.
Specificity and sensitivity can be further adjusted by modulating salt concentration within
the incubation buffer and other factors such as probe design. We have previously shown
that aptamer species selected under dissimilar SELEX (systematic evolution of ligands by
exponential enrichment) conditions can function effectively together in a single optimized
incubation buffer [239]. It should be possible to use the same design principles distilled
from that study to formulate buffers and reporting strategies that can simultaneously
capture and label DNA, miRNA, mRNA, and proteins with high efficiency. In addition, it
should also be straightforward to adapt the RCA reporting scheme for the labeling of single-
molecule binding events of proteins and mRNAs by attaching appropriate DNA primer
sequences to the reporter antibodies and label extenders that are employed for target
quantification.
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